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SUMMARY 
The congenital skeletal and limb defects occur in 1 in 500 to 1 in 1000 
births. As the limbs were a relatively recent developmental event in 
the evolution of vertebrates, many molecular pathways controlling the 
limb/ skeletal formation were co-opted from already existing 
patterning programs. Because of this genetic pleiotropy, more than 
50% of affected individuals have associated inborn defects of other 
organs and tissues. The consequence of this relatively high frequency 
and severe, lifelong multiorgan burden is that these patients represent 
a substantial proportion of the consultations in the clinic and require a 
multidisciplinary approach, including not only medical but also 
several paramedical specialties like physiotherapists, psychologists 
and social workers. Thus, the congenital limb / skeletal defects are 
also of significant social importance.  
Since many years the vertebral limb development has served as an 
important model to study morpho- and organo-genesis. Several 
spontaneous and genetically manipulated (transgenic) animal models 
contributed to the discovery of important signalling pathways 
involved in limb and skeletal formation. In addition, as several of 
these key genetic players are involved in other developmental 
cascades, this knowledge contributed significantly to the 
understanding of the patterning of other organs and systems. The 
enormous impact of this has been the development of new medical 
branches and therapeutic approaches. 
Surprisingly, despite this importance in developmental biology and 
genetics, the genetic studies of congenital limb/ skeletal defects in 
man have been a relatively neglected topic. Therefore, by applying 
both different classical as well as new techniques, we aimed to 
increase the current knowledge regarding the causal molecular 
mechanisms involved in this group of congenital anomalies. In 
addition, we aimed to establish a systematic approach to clinical 
management and genetic analysis in order to arrive at a correct 
diagnosis. Last but not least, the consequence of this will be the 
opportunity to provide appropriate genetic counselling to affected 
individuals and their relatives and thus possibilities for more effective 
prenatal diagnosis.  
For this reason, a group of patients with clinically and genetically 
unexplained complex skeletal phenotypes were clinically well 
characterized and sub-grouped for further research utilizing classical 
“forward genetic” and “reverse genetic” methodologies.  
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In the first part of this project, we analyzed, at molecular level, two 
balanced chromosomal rearrangements (de novo translocation and 
inversion) associated with the congenital skeletal abnormalities, 
Mesomelic Skeletal Dysplasia and Klippel-Feil syndrome. The precise 
breakpoint mapping revealed neither directly disrupted known genes 
nor abnormal expression in EBV-cell lines of selected candidate genes 
within the vicinity. This absence of plausible candidate genes, which 
could explain the patients’ phenotypes, currently represents a real 
challenge. There is still the possibility that the observed chromosomal 
aberrations contribute to at least some of the observed phenotypic 
abnormalities in these individuals and that only technological 
limitations restrict our ability to prove this. Therefore, we cannot 
presently exclude or confirm with certainty the genotype/ phenotype 
relationship in the studied patients. With future application of systems 
biology approaches and new technologies, we will be able to further 
extend our studies.  
As submicroscopic copy number variations were found to be causal in 
a significant proportion of patients with unexplained congenital 
malformations, in the second part of this project, we analyzed 58 
individuals with different types of skeletal anomalies with either real-
time quantitative PCR or array CGH.  
Based on this approach, we were able to define 10q24 
microduplication/ triplication as the molecular cause of Distal Limb 
Deficiency Micrognathia Syndrome. In addition, we showed that the 
same chromosomal aberration could also be associated with 
syndromic forms of SHFM thus extending the clinical spectrum of 
SHFM3. Our findings not only confirm the existence of DLDMS but 
also contribute to the understanding of the underlying molecular 
mechanisms of this congenital limb anomaly. For the first time we 
demonstrate that the severity of the phenotype is affected by the 
increased genomic copy numbers within the SHFM3 locus supporting 
the hypothesis that an altered balance between regulatory elements 
and their target genes could explain this complex phenotype.  
Another original finding was the delineation of two new syndromes 
within the Cenani-Lenz oligosyndactyly spectrum caused by genomic 
rearrangements of the GREMLIN1-FORMIN1 locus- (1) 
Oligosyndactyly, Radio-Ulnar synostosis, Hearing loss and Renal 
defects, and (2) Cenani-Lenz-like oligosyndactyly.  There are 
corresponding animal models with a reminiscent phenotype to those 
of our patients with GREM1 and FMN1 aberrations, and future studies 
should demonstrate to what extent each of these two genes contributes 
to the observed patients’ phenotypes.  
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Finally, we re-evaluated the clinical phenotype in patients with 2q31 
deletions and precisely redefined the genotype/phenotype correlations. 
We were able to demonstrate that there is no separate SHFM5 locus 
and that only the HOXD genes are involved in the pathogenesis of the 
observed variable limb defects in individuals with 2q31 deletions. 
Furthermore, we delineated for the first time the critical loci 
responsible for the facial gestalt and skeletal abnormalities suggesting 
the existence of a clinically recognizable 2q31.1 microdeletion 
syndrome. Future characterization of the deletion size in more 
individuals with 2q31.1 deletions will allow us to determine to what 
extent a single gene could be assigned to specific facial characteristics 
or whether the delineated typical facial gestalt is a result of a 
continuous gene syndrome. 
In conclusion, based on our systematic approach to clinical selection 
and genetic analysis and by exploiting currently available classical 
and new techniques, we were able to detect causal genetic 
abnormalities in 18.5% of the studied individuals. In addition, we 
found the genetic cause of Distal Limb Deficiency Micrognathia 
Syndrome, extended the clinical phenotype of the SHFM3 spectrum 
and delineated three new syndromes- (1) Oligosyndactyly, Radio-
Ulnar synostosis, Hearing loss and Renal defects, (2) Cenani-Lenz-
like oligosyndactyly and (3) 2q31.1 microdeletion syndrome. 
 

xi 
 
SAMENVATTING 
Aangeboren afwijkingen van skelet en ledematen komen voor bij 
1/500 à 1/1000 pasgeborenen. De vorming en uitgroei van ledematen 
is een relatief recente ontwikkeling bij vertebraten. Dit verklaart 
waarom een groot aantal, reeds bestaande, moleculaire 
ontwikkelingsmechanismen hierbij werden overgenomen en 
ingeschakeld. Het is ook de uitleg voor het voorkomen van 
geassocieerde aangeboren afwijkingen bij meer dan 50 % van deze 
patiënten, en onderlijnt de noodzaak om deze groep van patiënten 
multidisciplinair te volgen. 
Sinds vele jaren is de ontwikkeling van de ledematen bij vertebraten 
een belangrijk model geweest voor onderzoek van morfogenese en 
organogenese in het algemeen, en dit onderzoek heeft geresulteerd in 
belangrijke nieuwe inzichten.  
In dit proefschrift hebben we verschillende klassieke en nieuwe 
technieken toegepast om een beter inzicht te krijgen in de moleculaire 
mechanismen van deze groep van aangeboren afwijkingen. Het 
uiteindelijke doel is een accurate klinische follow-up aan te bieden 
dankzij een correcte diagnose, die bovendien ook de mogelijkheid 
biedt voor adequate genetische counseling met de mogelijkheid van 
eventuele prenatale diagnostiek. 
Voor dit onderzoek hebben we een groep patiënten geselecteerd met 
complexe skeletale afwijkingen na een voorafgaandelijke grondige 
klinische en morfologische phenotypering. 
In het eerste deel van het proefschrift werden 2 patiënten die drager 
zijn van een zogenaamde gebalanceerde chromosomale herschikking, 
respectievelijk een translocatie en een inversie, verder moleculair 
onderzocht. Het betrof een persoon met een mesomelische 
skeletdysplasie, respectievelijk een persoon met Klippel-Feil 
syndroom. Onderzoek van de breukpunten betrokken in de 
chromosomale herschikkingen toonde geen disruptie van bekende 
genen, noch afwijkende expressie van geselecteerde genen die gelegen 
zijn in de nabijheid van de breukpunten. Verder onderzoek met 
nieuwe technologies zal hopelijk meer inzicht bijbrengen in de 
genotype/phenotype correlatie bij deze twee patiënten. 
In het tweede deel van dit proefschrift hebben we onderzoek verricht 
bij 58 personen met complexe aangeboren skeletafwijkingen met 
behulp van de zogenaamde microarray-CGH technologie. Als eersten 
konden we aantonen dat een microduplicatie/triplicatie ter hoogte van 
chromosoom 10q24 de moleculaire basis is van het zogenaamde 
“Distal Limb Deficiency-Micrognathia” syndroom. Verder onderzoek 
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toonde dat deze 10q24 duplicatie/triplicatie eveneens teruggevonden 
wordt bij patiënten met syndromische vormen van kreefthand-
kreeftvoet malformatie (SHFM3). De ernst van de lidmaatafwijking is 
bovendien gecorreleerd met de toename van het aantal genomische 
kopijen binnen deze locus. 
Een originele bijdrage is eveneens de aflijning van twee nieuwe 
syndromen binnen het zogenaamde Cenani-Lenz oligosyndactylie 
spectrum veroorzaakt door genomische herschikkingen in de 
GREMLIN1-FORMIN1 locus:  
1) Een syndroom gekenmerkt door oligosyndactylie, radio-
ulnaire synostose, gehoorverlies en nierafwijkingen; 
2) Een vorm van oligosyndactylie, gelijkend op Cenani-Lenz 
syndroom. 
Verder onderzoek is nodig om uit te maken in welke mate de GREM-
1, respectievelijk FMN1, herschikkingen verantwoordelijk zijn voor 
deze phenotypes. 
In een finaal, derde onderzoeksdeel hebben we het klinisch phenotype 
bij patiënten met een 2q31 deletie verder gepreciseerd. We hebben 
aangetoond dat er geen aparte locus voor SHFM5 (kreefthand-
kreeftvoet malformatie – syndromische vorm 5) is, en dat enkel de 
HOXD genen betrokken zijn in de pathogenese van de variabele 
lidmaat defecten bij deze patiënten. 
Verder definieerden we de kritische loci voor het typische faciale 
voorkomen en de skeletafwijkingen, die resulteren in een klinisch 
herkenbaar 2q31.1 microdeletie syndroom. Verder onderzoek is nodig 
om uit te maken of 1 gen of meerdere genen (contigu gen deletie) 
verantwoordelijk is voor het specifiek faciale phenotype. 
In conclusie, bij 18,5 % van de onderzochte patiënten vonden we 
genetische afwijkingen die causaal zijn voor de 
skelet/lidmaatafwijkingen. De genetisch moleculaire oorzaak van het 
zogenaamde “Distal Limb Deficiency-Micrognathia syndroom” werd 
gevonden, en het klinische phenotype van het “SHFM3 spectrum” 
werd verder gedefinieerd. Tenslotte werden drie nieuwe syndromen 
afgelijnd: 
1) Het “oligosyndactylie - radio-ulnaire synostose – gehoorverlies 
– nierafwijkingen” syndroom; 
2) een vorm van oligosyndactylie gelijkend op Lenz-Cenani-
syndroom en; 
3) het 2q31.1 microdeletie syndroom. 
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1. INTRODUCTION 
1.1. The complexities of skeletal biology 
The human skeleton (from the Greek word “skeletos”, dried up”) 
consists of 206 bones (126 appendicular, 74 axial and 6 ossicles), 
developing from three distinct embryonic lineages. It serves many key 
functions including mechanical support for movements, protection of 
vital organs, and a reservoir of blood and minerals. In total, two 
tissues (bone and cartilage) and three cell types  construct all skeletal 
elements during the development (chondrocytes and osteoblasts) and 
postnataly (chondrocytes, osteoblasts and osteoclasts) (Savarirayan 
and Rimoin, 2002). 
The skeleton has to fulfil a series of functions, about which we have 
little understanding in molecular terms, but which are of critical 
importance as they are often affected in common degenerative 
diseases. Among these functions are the molecular mechanisms 
determining the extent of longitudinal growth, the spatial restriction of 
extracellular matrix mineralization to bone, and the maintenance of a 
constant bone mass. These properties raise additional questions about 
the molecular control of the allocation of specific cell lineages and the 
determination of the final location and shape of the different skeletal 
bones. 
The remarkably similar distribution of skeletal elements in more than 
220 locations in the human and mouse body (to some extent also in 
the chick) and the significant functional conservation of genes 
involved in the skeletal development and physiology explain why our 
ability to generate genetically modified animal models has so 
dramatically improved the present knowledge about skeletal genetics. 
Probably there is no other organ in the vertebrate biology that has 
benefited so much from the study of mouse and chick mutants. In 
addition, the molecular understanding of the skeletal physiology has 
increased considerably by analyzing the skeletal cells themselves and 
their interactions with hormones and the nervous system (Karsenty, 
2003; Niswander, 2003).  
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1.2. Skeletal development (skeletogenesis) 
The vertebrate skeleton derives from three distinct embryonic lineages 
(Figure 1). Undifferentiated descendants of these lineages migrate 
and/or proliferate to sites in the embryo where skeletal elements will  
 
Figure 1. Developmental processes involved in the skeletal patterning and bone 
formation (modified from Olsen et al., 2000). 
 
develop. The location of the initial skeletal formation will determine 
which one of these three mesenchymal cell-lineage contributes to 
particular bones and cartilage of the future skeleton. Cranial neural 
crest cells migrate from the branchial arches to the craniofacial 
skeleton, the axial skeleton derives from the paraxial mesoderm 
(somites), and the limb skeleton is the product of lateral plate 
mesodermal cells. Later on several morphogenic transformations will 
occur to form the mature skeleton, called skeletogenesis. In general, 
the skeletal morphogenesis can be divided into two major phases. 
During the first phase, following the pattern formation of the general 
body plan (trunk, head and appendices), characteristic mesenchymal 
condensations of high cell density will be formed. These 
condensations outline the pattern of the future bones, referred to as 
3 
skeletal patterning. This morphogenesis is under the control of several 
known major signalling pathways such as Wnts, Hedgehogs, Bmps, 
Fgfs and Notch/Delta. Precisely adjusted cell fate determination, 
proliferation and differentiation/ maturation will follow these early 
patterning events. As a result, a common progenitor cell 
(osteochondral progenitor) within the mesenchymal condensation will 
give rise to precursors of both the cartilage (chondrocytes) and bone 
(osteoblasts) cells. Subsequent vascular invasion will facilitate the last 
phase of the skeletogenesis, namely the bone formation. In some 
regions of the craniofacial skeleton and the clavicle, the mesenchymal 
cell condensations are directly transformed in bone forming 
osteoblasts (intramembranous ossification). However, in the 
remaining majority of the skeleton, a chondrocyte differentiation leads 
to the creation of a framework of cartilage models (anlagen) of future 
bones, as in the limbs. These anlagen, following the progressing 
vascularisation, will be replaced by bone and bone marrow 
(endochondral ossification). Finally, skeletal growth and remodelling 
after birth will lead to a dynamic adaptation of the skeleton to its 
functions as a body scaffold providing and supporting movements, 
protecting internal organs, housing haematopoiesis, and serving as an 
integral part of the endocrine system. These cascades of pre- and post-
patterning events are under a tight genetic control. Often signalling 
pathways and transcription factors are shared between the two major 
phases of the skeletogenesis (pattern formation and organogenesis) but 
in a different context controlling the cell fate determination, 
proliferation and maturation. Thus, abnormalities of these 
developmental programs give rise to a cascade of disturbances in the 
patterning, growth and maintenance of skeletal components and 
functions. The result is a variety of skeletal anomalies, in particular 
skeletal dysplasias/dysostoses and arthropathies, that collectively 
represent a significant proportion of the cases presenting to medical 
specialists (Olsen et al., 2000; Karsenty et al., 2009). 
Mutations of early patterning genes, which regulate the 
skeletogenesis, cause disorders called dysostoses (Figure 1). These are 
most frequently cell-to-cell signalling molecules and transcription 
factors regulating cell migration, proliferation and fate determination 
events. The disturbed gene function(s) affect(s) only specific skeletal 
elements, whilst the rest of the bones may remain unaffected. A 
primary target of the abrogated morphogenesis could be all three 
major divisions of the vertebrate skeleton: craniofacial, axial, and 
appendicular. However, genes/pathways active during the skeletal 
patterning are also involved in other morphogenic/ organogenic events 
Introduction 
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so that, when mutated, the resulting skeletal defects are part of (a) 
syndrome(s) which may include anomalies of non-skeletal tissues. 
This phenotypic phenomenon is known as pleiotropy and studying 
different forms of dysostoses has helped to obtain important insights 
not only into skeletogenesis but also into other developmental 
processes. 
In contrast, mutations in genes that are involved mainly in  
organogenesis cause disorders called osteochondrodysplasias (Figure 
1). In this group, the development and growth of most skeletal 
elements are affected in a generalized fashion. In addition, the 
cartilage and bone formation includes the synthesis of specialized 
extracellular matrices, which also play a crucial role in the developing 
bones. This is illustrated by a large number of skeletal dysplasias 
resulting from mutations in matrix molecules (collagen types I, II, IX, 
X, XI, perlecan, aggrecan) (Olsen et al, 2000; Hermanns and Lee, 
2001; Yang and Karseny, 2002; Newman and Wallis, 2003; 
Niswander, 2003; Zelzer and Olsen, 2003; Karsenty et al., 2009).  
Finally, many genes play an important role in both the skeletal 
morphogenesis (patterning) and organogenesis (cartilage and bone 
formation) and as a consequence some inherited bone disorders can 
display features of both- dysostoses and chondrodysplasias. A good 
example is Cleidocranial dysplasia (MIM 119600) caused by RUNX2 
mutations. 
The present knowledge about the molecular and cellular basis of 
skeletal development is largely the result of experimental animal 
studies and investigations of inherited human bone disorders. 
Transgenic chick/ mouse models and more recently zebrafish mutants 
helped to explore correlations between specific embryological events 
and gene functions. This basic knowledge has supported further the 
research of human disorders with abnormal skeletal development and 
resulted in the identification of novel genes and pathways involved in 
skeletogenesis (patterning, chondrogenesis and bone formation), and 
deepened our understanding of previously characterized molecular 
mechanisms (Olsen et al., 2000; Karsenty et al., 2009). 
 
1.2.1. Molecular embryology of the craniofacial skeletal 
patterning 
Neural crest cells from the branchial arches mainly contribute to the 
craniofacial skeletal patterning under the tight spatio-temporal control 
of signals between the cells of the neural crest itself and epithelial 
cells of the surface ectoderm, neural ectoderm or the endoderm. FGF 
5 
signalling from the ventral forebrain and pharyngeal endoderm will 
pattern the pharyngeal skeleton. Later, surface ectoderm FGFs will be 
required for the frontonasal skeletal pattering. Recent studies 
demonstrate that BMPs also contribute to the last process (see Rice 
and Rice, 2008; Yang, 2009).  
1.2.2. Molecular embryology of the axial skeleton patterning 
The axial skeletal patterning is a result of morphogenetic events 
leading to segmentation of the paraxial presomitic mesoderm (PSM) 
and formation of epithelial blocks of segmented mesoderm (somites) 
on both sides of the neural tube, and the underlying notochord. They 
form at regular intervals under the control of oscillatory waves of 
signals in an anterior-to-posterior direction and synchronized left-right 
symmetry. Definitive patterning of the future vertebrae is formed 
following a process of re-segmentation and subsequent anterior-
posterior fusion of two consecutive somite compartments. The 
formation of morphological boundaries finally separates these 
epithelial somites from the PSM.  
Soon after their patterning, the somites subdivide into the ventral 
sclerotome and dorsal dermomyotome, precursors of the future 
vertebrae, ribs, sternum, and skeletal muscles, respectively. Shh, 
produced in the notochord and the floor plate of the neural tube, 
determines the sclerotome formation. These sclerotome cells express a 
high level of Pax1. Wnt pathway signals coming from the dorsal 
neural tube inhibit Shh, which in turn inhibits sclerotome formation in 
the dorsal part of the PSM, and thus induces the development of 
dermomyotome, which expresses Pax3. 
Over the last twenty years a series of experimental studies exploring 
chick, mouse and zebrafish animal models have provided growing 
information about the molecular content of the oscillatory mechanism 
controlling the somitogenesis. This process, called the segmentation 
clock, triggers a cyclic expression of 50 to 100 genes, most of which 
are components of Notch, canonical Wnt and Fgf signalling pathways. 
This results in a specific pattern of periodic Mesp2 expression and 
thus subsequently defines the ultimate rostro-caudal specification of 
the future vertebrae. 
The Notch signalling pathway mediates short-range cell-to-cell 
interactions activating the Notch receptor by binding to a ligand (Delta 
or Jagged) of a neighbouring cell. This process is modulated by 
glycosylation, e.g. glycotransferases such as Fringe, which can 
preferentially favour an interaction with Delta. Many cyclic genes like 
Hes family members (Hes7), Lfng, Delta and Jagged are downstream 
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Notch targets. Interestingly, downstream genes in the long-range 
Wnt/beta-catenin canonical signalling pathway (Wnt3a, Axin2, Nkd1 
and Ripply2) oscillate out of phase with the Notch components. 
Finally, by creating an opposing rostro-to-caudal PSM expression 
gradient, Fgf8/Wnt3a and RA/Raldh2 define the proper localization of 
the determination front, the place where the competent PSM cells 
undergo segmentation. Crosstalk at several levels between all these 
major players allows a fine tuning of the somitogenesis and a correct 
axial skeleton patterning. 
Mutations in genes involved in the segmentation clock cause an 
abnormal axial skeletal patterning in animal models. Currently, only 
five of them have been associated with congenital vertebral 
malformations in humans - JAGGED1 (Alagille syndrome, MIM 
118450), NOTCH 2 (Alagille syndrome, MIM 118450), DLL3 (SCD, 
MIM 277300), MESP2 (SCD, MIM 277300) and LFNG (SCD, MIM 
277300). However, the genetic defects in a few MCA syndromes with 
vertebral involvement have also been identified, suggesting their 
involvement in the segmentation of vertebrae: GDF6 (Klippel-Feil, 
MIM 148900), COG1 (CCMS-like, MIM 117650), HOXD13 
(VATER/VACTERL, MIM 192350), CHD7 (CHARGE syndrome, 
MIM 214800), FLNB (Atelosteogenesis III, MIM 108721; Larsen 
syndrome, MIM 150250; Spondylocarpotarsal synostosis, MIM 
272460), SOX9 (Campomelic dysplasia, MIM211870), HLXB9 
(Currarino syndrome, MIM 176450), ACVR1 (Fibrodysplasia 
ossificans progressiva, MIM 135100), RECQL4 (Rapadilino 
syndrome, MIM 266280), ROR2 (Robinow syndrome, MIM 268310), 
NEMO (Incontinentia pigmenti, MIM 308300), MKKS (Kaufman-
McKusick syndrome, MIM 236700), HSPG2 (Silverman syndrome, 
MIM 224410) and GPC3 (Simpson-Golabi-Behmel syndrome, MIM 
312870). Further research is needed to elucidate the importance of 
these genes for the axial skeleton patterning (Shifley and Cole, 2007; 
Dequeant and Pourquie, 2008; Giampietro et al., 2009; Yang, 2009). 
 
1.2.3. Molecular embryology of limb patterning 
The limb patterning proceeds along three axes during the embryonic 
development in vertebrates: proximal-distal (PD) starting from the 
shoulders and ending at the digit tips, anterior-posterior (AP) from the 
first to the little (fifth) digits, and dorsal-ventral (DV) from the back of 
the hands/ feet to the palms/ soles. As a result, the three limb segments 
are formed: (1) the stylopod that contains the humerus and femur, (2) 
the zeugopod in the middle containing the radius and ulna or tibia and 
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fibula, and (3) the autopod at the end composed of carpal/ tarsal, 
metacarpal/ metatarsal bones and fingers/ toes. Any one of these limb 
compartments has a unique tri-dimensional structure distinguishing it 
from all the other limb components. This specific pattern is under the 
tight control of spatio-temporally synchronized and simultaneously 
orchestrated signals of three important centres derived from the flank 
mesenchyme early limb primordium called the limb bud: (1) the 
Apical Ectodermal Ridge (AER), (2) the Zone of Polarizing Activity 
(ZPA) and (3) the non-AER ectoderm (Mariani and Martin, 2003; 
Niswander, 2003; Tickle, 2006)  
The first morphological indication for limb development is a rapidly 
growing bulge in the lateral body wall at the positions where future 
upper and lower limbs will emerge. This early limb bud is composed 
of proliferating mesenchymal cells from the lateral plate mesoderm 
covered by ectoderm. The part of the body flank where it appears is 
called the “limb field”. In humans this occurs at days 27 and 28 for the 
upper and lower limbs, respectively (Nissim and Tabin, 2004). Several 
data indirectly suggest that HOX genes expressed in the intermediate 
mesoderm probably mark the exact position of the limb field 
(Stephens and McNulty, 1981; Kessel and Gruss, 1990, 1991; Burke 
et al., 1995; Rancourt et al., 1995; Cohn et al., 1997) 
Soon after the initial budding, an epithelial rim at the distal border of 
the limb bud is formed, the Apical Ectodermal Ridge (AER). It is 
covered with overlying periderm and extends from anterior to 
posterior separating the limb bud into dorsal and ventral parts. 
Currently, there are no clear data about the molecular mechanisms that 
initiate the limb bud formation (Fernandez-Teran and Ros, 2008; 
Zeller et al., 2009). Ffgs and Wnt ligands can induce ectopic limb 
development (Cohn et al., 1995; Kawakami et al., 2001). A 
hypothesis suggests that Wnts induce Fgf10 mesenchymal expression. 
Later, Fgf10, with the support of Bmp4, will prompt the AER 
establishment by the initiation of Fgf8 expression in prospective AER 
progenitors and creation of a growth-promoting mesenchymal-
ectodermal (m-e) feedback-loop between Fgf8 (produced by the AER-
progenitors) and the mesenchymal Fgf10 (Ohuchi et al., 1997; Sekine 
et al., 1999; Agarwal et al., 2003; Benazet et al., 2009). The major 
AER function is to promote the linear PD outgrowth and patterning by 
keeping the most distal underlying mesenchyme in a proliferative and 
undifferentiated state. This instructive role for PD pattering is 
mediated by the production of five Fgfs: Ffg8, Ffg4, Ffg2, Ffg9 and 
Ffg17. After the AER specification, only Ffg8 expression is initially 
observed, equally distributed from anterior to posterior. Fgf4, Fgf9 
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and Fgf17 are later activated in the posterior AER part and 
subsequently expand in an anterior direction during the progression of 
the limb development. It was demonstrated that the AER-Fgfs are 
essential for the limb bud development (Lewandoski et al., 2000; Sun 
et al., 2002; Mariani et al., 2008). They are also capable of inducing 
distal cell identity by activation of Hoxa11 and Hoxa13. This indicates 
the presence of an Fgf dependent distal fate specification of cells 
giving rise to the zeugopod and autopod. It was believed that these 
AER-Fgf morphogenic activities are a result of direct Fgf antagonism 
with RA signalling from the most proximal limb bud mesechyme 
(Mercader et al., 2000). As a result, the RA induced Meis1 and Meis2 
expression remains restricted within the proximal territory of the 
future stylopod (Captevila et al., 1999; Mercader et al., 2000; 
Niederreither et al., 2002). However, recent genetic studies suggest 
that the AER-Fgfs determine the PD limb axis early in the limb 
development and the specified progenitor pools progressively expand 
during the later phases of the limb patterning (Dudley et al., 2002; 
Galloway et al., 2009). In addition, ectodermal Wnt signals interact 
and support the AER-Fgfs to keep the most distal mesenchyme in an 
undifferentiated, proliferative state (ten Berge et al., 2008). Beyond 
the range of these proliferative signals, the mesenchymal cells delay 
their proliferation, start to express Sox9 and initiate production of 
cartilage anlagen of the future bones (Hill et al., 2005).   
Classical grafting experiments led to the detection of a limb organizer 
located in the posterior limb bud mesenchyme - the Zone of Polarizing 
Activity (ZPA) (Hamburger, 1938; Tickle et al., 1975; 1981). Its 
function is to define the AP limb axis by instructing limb bud 
mesodermal cells of their final fate depending on to their AP position. 
The classical Wolpert hypothesis was that it is done by establishment 
of an AP gradient of a hypothetical ZPA morphogen within the limb 
bud (Wolpert, 1969). Later studies demonstrated that ZPA derived 
Shh signalling is both necessary and sufficient to maintain these ZPA 
functions (Riddle et al., 1993; Chiang et al., 2001; Kraus et al., 2001). 
The initiation and position of an Shh expressing domain at the 
posterior limb bud margin is under the control of many transcription 
factors including dHand, 5’-Hox, Tbx, Alx4, Twist, Gli3 and Fgf8 
genes as well as RA signalling from the flank (Wang et al., 2000; 
Niederreither et al., 2002; te Welscher et al., 2002a; Rallis et al., 
2005; Capellini et al., 2006; Tarchini et al., 2006; Gonzales et al., 
2007; Montavon et al., 2008). In the so-called pre-Shh AP patterning, 
Gli3R and Alx4 establish the anterior territory by restricting the dHand 
and 5’-Hox expression to the posterior limb (te Welscher et al., 
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2002a). This in turn will activate Shh. In agreement with this model, it 
was demonstrated that both dHand and 5’-Hox directly bind to limb 
specific Shh cis-regulatory sequences (Capellini et al., 2006). The 
dHand activity in the posterior region is antagonized by Twist1 via 
production of Twist1-dHand heterodimers. Activated posterior Shh 
signalling inhibits the constitutive processing of Gli3 to its repressor 
form (Gli3R). The full-length activator Gli3 form acts as 
transcriptional Shh activator. As a result the high Gli3R anterior and 
high Gli3A posterior expression is consolidated, thus restricting 
Hand2, 5’-Hox and respectively Shh to the posterior limb bud (Wang 
et al., 2000; Litingtung et al., 2002; te Welscher et al., 2002b). In 
addition, Shh establishes an AP concentration gradient by cholesterol 
promoted diffusion (Li et al. 2006). The digit AP identity is therefore 
patterned by both the spatial gradient and the temporal duration of the 
Shh morphogenic activity. There is experimental evidence that digit 
two and part of digit three depend on long-range Shh signalling, 
whereas the posterior part of the third and the other remaining digits 
derive from Shh-expressing cell descendants. Thus, the last digit is 
being exposed for the longest time to the Shh activity (Ahn and 
Joyner, 2004; Harfe et al., 2004; Scherz et al., 2007). Only digit one 
does not require Shh signalling. Its development is under the control 
of other transcription factors such as Sall4, Tbx5 and Hox genes 
(Koshiba-Takeuchi et al., 2006; Montavon et al., 2008). This gradual 
duration of Shh expression most likely provides cells with a temporal 
memory contributing to the determination of their fate and later digit 
identification. Therefore this Shh dependant digit specification is 
mostly linked to the Shh promoted limb bud mesenchyme 
proliferation (Towers et al., 2008). Interestingly, more recent studies 
indicate that in fact the Shh promoted digit identities are defined very 
early in the limb development and Shh is later required for 
proliferation of the determined progenitors in a temporally uncoupled 
manner (Zhu et al., 2008). In addition, it is possible that part of the 
Shh actions are the indirect result of Shh activated downstream 
targets/signals such as BMPs (Bmp2), Gli1 and Ptch1. Currently, 
despite the absolute Shh requirement for AP patterning of the limbs, 
there is no direct prove that the Shh gradient also patterns the limb 
skeleton (Zeller et al., 2009). 
The crosstalk between the ZPA and the AER was found to be crucial 
in the complex process of limb formation. Key components of m-e 
interaction are Shh, limb specific FGFs, BMPs and BMP antagonists 
like Grem1 (Zuniga et al., 1999; Scherz et al., 2004). The study of 
targeted mutations of limb specific FGF and BMP/ BMP antagonist 
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genes revealed the existence of self regulatory loops controlling the 
appropriate initiation and termination of m-e signalling in the 
coordination of limb development (Khokha et al., 2003; Mariani et al., 
2008; Verheyden and Sun, 2008; Benazet et al., 2009). In addition, the 
correct spatio-temporal expression of these limb morphogens depends 
on regulatory sequences surrounding the gene landscape in the 
vicinity (Zuniga et al., 2004; Zeller and Zuniga, 2007).  
Another aspect of the m-e crosstalk is the establishment of DV limb 
polarity. An important signalling centre in this process is the non-AER 
limb ectoderm. Wnt and Bmp signals are key components in the 
ventralization of both the ectoderm and the mesoderm (Wang et al., 
2004). Thus, the dorsal ectoderm expressed Wnt7a activates 
mesodermal Lmx1b expression, which in turn is sufficient to pre-
pattern dorsal identity of all components of the developing limbs (Parr 
and McMahon, 1995; Riddle et al., 1995; Vogel et al., 1995; Chen et 
al., 1997, Loomis et al., 1998). En-1 restricts the Wnt7a activity to the 
dorsal ectoderm and thus functions as a ventralizing factor (Loomis et 
al., 1996; Logan et al., 1997). Upstream of En-1, Bmp signalling is 
also required for the early limb bud ventralization. It is mediated by 
Bmp2, Bmp4, Bmp7, BmpRIA, Msx1 and Msx2 to activate the En-1 
ventral expression. There are data that the Bmps may also have an En-
1 independent ventralizing effect. Finally, Wnt7a in the dorsal 
ectoderm directly regulates the Shh expression within the ZPA (Wang 
et al., 2004). 
The upper and lower limbs share common morphogenic events and 
morphological regulation during their development. However, there is 
also an obvious need for functional and corresponding morphogenic 
difference between them. Tbx4 and Tbx5 genes, both T-box 
transcription factors, were found to be specifically expressed in the 
lower and upper limbs, respectively (Gibson-Brown et al., 1996; 
1998). Their expression in the corresponding limb field is present 
prior to the limb bud initiation (Isaak et al., 1998; Logan et al., 1998). 
In addition, there is a synchronized interaction between them, as Tbx5 
down-regulates Tbx4 in the forelimbs. Conversely, Pitx1, another gene 
specifically expressed only in the lower limbs, up-regulates the Tbx4 
expression levels in the hind limbs. Thus, they seem to be limb 
specific regulators (Rodriguez-Esteban et al., 1999; Takeuchi et al., 
1999; Logan and Tabin, 1999). Other parallel pathways may also be 
involved in the control of the upper/ lower limb identities. It is 
possible that Hox genes participate in this process as in general they 
are important for the AP body patterning (Nissim and Tabin, 2004). 
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Over the years, a few models were proposed to explain separate 
aspects of the complex limb development (reviewed by Tabin and 
Wolpert, 2007; Towers and Tickle, 2009; Zeller et al., 2009). 
However, there is strong evidence for an obviously integrated, three-
dimensional function of all currently known pathways in the 
orchestration of the limb patterning. In an attempt to collate all the 
available knowledge, Zeller et al. (2009) suggested an integrative 
patterning design for the limb morpho- and organogenesis. During the 
first phase of limb bud initiation, opposing mesenchymal signals of 
Gli3, Hand2, 5’-Hox, Bmps, Fgfs and RA pre-pattern the nascent limb 
bud and support the establishment of the two major signalling centres 
in the developing limb - the AER and the ZPA. Activation of the 
AER-Fgf and ZPA-Shh signalling creates morphogen gradients across 
the limb bud and leads to early specification of the two main limb 
axes - PD and AP. At this stage cell identities are not yet determined. 
How the cell fates are specified is not yet known but transcriptional 
regulators Hoxa, Hoxd and Tbx genes are probably involved. At that 
time the Bmp activity decreases and the e-m Shh-Grem1-Fgf feedback 
loop is initiated to promote subsequent proliferation, determination 
and differentiation. The expansion of the progenitor cell pools is under 
the control of the self-terminating Shh-Grem1-Fgf signalling, 
ectodermal Wnts (e-Wnts) and persistent low levels of Bmps. At the 
time when core mesenchymal cells escape the control of the above 
signals due to the progressing proliferation, they start to express Sox9 
and undergo chondrogenic differentiation. Proximal to this 
differentiation front, the PD and AP identities are completely 
determined thus allowing the initiation of the differentiation process. 
Therefore, the differentiation of digit patterns occurs the last. At the 
end of this phase, the Bmp activity again increases as a consequence 
of Shh-Grem1-Fgf self-termination. The digit identities are later 
determined with the involvement of Bmp, 5’-Hox and Sall genes. No 
specific regulators of individual digits are currently known (Zeller et 
al., 2009).  
1.2.4. Molecular embryology of bone formation 
As described above, early patterning mechanisms define the places 
were future bones will be formed within mesenchymal condensation. 
Although the intramembranous ossification is different than the 
endochondral, the participating osteoblasts in these two processes 
share morphological identity. This suggests common pathways and 
regulation of the osteochondral progenitors in these two mechanisms 
of bone formation. Sox9 and Runx2 transcription factors are the first 
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currently known molecular markers that are required for chondrocyte 
and osteoblast cell fate determination. The initiation of their 
expression is coordinated thus that the Sox9 activity precedes that of 
Runx2. The Sox9 effects are further enhanced by two other members 
of the Sox family, Sox5 and Sox6 (Lefebvre et al., 1998; Akiyama et 
al., 2002). In addition to the Sox9 and Runx2 function, Wnt, Ihh, Bmp 
and Fgf signalling pathways are also incorporated within the process 
of cartilage and bone formation. Thus, the enhanced Wnt signalling 
results in an increased bone formation and Runx2 expression by 
decreasing the Sox9 levels and the chondrogenic differentiation 
potential of the bi-potential osteochondral progenitors. Vice versa, a 
preferential osteoblast differentiation follows the decreased Wnt 
signalling in both membranous and endochondral ossification. 
Ihh activates Runx2 and osteoblast differentiation only during the 
endochondral bone formation but does not affect the fate of the 
mesenchymal progenitor cells. This Ihh function is mediated by two 
transmembrane proteins, Ptch1 and Smo, which in turn trigger a 
cascade of events targeting many genes like Gli1 and Hip1. It is not 
yet clear how the Runx2 expression is controlled during the 
intramembranous bone formation. It is possible that the Ihh function 
there is replaced by Shh. 
The Bmp signalling promotes the osteochondral progenitor 
differentiation to both chondrocytes and osteoblasts via two currently 
known pathways. The first one (canonical Smad-mediated) exploits 
Bmp type II and I receptors (BmpRII, BmpRIA, BmpRIB and Alk2) 
to activate Bmp-receptor-regulated Smads (R-Smads) Smad1, Smad2 
and Smad8. Subsequently these R-Smads bind Smad4 to enter the 
nucleus and to reach and affect the expression of target genes. In the 
second (non-canonical) pathway, Bmps activate consecutively Tak1 
and p38 Mapks. In addition, the Bmp chondro- and osteogenic 
functions are modulated by inhibitors Noggin, Chording and Grem1.  
The importance of the Fgf ligands and their receptors in osteogenesis 
was elucidated by the discovery that several chondrodysplasias/ 
dysostoses in humans are caused by mutations in FGFR1, FGFR2 and 
FGFR3. Studying the molecular mechanisms underlying the disturbed 
skeletal development in patients with achondro-/hypochondroplasia/ 
thanatophoric dysplasia (MIM 100800/ MIM 146000/ MIM 187600 
and MIM 186601) and corresponding animal models revealed that 
FGFR3 regulates the chondrocyte proliferation and differentiation. 
There are no data how Fgfs control the mesenchymal condensation 
and chondrocyte differentiation. However, there is no doubt about 
their importance in this process, at least during the intramembranous 
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bone formation, since FGFR1, FGFR2 and FGFR3 mutations cause 
craniosynostoses (Apert syndrome, MIM 101200; Beare-Stevenson 
cutis gyrate, MIM 123790; Crouzon syndrome, MIM 123500; Pfeiffer 
syndrome MIM 101600; Jackson-Weiss syndrome MIM 123150; 
Muenke syndrome MIM 602849; Crouzon-dermo-skeletal syndrome, 
MIM 134934; Osteoglophonic dysplasia, MIM 166250). Depending 
on the cell, the Fgfs have a dual function concerning the osteoblast 
proliferation and differentiation. By activating Sox2 and thus down-
regulating Wnt/ beta-catenin activity, they inhibit the osteoblast 
differentiation. The opposite effect is via promoting Bmp2 and 
suppressing Noggin (Olsen et al., 2000; Wagner and Karsenty, 2001; 
Cohen, 2006; Karsenty, 2008; Karsenty et al., 2009; Yang, 2009).  
 
1.2.4.1. Chondrogenesis 
During the endochondral bone formation, the chondrocytes are the 
first specific skeletal cell type that appear. They provide multiple 
functions: (1) being an important player in the process of ossification; 
(2) allowing and participating in the longitudinal skeletal growth; and 
(3) forming joints to enable the mobility of the skeleton.  
During the early phase of chondrogenesis, mesenchymal 
osteochondral progenitors within the previously formed mesenchymal 
condensations start to produce an extracellular matrix (ECM) made of 
ColI. The Bmps influence this first step of chondrogenesis by 
controlling the compaction of mesenchymal cells and thus the process 
leading to cell cohesion in condensations (Barna and Niswander, 
2007). Subsequently, at the sites of endochondral bone formation, 
progenitor cells differentiate into round chondrocytes producing ColII, 
ColXI and aggrecan under the control of Sox9 (Lefebvre et al., 1997; 
Bi et al., 1999; Akiyama et al., 2002; Barna and Niswander, 2007). 
The aggrecan is a proteoglycan protecting the collagen fibrils and 
providing mechanical resistance. In addition, together with other 
proteoglycans it is involved in the Fgf and Shh/ Ihh signalling (Ornitz, 
2000; Koziel et al., 2004; Settembre et al., 2008). The peripheral 
mesenchymal cells do not differentiate into chondrocytes. They 
continue to synthesize ColI and form a structure called the 
perichondrium (Karsenty et al., 2009).  
Later, the chondrocytes located in the centre of the mesenchymal 
condensations stop to proliferate and form the prehypertrophic 
chondrocytes that still produce ColII. These cells express Fgfr3 to 
suppress the chondrocyte proliferation via STAT1/ p21 cell cycle 
inhibition (Peters et al., 1992; Colvin et al., 1996; Deng et al., 1996; 
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Naski et al., 1996; Su et al., 1997; Sahni et al., 1999). Favourite Fgfr3 
chondrocyte ligands are Fgf9 and Fgf18. Fgf18 is produced in the 
perichondrium under the control of Runx2 (Liu et al., 2002; 
Ohbayashi et al., 2002; Hinoi et al., 2006). The function of Fgf9 is 
restricted only to the proximal bones (Hung et al., 2007).  
Ihh is the only hedgehog family member expressed during 
endochondral bone formation. Its synthesis belongs to the 
prehypertrophic and early hypertrophic chondrocytes. The Ihh effect 
to promote chondrocyte proliferation seems to be due to a direct cell 
action. This process is mediated by the Shh-receptors Ptch1 and Smo 
as discussed above (St-Jacques et al., 1999). Another Shh function is 
to accelerate the differentiation of the early round proliferating 
chondrocytes in the growth plates into columns of flat proliferating 
cells. This is done by two actions that control the column length: (1) a 
direct stimulation of the cell proliferation at the top of the columns; 
and (2) an indirect, PTHrP related cell effect of delay of the 
chondrocyte hypertrophy at the bottom of the columns via the creation 
of a negative feedback loop with the PTHrP (Vortkamp et al., 1996; 
Kobayashi et al., 2005; Koziel et al., 2005).  
Following the canonical Wnt pathway, Wnt proteins (Wnt1, Wnt3a, 
Wnt4, Wnt7a, Wnt9a, and Wnt11) inhibit chondrogenesis and 
chondrocyte proliferation via binding to frizzled and lrp6 receptors 
(Day et al., 2005; Hill et al., 2005; Hartmann, 2007). Transcription 
factors belonging to other families are also involved in the negative 
(H1Fα, NFatc2) and positive (c-Fos) control of this process (Schipani 
et al., 2001; Wagner and Eferl, 2005). 
After exiting the cell cycle, the prehypertrophic chondrocytes 
progressively become hypertrophic chondrocytes. The last are 
morphologically well distinct. Stimulated by Mefc2, they produce 
ColX and express only Fgfr1 (Linsenmayer et al., 1991; Karsenty et 
al., 2009). Key regulator of the process of chondrocyte hypertrophy is 
the PTHrP gene. During skeletal development, it is expressed in cells 
of the perichondrium and the early proliferative chondrocytes. The 
main chondrogenic PTHrP function is to prevent chondrocyte 
hypertrophy in an ultimately coupled action with Ihh (Karaplis et al., 
1994). Wnt and Fgf signals are also involved in the control of this 
process: Wnt5 and Fgfr3 inhibit, whileWnt4 and Wnt8 accelerate it 
(Hartmann and Tabin, 2000; Akiyama et al., 2004; Murakami et al., 
2004).  
At the same time with the chondrocyte hypertrophy, cells of the 
perichondrium (bone collar) start to express Runx2. One of the Runx2 
targets is to stimulate Fgf18. This results in inhibition of further 
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chondrocyte proliferation and hypertrophy (Ducy et al., 1997; Takeda 
et al., 2001; Hinoi et al., 2006).  
The presence of ColX makes the ECM competent to allow 
mineralization around the hypertrophic chondrocytes. This also 
supports vascular invasion from the bone collar under the control of a 
VEGF dependent pathway (Vu et al., 1998). The hypertrophic 
chondrocytes die through apoptosis and are soon replaced by 
osteoblast progenitors following the invading vessels. These new cells 
eventually become osteoblasts producing bone ECM with ColI on the 
top and ColX in the middle. This region, called the primary spongiosa, 
defines the trabecular bone of the future mature bones.  
The ossification process described above occurs centrifugally. The 
chondrocytes immediately adjacent to the ossification front continue 
to proliferate. Thus, proliferating and hypertrophic chondrocytes form 
columns of an avascular structure called the growth plate. This is the 
place where the continuing process of chondrocyte proliferation, 
hypertrophy and apoptosis, followed by replacement with osteoblasts, 
and new-formed bone allows the longitudinal growth of the skeleton 
(Karsenty and Wagner, 2002; Kronenberg, 2003).  
 
1.2.4.2. Osteoblast and bone formation 
Bone formation is the final step of osteogenesis in both endochondral 
and intramembranous ossification. The coordinated activities of two 
bone cell types maintain this process - osteoblast and osteoclasts. 
These two cell lines have different embryonic origin. The osteoblasts 
derive from the pool of the mesenchymal osteochondral progenitors. 
They are responsible for the bone formation, for the extracellular 
matrix mineralization, for the osteoclast differentiation and for the 
endocrine functions of the bone (Lee et al., 2007). The osteoclasts 
originate from blood myelo-monocytic cells and their main 
responsibility is the bone resorption and remodelling. 
Not surprisingly, due to their common origin, the chondrocytes and 
osteoblasts share many regulatory mechanisms, e.g. Ihh is, besides its 
chondrogenic function, also implicated in the osteoblast differentiation 
of progenitor cells within the bone collar (St-Jacques et al., 1999). In 
addition, Ihh activity is necessary for osteoblast proliferation and 
survival in postnatal life (Maeda et al., 2007). Fgf signalling via Fgf18 
and Fgfr2 is the other pathway shared between chondrogenesis and the 
osteoblast differentiation (Liu et al., 2002; Ohbayashi et al., 2002). 
Currently, there are no unequivocal molecular data for the importance 
of Bmps in this process. However, Bmp3 inhibits the osteoblast 
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formation and human ACVR1 mutations, a gene coding a Bmp 
receptor type I, cause fibrodysplasia ossificans progressiva presenting 
with an ectopic bone production (Daluiski et al., 2001; Shore et al., 
2006). These data suggest that in addition to its important functions 
during the early mesenchymal morphogenic events, this pathway may 
affect directly the osteoblast differentiation.  
LRP5 mutations cause two human diseases associated with an 
abnormal bone mass, osteoporosis-pseudoglioma syndrome and the 
high bone mass syndrome. This indicates that Wnt signalling may be 
implicated in the osteoblast development and control (Gong et al., 
2001; Boyden et al., 2002; Little et al., 2002) as LRP5 is believed to 
be a canonical Wnt co-receptor (Bhanot et al., 1996). In the case of 
osteoporosis pseudoglioma syndrome, a rare form of childhood onset 
osteoporosis and blindness, loss-of-function mutations abrogate the 
LRP5 function. In contrast, the high bone mass syndrome is a result of 
gain-of-function mutations of the same gene. The suggested link 
between LRP5, canonical Wnt signalling and the osteoblast 
differentiation was further supported by genetic manipulation of 
mouse Lrp5/6 genes or LRP5 inhibitors as Dkk1 and Sclerostin 
(Boyden et al., 2002; Tian et al., 2003; Holmen et al., 2004; Li et al., 
2005; Li et al., 2006). However, despite these data, there is not yet 
direct evidence proving this Wnt dependent LRP5 activity (Karsenty 
et al., 2009). Even more, another hypothesis explains this LRP5 
regulatory effect upon the osteoblast differentiation via stimulation of 
serotonin expression (Yadav et al., 2008).  
Notch signalling seems to be also directly involved in the 
developmental control of the osteoblasts. It inhibits the osteoblast 
differentiation as a result of NICD release and direct NICD-Runx2 
interaction. In addition, the osteoblast Notch expression increases the 
Osteoprotegerin, a TNF factor, and thus suppresses the osteoclast 
differentiation (Engin et al., 2008; Hilton et al., 2008). 
Three important transcription factors Runx2, Osterix and Atf4 
regulate the osteoblast biology at different developmental levels to 
facilitate the osteoblast differentiation (Ducy et al., 1997; Lee et al., 
1997; Mundlos et al., 1997; Nakashima et al., 2002; Harding et al., 
2003; Yang et al., 2004). There are also several others that act 
upstream/ downstream of the first three or independently as inhibitors 
(Twist1, Twist2) or enhancers (Mef2c, Msx2, Bapx1, Satb2, Nfatc1, 
Ap1) of this process (El Ghouzzi et al., 1997; Howard et al., 1997; 
Karin et al., 1997; Tribioli and Lufkin, 1999; Satokata et al., 2000; 
Eferl et al., 2004; Kenner et al., 2004; Koga et al., 2005; Dobreva et 
al., 2006). 
17 
  
Introduction 
18 
1.3. Skeletal dysplasias/ dysostoses 
Definition and epidemiology 
The skeletal dysplasias are a large, heterogeneous group of genetic 
conditions characterized by abnormal development, linear growth and 
maintenance of the human skeleton. There are more than 370 well-
recognized forms of osteodysplasias, chondrodysplasias and skeletal 
dysostoses, which can be delineated by clinical, radiological and 
morpho-etiological features (Rimoin at al., 2007). Many result in 
deformity of skeletal cartilage or bone, leading to common features 
such as short stature, limb mal-alignment, muscle hypotonia and joint 
contractures. Non-skeletal cartilage may also be involved, resulting in 
upper airway or respiratory disorders in infancy and hearing defects. 
Dental, ocular, heart and urinary tract pathology can also be observed. 
The overall prevalence rate of congenital anomalies affecting the 
skeleton reaches almost 16 per 10000 births and congenital skeletal 
dysplasias represent less than 1/3 of all inborn skeletal abnormalities. 
The overall frequency of skeletal dysplasias among perinatal deaths is 
9.1 per 1000 (Wynne-Davies and Gormley, 1985; Orioli et al., 1986; 
Andersen, 1989; Stoll et al., 1989; Rasmussen et al., 1996; Dimitrov 
et al., 2000).  
 
Classification and aetiology 
The last ISDS Nosology and Classification of Genetic Skeletal 
Disorders (2006) is still based on an artificial grouping of more than 
370 conditions and is built on a combination of morphological, 
pathogenic/ molecular and/ or pure descriptive criteria. At present, 37 
groups of disorders are delineated - 29 osteochondrodysplasia and 8 
dysostosis/ congenital limb defect families (Appendix A) (Superti-
Furga et al., 2007). Within the last 10 years, the rapid progress in 
molecular genetics and the influence of the Human Genome Project 
resulted in the elucidation of the underlying genetic defect in more 
than fifty percent of the skeletal phenotypes included in the last 2006 
Classification. Currently disturbed function of more than 160 genes or 
their regulatory sequences by mutations and/ or genomic deletions/ 
duplications is the cause of over 260 abnormal skeletal phenotypes. 
This number of causal single gene and/or genomic aberrations is 
progressively increasing and resulted in the clinical delineation of new 
disorders/ syndromes with skeletal involvement, which certainly will 
find a place in a upcoming revision of the Nosology. On the other 
hand, despite the fact that the clinically defined entities are presently 
well identifiable on clinical and radiological grounds, the difference 
between dysplasias, dysostoses, metabolic bone diseases and 
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malformation syndromes is becoming blurred. The advent of new 
technology with the application of systems biology approaches for 
precise experimental manipulation, fate tracing, conditional gene 
manipulation, quantitative whole genome screening and 
computational modelling elucidates the molecular content of basic 
developmental processes controlling skeletogenesis. It became 
obvious that conserved developmental pathways are shared at several 
levels during the morpho- and organogenesis, but in a different 
context. This logically explains the observed overlapping features of 
genetic skeletal disorders, which were believed to be the result of 
different pathogenic mechanisms. Therefore, to promote the 
understanding of the pathogenesis of individual disorders, parallel 
classifications have been established. They further subgroup the 
genetic bone dysplasias/ dysostoses depending on the predominantly 
affected molecular pathway or based on the disturbed spatio-temporal 
developmental process during the early skeletal patterning and later 
osteochondral progenitor differentiation and maturation (Appendix B) 
(Superti-Furga et al., 2001; Kornak and Mundlos, 2003; Newman and 
Wallis, 2003; Alman, 2008; Phornphutkul and Gruppuso, 2009). 
Finally, the rapidly growing information in the field requires the 
development of a unified electronic database which brings together 
the current knowledge in a user-friendly multidimensional format and 
serves both the clinic and the research (Rimoin et al., 2007).  
 
1.3.1. Acromesomelic/ Mesomelic dysplasias 
Dysplasias can result in proportionate or disproportionate short stature 
depending on the ratio of the trunk-to-limb length. Short limb 
conditions can be classified according to the site of the shortening as 
rhizomelic (proximal), mesomelic (middle) and acromelic (distal) 
dwarfism.  
Mesomelic skeletal dysplasias (MSD) (Goldblatt et al., 1987) are 
characterized by limb shortening involving the middle segment 
(forearm and lower leg). During the last years several distinct 
disorders of this form of disproportionate short stature have been 
described. They include Dyschondrosteosis (Leri-Weill), Langer type 
(homozygous Dyschondrosteosis), MSD Nievergelt type, MSD 
Kozlowski- Reardon type, MSD Reinhard- Pfeiffer type, MSD 
Werner type, AD and AR Robinow syndrome, MSD with synostoses, 
MSD Kantaputra type, MSD Verloes-David-Pfeiffer type, MSD 
Savarirayan type, AD and AR Omodysplasia (International Nosology 
and Classification of Constitutional Disorders of Bone 2006- 
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Appendix C), sporadic cases and a few familial cases of MSD 
(Ventruto et al., 1983; Fryns et al., 1988; Brodie et al., 1998; Kerner 
et al., 1998; Nishimuraet al., 1998; Kozlowski and Masel, 1999, Kitoh 
and Lachman, 2001; Camera and Camera 2003). 
 
1.3.2. Klippel-Feil anomaly (KFA) 
The Klippel–Feil anomaly is a clinically and genetically 
heterogeneous group of disorders characterized by cervical vertebral 
fusions and may be associated with a variety of other congenital 
anomalies. The reported incidence varies from 0.02% to 0.71% live 
births, but most frequently it occurs as an isolated fusion of one or two 
intervertebral spaces with a prevalence of 7.3/1000 (Clarke et al., 
1998; Papagrigorakis et al., 2003).  
Since the original report (Klippel and Feil, 1912), the large number of 
KFA patients described have shown variable inheritance and a broad 
spectrum of associated skeletal and non-skeletal congenital defects. 
This anomaly usually occurs sporadically, but dominant, recessive and 
X-linked familial forms have also been observed. Several reports 
suggest autosomal dominant inheritance with reduced penetrance and 
variable expression, which explains the majority of the sporadically 
affected individuals. Male and female patients are almost equally 
presented with a mild, insignificant predisposition to females (1:1.3). 
Until now, four chromosomal aberration have been associated with 
KFA: a four-generation familial inversion inv(8)(q22.2q22.3) (Clarke 
et al., 1995), a de novo balanced reciprocal translocation 
t(5;17)(q11.2;q23) (Fukushima et al., 1995), a de novo pericentric 
inversion inv(2)(p12q34) (Papagrigorakis et al., 2003) and a three-
generation familial translocation t(5;8)(q35.1;p21.1) (Goto et al., 
2006). These chromosomes provided good candidate loci for further 
research to unravel the molecular mechanisms causing KFA 
syndrome. Recently, two independent groups were able to identify the 
first gene implicated in KFA based on positional cloning via 
translocation breakpoint mapping or candidate gene approach. 
Affected individuals carried heterozygous mutations in GDF6 located 
at chromosome 8q22. Incomplete penetrance for the associated 
variable ocular defects, vertebral segmentation anomalies and carpal/ 
tarsal synostoses was noted in both patients and corresponding animal 
models (Tassabehji et al., 2008; Asai-Coakwell et al., 2009). Another 
gene probably involved in KFA is PAX1. Analysis for PAX1 
mutations in a group of 63 KFA patients revealed three affected 
individuals with a PAX1 sequence variation of significant 
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physiological impact (McGaughran et al., 2003). However, whether it 
represents the real cause for this entity or a non-pathogenic 
polymorphism remains unclear. 
Several KFA classifications have been proposed (Appendix D) 
(Giampietro et al., 2009). They are based on morphological criteria 
facilitating the clinical diagnosis, patient management and prognosis. 
Interestingly, it is difficult to define a single classification subtype of 
the KFA patients with currently known molecular defects (Tassabehji 
et al., 2008; Asai-Coakwell et al., 2009).  Furthermore, the phenotype 
of some of these individuals overlaps with those of more generalized 
malformation syndromes with vertebral involvement such as 
Spondylocostal Dysostosis/ Jarcho–Levin syndrome and Wildervanck 
syndrome. In addition, the genetic aetiology of the majority of the 
KFA cases remains unknown (Giampietro et al., 2009). Therefore, 
further research should explain the observed pleiotropy and should 
provide a basis for future phenotype/ genotype correlations, based on 
a more advanced classification. 
 
1.3.3. Limb Reduction Defects (LRD) 
Definition and epidemiology  
Limb reduction deficiencies (LRD) are defined as congenital absence 
or severe hypoplasia of both skeletal and soft tissue limb components. 
There is high clinical variability of the observed combinations of 
defects due to the complex architecture of the appendicular skeleton 
including 120 individual bones, separated in several segments and 
rays between the upper and lower limbs. With a prevalence rate 
ranging between 4.5-7.8/ 10000 births, LRDs are the second most 
common congenital anomaly after the congenital heart defects (CHD). 
They may present as an isolated malformation (42.1%) or as part of a 
syndrome (57.9%). The most common associated congenital 
anomalies (57.9%) are heart (~11.5%), urogenital (~14%) and 
craniofacial defects (~12.5%). Almost half of the syndromic forms are 
part of a recognizable disorder (~23%) (Calzolari et al., 1990; Froster 
et al., 1992a, 1992b, 1993a, 1993b; Evans et al., 1994; Stoll et al., 
1996; McGuirk et al., 2001; Makhoul et al., 2003; Stoll- unpublished 
data).  
 
Classification and aetiology 
The currently available clinical LRD classifications are based on 
description of the missing part of the limb (Swanson et al., 1983; de 
Smet, 2002; Tonkin, 2006) and they are generally divided into 
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terminal or intercalary defects and subsequently according to the axis 
of the deficiency into transverse and longitudinal defects. In addition, 
based on the missing limb segment they are subdivided in proximal, 
middle and terminal defects corresponding to the arm, forearm and 
hand in the upper limb, and to the thigh, leg, and foot in the lower 
limb, respectively. The deficient bone or longitudinal ray of the 
middle and distal part of the limb (pre-axial, post-axial, central, radial, 
ulnar and I-V digit rays) are also often used to further specify the 
observed anomaly. The idea of these classifications was to unify the 
terminology across the medical specialities, to provide a basis for 
grouping patients within a defined nosology, and to promote further 
research to unravel the underlying aetiology (de Smet, 2002). 
However, several individual patients fail to fit into any group of the 
current classifications, thus indicating a need for revision (de Smet, 
2002; Elliott et al., 2009). 
In an attempt to include only well defined genetic disorders, the last 
ISDS Nosology and Classification of Genetic Skeletal Disorders 2006 
(Appendix E) (Superti-Furga et al., 2007) lumps the genetic LRD in 
one group with 29 separate clinical entities. However, the increasing 
knowledge over the last years unambiguously demonstrates that the 
LRDs are inborn errors of development caused by multiple 
environmental and genetic aetiological factors. In addition, epigenetic 
modifications and stochastic events substantially contribute to their 
pathogenesis. Depending on the combination of the complex aetiology 
and specific spatio-temporal position of disrupted morphogenesis, a 
variety of abnormal phenotypes occurs, often presenting overlapping 
clinical features. The observed phenotypic pleiotropy and incomplete 
penetrance/ expression of the LRDs are probably a consequence of the 
multifaceted and interlinked developmental mechanisms involved in 
limb patterning. Further research is needed to delineate how different 
aetiological components contribute to this process. 
 
Environmental factors causing LRDs 
Environmental insults after fertilisation, capable of disturbing the 
normal morphogenesis and of causing congenital structural defects are 
coined teratogens, coming from the Greek words “teratos” (monster) 
and “gen” (creation). However, many teratogenic agents also produce 
functional disturbances such as mental retardation, impaired vision 
and hearing loss. Clinical and experimental data demonstrate that 
several teratogenic factors may preferentially disturb the proper limb 
development. The resulting limb defects reflect the underling 
mechanism of abrogated morpho- and organogenesis. Studying these 
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teratogenic events was thus believed to help our understanding of the 
complex limb patterning.  
There is no other teratogenic agent that has attracted more attention in 
the society and the medical audience then Thalidomide, prescribed to 
pregnant women in the fifties of the last century. After being on the 
market for almost four years its teratogenic potential was suspected 
and probably more than 5800 infants were identified with a potential 
exposure (Lenz, 1988). There is a consistent clinical phenotype in 
affected individuals with distinct bilateral, symmetric preaxial limb 
reductions with thumb hypo-/ aplasia and/ or more extended radial ray 
deficiencies. Postaxial/ ulnar ray defects are also observed. The upper 
limbs are more frequently affected. If there are lower limb anomalies, 
these involve the femur, tibia and the first toe (Holmes, 2002; 
Stevenson, 2006; Everman, 2006). Recent experimental studies 
suggest that its teratogenic effect is due to primary blocked angiogenic 
outgrowth during early limb development and/ or induced Caspase-
dependent cell death (Knobloch et al., 2008; Therapontos et al., 
2009). 
A well-documented teratogenic drug with skeletal effect is the 
anticonvulsant Phenytoin. Affected individuals have hypoplasia of 
distal phalanges, shortness of metacarpals, cone-shaped epiphyses, 
limited movements at interphalangeal joints and tapering fingers with 
nail hypoplasia. These skeletal anomalies are often observed only after 
an X-ray examination (Lu et al., 2000; Holmes et al., 2001; Holmes, 
2002). Terminal transverse limb reductions are infrequently reported 
and suggest a vascular disruption to explain at least partially the 
Phenytoin teratogenesis (Sabry and Farag, 1996). Similar terminal 
transverse LRDs affecting distal phalanges and tubular hand bones are 
also observed after intrauterine exposure to the anticoagulant Warfarin 
and the anticonvulsant Valproic Acid (VA). However, thumb 
hypoplasia/aplasia and other preaxial/radial ray deficiencies are the 
most commonly observed limb malformations in the VA embryopathy 
(Holmes, 2002).  
Variable transverse reduction defects are induced by Misoprostol, a 
synthetic analog of prostaglandin E1. This drug was often prescribed 
for initiation of illegal abortions in Latin America. Its pathogenic 
effect is due to stimulation of uterine contractions resulting in 
hypovolemia and hypoperfusion of the embryo or the foetus and 
terminal vascular disruption limb anomalies as a consequence (Los et 
al., 1999; Coelho et al., 2000).  
There are additional environmental factors that cause RLDs due to 
vascular compromises. Examples are maternally related conditions 
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such as amniotic bands, other constrictive forces (uterus 
malformations, tumours) (Stevenson, 2006; Everman, 2006), 
thrombophilia (Hunter, 2000) and thalassemia (Lam et al., 1997; Li 
and Li, 2008) or maternal addictions such as cocaine use during the 
pregnancy. It is believed that they disrupt the limb morphogenesis via 
vascular insults. Other causes are mechanical forces producing trauma 
during pregnancy like chorionic villus sampling (Firth et al., 1991; 
Stoler et al., 1999; Holmes, 2002), cervical dilatation, curettage, 
placental trauma, amniocentesis (Lamb, 1975; Hall, 1996; Viljoen, 
1995; Holmes, 1995, 1997) and selective reduction of multiple 
gestations (Holmes, 2002; Simeonov and Dimitrov- unpublished 
data). 
Diabetes mellitus is another maternal condition with an indisputable 
teratogenic effect. Children born to diabetic mothers have a two- to 
eight-fold higher risk of congenital anomalies than the general 
population. The heart, CNS, spine and limbs are the most commonly 
involved. Almost a third of the infants with malformations present 
with limb anomalies (Holmes, 2002; Stevenson, 2006; Everman, 
2006; Frias et al., 2007). The lower limbs are predominantly affected 
often in combination with abnormalities of the lower spine. A specific 
phenotypic pattern with caudal deficiency, preaxial hallucal 
polydactyly and femoral hypoplasia/unusual faces syndrome (MIM 
134780) is 65-200 times more frequent in these patients, challenging 
the correct differentiation between a teratogenic effect versus a 
molecular defect to explain the phenotype (Farrell et al., 2002; Yang 
et al., 2006; Frias et al., 2007; Correa et al., 2008; Adam et al., 2009). 
In all individuals with skeletal involvement there are associated 
defects of the heart (84.6%), kidney (50%), ears (38.8%) and cleft 
palate (33%). The combination of anomalies may overlap with the 
VACTERL association and OAVS (Wang et al., 2002; Frias et al., 
2007; Castori et al., 2008). Hyperglycemia and subsequent fetal 
oxidative stress with high levels of free reactive radicals are supposed 
to be the primary teratogenic mechanism (Allen et al., 2007; Eriksson, 
2009). However, this general pathway cannot explain sufficiently the 
predilection to specific patterns of congenital anomalies. The diabetic 
predisposition itself does not seem to be directly related to this. 
Epidemiological human and molecular animal studies suggest the 
presence of a multifactorial effect of oligo-/polygenic susceptibility 
and environmental triggers which determine the presence of particular 
disruption during the embryonic development. This complex oligo-
/polygenic and multifactorial pathogenic mechanism may be applied 
not only to the diabetic embryopathy, but also to other teratogenic 
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drugs/ chemicals (Pavlinkova et al., 2008; Eriksson, 2009; Zhu et al., 
2009). 
LRDs are also sporadically observed after intrauterine exposure to 
several other teratogens such as ethanol, aminopterin (methotrexate), 
retinoic acid, fluconazole, smoking cigarettes, varicella and 
hyperthermia (Holmes, 2002; Stevenson, 2006; Everman, 2006). 
 
Genetic factors causing LRDs 
Several inheritable AD, AR and X-linked forms of isolated and 
syndromic LRDs are described (Superti-Furga et al., 2007). In 
addition, chromosomal aberrations (6.8% of all RLDs) are also 
consistently associated with congenital limb deficiencies. A small 
proportion of patients with trisomy 18 (less than 10%) can have absent 
radial/ tibial ray and oligodactyly (Christianson et al., 1984; 
Stevenson, 2006; Everman, 2006). Thumb a(hypo)plasia and other 
distal limb anomalies are associated with terminal deletions of 
chromosome 13q (13q31.3–q33.1 and 13q33.3–q34) (Kirchhoff et al., 
2009). Severely a(hypo)plastic distal phalanges are characteristic for 
the 9p duplication syndrome (Fryns et al., 1979; Zou et al., 2009). 
Radial ray reductions and other skeletal defects are rarely reported in 
patients with 22q11 deletion syndrome (Digilio et al., 1997; Kokitsu-
Nakata et al., 2008; Simeonov and Dimitrov- unpublished data). 
Severe reduction limb anomalies/ monodactylous ectrodactyly have 
been observed in a few individuals with 2q31 deletions suggesting a 
new SHFM5 locus (Del Campo et al., 1999; Goodman et al., 2002; 
Bijlsma et al., 2005). Based on phenotype/ karyotype correlations of 
published patients with SHFMs and associated chromosomal 
aberrations, Niedrist et al. (2009) proposed two additional loci - 
chromosomal bands 4q32–q35 and 6q16–q22 - that are significantly 
associated with this phenotype. Several additional chromosomal 
abnormalities can also result in LRDs such as trisomy 13 (radial 
aplasia), triploidy (radial aplasia, oligodactyly), Turner syndrome (45, 
X), Klinefelter syndrome (47, XXY) and trisomy 21. 
The Human Genome Project with the introduction of new techniques 
for whole genome analysis and the establishment of worldwide 
collaborative databases collecting data on patients and/ or animal 
models significantly improved our knowledge about the molecular 
basis of many genetic disorders, including the genetics of monogenic 
forms of LRDs. In addition to well known disorders like Holt-Oram 
syndrome (TBX5), Ulnar-mammary syndrome (TBX3), the EEC/ 
EEM/ ADULT/ SHFM4 phenotypic spectrum (p63), Acheiropodia 
(LMBR1), Okihiro syndrome (SALL4), Cornelia de Lange syndrome 
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(NIPBL) and Roberts syndrome (ESCO2), many new phenotypes were 
delineated and the corresponding molecular defect identified. Thanks 
to the application of array CGH technique in the analysis of patients 
with unknown diagnosis, new chromosomal deletions/ duplications 
causing LRDs were found with the discovery of new monogenic 
(FAM58A and STAR syndrome- Unger et al., 2008) or genomic 
disorders (1q21.1 microdeletion in TAR syndrome - Klopocki et al., 
2007). In addition, the difference between single gene defects and 
genomic syndromes became blurred since the newly detected genomic 
rearrangements may be Mendelian inherited (de Mollerat et al., 2003, 
Klopocki et al., 2007).  
In the last five years several new genes have been implicated as a 
cause of different inherited/ inborn syndromes in individuals with an 
abnormal skeletal development, particularly the group of the 
oligodactylies and SHFMs. Oligodactyly is the congenital absence of 
digits. More than one digital ray may be involved. The number of 
affected limbs and the symmetry of the observed defect may vary. 
Depending on the AP polarity the deficiency can involve only 
anterior, posterior, central ray digits or all of them. In some patients 
the severity of the defect makes the recognition of specific digit 
patterns impossible. All bones of the hands and feet may be involved 
and syndactyly between the remaining digits is often observed. In this 
clinical spectrum of terminal limb defects, SHFM (ectrodactyly) is 
defined as an absence of central digit rays. However, clinical, 
experimental and molecular data suggest that there is a high clinical 
variability starting from the classical bidactylous SHFM phenotype, 
through different levels of missing digits to a total lack of hands and 
feet. In addition, SHFMs may be part of a syndrome or an isolated 
anomaly. Arbitrary, this continuum of abnormalities was divided in 
classical and atypical SHFM forms based on the type of limb defects 
present.  
Until recently, five SHFM loci were defined on clinical findings and 
genetic mapping: SHFM1 at 7q21.2q22.1; SHFM2 at Xq26; SHFM3 
at 10q24q25; SHFM4 at 3q27 (p63); and SHFM5 at 2q31. The p63 
gene causes SHFM4 (Basel et al., 2006). There is variable 
expressivity amongst the p63 mutations (Rinne et al., 2006, 2007). For 
the SHFM3 locus, the limb defects in humans are associated with a 
unique, most commonly 500Kb 10q24.31q24.32 microduplication (de 
Mollerat et al., 2003). Based on analogy with the corresponding 
dactylaplasia (dl) mouse model, FBXW4 was suggested as the most 
plausible candidate gene responsible for the phenotype. Later studies 
disagree with this hypothesis and favour a disturbed balance between 
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regulatory sequences and causal genes in the chromosomal 
rearrangements (Kano et al., 2007; Friedli et al., 2008; Dimitrov et al., 
2010).  
New SHFM loci were reported: SHFLD6 at 1q42.2-q43 and 6q14.1 
(Naveed et al., 2007); SHFLD7 at 2q14.2 (Babbs et al., 2007); 
SHFLD8 at 17p13.1–p13.3 (Lezirovitz et al., 2008); and SHFM9 at 
12q13.11–q13 (WNT10b) (Ugur and Tolun, 2008). Two additional 
loci, at chromosomes 4q32q35 and 6q16q22 (Niedrist et al., 2009), 
provide promising options for further research. In addition, the 
phenotypic spectra of SHFM1 and SHFM3 were extended. A 7q23.1 
microdeletion removing only three genes, DLX5, DLX6 and DSS1, 
was found in patients with Fontaine syndrome (Bigo et al., 2009). 
Finally, DLDMS and syndromic forms of SHFM were associated with 
10q24 microduplications and linked to the SHFM3 locus (Dimitrov et 
al., 2010). Therefore, a future LRD classification should certainly 
reflect these new data. 
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1.4. How rare are the congenital limb defects and is it worth 
to study them? 
Since many years the vertebral limb development serves as an 
important model to show how different processes and pathways are 
synchronized and involved in morpho- and organo-genesis. Because 
of relatively easy accessibility and experimental manipulation at an 
acceptable cost level, the chick limb patterning was the pioneer model 
used to study fundamental developmental processes in the second half 
of the last century. As limb formation is not necessary for embryonic 
survival, several spontaneous and genetically manipulated (transgenic) 
animal models contributed to the discovery of important signalling 
pathways and their molecular content involved in limb and skeletal 
development. As several of these key genetic players have an 
important role in other developmental cascades, this knowledge 
contributed significantly to the understanding of pattern formation of 
other tissues and organs (Niswander, 2003; Tickle, 2006). However, 
despite this substantial contribution to developmental biology and 
genetics over the last five decades, the genetic studies of LRDs in man 
have been a relatively neglected topic. At present there are only a few 
genes that cause such phenotypes compared to other genetic skeletal 
disorders, e.g. osteochondrodysplasias. This is mainly due to some 
widely accepted misleading prejudices. The first is the assumption that 
they are very rare and not life-threatening. The second is that there is 
no curative treatment possible. Even if the molecular defect is known 
there will not be a fast and easily visible benefit to the society because 
it will not lead to the immediate development of a new treatment 
strategy different from those currently available (e.g. the surgical 
correction). The automatic consequence is poor research interest 
within the medical specialities dealing with these patients, namely 
surgery and clinical genetics, as the chance of a successful grant 
application is negligible. This is unfortunate, not only because the 
contribution limb malformation studies would make to human health 
and developmental biology, but also the great impact and potential 
knowledge this would bring to developing branches in medicine and 
the biomedical industry.  
Like most genetic diseases, limb anomalies are individually rare but 
taken together, congenital skeletal defects occur in 1 in 500 to 1 in 
1000 births (Wilkie, 2003; Ferretti and Tickle, 2006). Because of this 
elevated frequency and severe, long time burden they are of 
significant clinical and social importance. In addition, the limb 
formation was a relatively recent event in the evolution of vertebrates 
and many developmental pathways controlling the limb/ skeletal 
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development were co-opted from already existing patterning programs 
of other body parts. Therefore, LRDs are often (~58%) associated 
with other congenital defects. Based on this pleiotropy, genetic studies 
of diseases that affect the skeletal development and growth provide 
invaluable insights about the role of not only individual gene(s), but of 
entire developmental pathways into the morphogenesis of many non-
skeletal organs (e.g. Holt-Oram syndrome, TBX5 gene and the heart 
development). Different mutations in the same gene may result in 
different phenotypes, and disease “families” are frequently caused by 
mutations in different genes as components of the same pathway. The 
correlation of these clinical phenotypes with the identified allelic 
changes provides a sensitive method for the analysis of structure-
function relationship and elucidates the intimate molecular 
pathophysiology of the observed dysmorphogenesis. Phenomena such 
as poly-A extension tract mutations (HOXD13 and HOXA13), gain-of-
function mutations (FGFRs), mutation hot-spots (FGFR2) and sperm 
cell mutation selective advantage (FGFR2 and FGFR3) have been 
discovered as a result of limb defect studies. Other observations, e.g. 
the sex-limited segregation distortion in SHFM with excess of 
affected male offspring born to affected fathers, remain to be 
explained (Jarvik et al., 1994; Wilkie, 2003).  
The analysis of human limb anomalies provides important information 
that complements data from experimental surveys of gene function in 
animals and cells, as even the closest evolutionary mouse models are 
not always sufficient to study and to discover causal genes for human 
skeletal disorders due to interspecies differences in development (this 
includes both qualitative and quantitative dissimilarities). Dominant 
phenotypes in man may only be observed in homozygous mice or in 
certain mouse strains. In addition, the study of the phenotypic 
consequences of gene mutations in animal strains demonstrates the 
gene function under conditions of minimal environmental and 
genomic modifications. In contrast, familial and human population 
studies can elucidate the plasticity and adaptability of the genome 
under the pressure of a variable environment. The abnormal 
phenotype may result from a combined effect of genetic and 
environmental factors, but can also be due only to an environmental 
insult. Therefore a correct diagnosis may be difficult, but important 
with significant impact on correct genetic counselling. It is often 
believed that terminal transverse, asymmetrical and/or single LRDs 
suggest a non-genetic aetiology and in general a low familial 
recurrence risk. However, clinical data demonstrate that this is not 
unequivocal. LRDs escaping clear Mendelian inheritance may be 
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caused by single gene disorders via a disruptive mechanism. This is 
the case in foetuses with homozygous HBA1/ HBA2 mutations and 
terminal transverse limb abnormalities or in patients with Fanconi 
anaemia and asymmetric limb deficiencies. In both situations the 
observed LRDs are a consequence of the chronic foetal hypoxia (Lam 
et al., 1997; Joenje and Patel, 2001; Wilkie, 2003). A non-Mendelian 
inheritance pattern of single gene phenotypes can also be the 
consequence of titrating effects of multiple alleles or loci 
(oligogenic/polygenic), gene pleiotropy, environmental and/ or 
stochastic events (multifactorial). For example, the variable 
expression and penetrance of SHFLD6 is probably due to biallelic 
inheritance (Naveed et al., 2006). A complex, non-Mendelian 
inheritance pattern as a result of single gene mutation was found in 
individuals with variable skeletal and associated non-skeletal 
anomalies carrying GDF6 or PITX1 mutations. The differences of the 
allele size effect upon the inconsistent patient phenotype were 
explained with the inconstant degree of redundancy and/ or variability 
of the pleiotropic GDF6 or PITX1 thresholds required for normal 
skeletal/ non-skeletal development among the affected individuals 
(Gurnett et al., 2008; Tassabehji et al., 2008; Asia Coackwell et al., 
2009). Finally, studying teratogen induced limb defects, particularly 
Thalidomide, substantially changed the modern pharmacogenetics and 
drug marketing (Wilkie, 2003).  
Nowadays, the impact of the information gathered by the analysis of 
abnormal human limb development is enormous and it gradually 
changed the scientific approach and study of complex developmental 
processes. In addition, it increased our understanding how disorders 
evolve and progress. Modern methodologies benefit from molecular 
genetic studies of inherited skeletal syndromes to study common 
population diseases such as osteoarthritis, rheumatoid arthritis and 
other degenerative skeletal disorders (Ikegawa, 2006; Kannu et al., 
2009). This knowledge substantially contributed to the development 
of new therapeutic approaches in medicine, e.g. the regenerative 
cartilage and bone medicine. One cannot imagine application of 
BMPs, FGFs and mesenchymal stem cells for bone/ cartilage healing, 
repair of bone defects or treatment of osteoporosis without the 
available basic information about limb and skeletal development 
(Beenken and Mohammadi, 2009; Chen and Tuan, 2008; Karsenty et 
al., 2009; Richardson et al., 2009; Sensebe et al., 2009; Yang, 2009).  
Last but not least, the opportunity to provide a correct diagnosis is of 
great importance for the individual patients and their families. The 
ability to provide a reliable prognosis and the possibility of prenatal 
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diagnosis depends on knowing of the molecular cause (Scambler, 
2006). In addition, the establishment of a systematic approach for 
assessment, management and genetic analysis of patients with LRDs 
will certainly lead to a chain-reaction of discoveries of new causal 
genes at a reasonable cost, disproving the prejudice that they are very 
rare and not important. Finally, from the point of view of the presently 
proposed personalized and preventive medicine, this will gradually 
improve the access to welfare and social support of the affected 
individuals and their families (Downing, 2009; Ginsburg and Willard, 
2009; Tweardy and Belmont, 2009; Collins, 2010). Of course, a 
multidisciplinary approach and open communication between 
specialists of different branches in bio-medical science are essential 
factors in this process.  
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2. AIMS OF THE PROJECT 
The congenital skeletal and limb defects are  a heterogeneous group of 
malformation syndromes, most of them with unknown genetic cause. 
There are several classical position-independent and positional 
strategies for cloning of new disease genes such as using previous 
knowledge about the protein product, through an animal model, 
linkage analysis or genome wide association studies. However, for 
sporadic and rare genetic disorders these approaches based on 
positional cloning, physical mapping or candidate-gene sequencing 
may be inefficient. For such conditions, mostly severe or lethal 
phenotypes, investigating patients who are carriers of chromosomal 
abnormalities such as translocations, inversions or micro-deletions/ 
duplications may help to identify their genetic cause.  
In this project two patients, a girl with a mesomelic form of skeletal 
dysplasia, congenital glaucoma and de novo translocation (13; 
18)(q14;q23), and a second non-related female with Klippel-Feil 
syndrome and de novo inversion (2)(p12q34), were selected for 
further genetic analysis. In addition, a selected group of patients with 
(1) complex skeletal phenotypes, combining features of two 
Mendelian conditions, (2) with a Mendelian condition plus mental 
retardation or (3) with an unknown molecular defect were analysed for 
the presence of genomic micro-deletions/ duplications. The aims of 
the study were to identify the molecular aetiology of these rare 
skeletal malformation syndromes and to increase the current 
knowledge about the underlying molecular mechanisms involved in 
skeletal and limb development. Therefore, classical and new 
techniques for positional cloning and candidate gene(s) selection/ 
validation were applied in a “positional candidate gene” approach.  
Finally, with the detection of the genetic cause of the selected rare 
skeletal phenotypes, we aimed to improve the clinical management 
and genetic counselling of individuals with congenital skeletal 
malformation syndromes and to contribute to the development of an 
advanced classification of this group of genetic skeletal disorders.  
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3. MATERIALS AND METHODS 
Patient’s material 
Sixty-five patients were selected for further genetic analysis. 
- two carriers of apparently balanced chromosomal translocations/ 
rearrangements and associated skeletal abnormalities, KFA and 
MSD; 
- forty-two patients with unexplained syndromic forms of skeletal 
anomalies for array CGH screening; 
- five patients with a 2q31.1 deletion for detection of the deletion 
size by array CGH; 
- sixteen patients with Holt-Oram syndrome for intragenic 
deletion/duplication screening; 
In all patients conventional GTG-banded cytogenetic analysis at a 
resolution between 650 and 850 bands had been performed previously. 
 
Patients’ DNA extraction 
Peripheral blood cell DNA from patients, parents and analysed 
relatives was obtained, following standard protocols. The quality and 
yield of extracted DNA was checked by NanoDrop ND-
1000spectrophotometer (NanoDrop Technologies, Wilmington, 
Delaware, USA). 
 
Fluorescence in situ Hybridization analysis (FISH) 
FISH analysis was used for: (1) fine breakpoint mapping by “walking 
FISH”; (2) primary screening for CNVs; (3) confirmation of array 
CGH data; and (4) analysis of the genomic architecture of detected 
CNVs. The probes were constructed with two alternative methods. In 
the first way, 1µg genomic DNA isolated from BACs and fosmids 
with the Nucleobond AX100 kit (Machery-Nagel, Dtiren, Germany) 
was labelled using incorporation of either biotin-16-dUTP (Boehringer 
Mannheim, Mannheim, Germany) by nick translation system 
(Invitrogen, Carlsbad, California, USA) or digoxygenin by DIG Nick 
mix (Roche Diagnostics, Mannheim, Germany). The BAC and fosmid 
clones were selected exploiting web-based electronic sources 
(Ensembl and UCSC Genome Browsers) and requested from the 
BACPAC (BPRC) Resource Centre at the Children’s Hospital 
Oakland Research Institute (BPRC-CHORI, Oakland California, 
USA) (Krzywinski et al., 2004). Alternatively, DOP amplified BAC 
DNA used for construction of array CGH platforms was labelled in 
SpectrumOrange™- dUTP (red signal) and SpectrumGreen™- dUTP 
(green signal) (Vysis, Abbot laboratories, Chicago, Illinois, USA) by a 
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second DOP amplification or random labelling (Invitrogen, Carlsbad, 
California, USA) (Backx et al., 2008). The hybridizations were done 
on metaphase chromosome spreads or interphase nuclei of peripheral 
white blood cells, EBV-immortalized lymphoblasts and skin 
fibroblasts as described (Menten et al., 2006, Backx et al., 2008). The 
signals were visualised by digital imaging microscopy with 
CytoVision capturing software (Applied Imaging, Santa Clara, 
California, USA). 
 
RNA extraction and cDNA synthesis 
Fibroblasts and EBV-immortalized lymphoblasts from the patients 
and control individuals were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM-F12) at 37°C under 5%CO2. Total RNA of the 
cultured cell lines was extracted with the RNeasy Kit (QIAGENE, 
Venlo, Netherlands) according to the manufacturer’s protocol. The 
samples were treated with DNaseI (Roche Applied Science, 
Vilvoorde, Belgium) to avoid DNA contamination. The quality and 
yield of extracted RNA were checked by NanoDrop 
spectrophotometer (ND-1000). Subsequent cDNA synthesis was 
performed using mixture of equimolar proportions (1:1) of poly-A and 
random primers (Invitrogen, Carlsbad, California, USA and 
Amersham, Diegem, Belgium) and Superscript III RNase (Invitrogen, 
Carlsbad, California, USA) according the manufacturer’s protocol. 
 
RT Q-PCR analysis of genomic DNA 
SYBR Green assays were designed using the program PrimerExpress 
v2.0 (Applied Biosystems, Foster City, California, USA) with default 
parameters in every case. To ensure they were unique for the region 
under study, the amplicon sequence and primer specificity were 
checked by BLAT and UCSC in-silico PCR (Kent, 2002; Karolchik et 
al., 2003). The efficiency of each assay was tested using serial 
dilutions of control DNA. Primer sequences and locations of the 
assays are provided in Table 1. All reactions used 10ng of genomic 
DNA and qPCR mastermix (Eurogentec, Seraing, Belgium). PCRs 
were set up in a 15ml volume in 96-well plates with two replicates per 
sample. Reactions were run in an ABI 7500 Sequence Detection 
System (Applied Biosystems, Foster City, California, USA) with 
standard conditions. Melting curves were implemented during the 
reactions to check for the possibility of primer-dimer formation. For 
data analysis, Ct values were obtained using SDS 2.0 (Applied 
Biosystems, Foster City, California, USA). Input DNA quantities were 
normalized to one assay from the p53 gene locus. Relative DNA copy 
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numbers were obtained by pair-wise comparisons of test and control 
DNAs using ∆∆Ct method (Livak and Schmittgen, 2001). Each assay 
of interest was repeated two times, thus providing in total four runs 
per sample. Means of these two independent experiments (four runs), 
with standard deviation (SD) less than 0.15, were used for final fold 
difference calculation. The computational analysis was carried out in 
Excel 2003 (Microsoft Corporation, Redmond, Washington, USA). 
 
Table 1. Primers for RT Q-PCR analysis of genomic DNA 
No ID Forward primer 5’→3’ Reverse primer 5’→3’ 
TBX5 gene 
1 TBX5ex1 GGAAGAAGACCTGGCCTAAAGAG GCAGGGCTCAGGTGAAGACT 
2 TBX5ex2 GCCTTCACCCAGCAGGTAAG AAAGCCAGACTCTGACTTTGATCTC 
3 TBX5ex3 CCACTACTGCCAGGGCTTGT GAGAAACACTTTGATTCCCTCCAT 
4 TBX5ex4 CGTTTCTCCAGGAATTGCTTTT GCGGGAATTAATGCCAGTATTT 
5 TBX5ex5 CGGTGCAGTGCGCTACCT CCGTCACAGACCTAGATGAAGGA 
6 TBX5ex6 CCAGCCTAGATTACACATCGTGAA GTGAGTGCAGAACGCTGTATTTTT 
7 TBX5ex7 CCAGGTAAGCCAGCAGCAA ATTTCCATGTGCCTGGCATT 
8 TBX5ex8 GCCTCCACCCAACCCATAC CCTTTCCTCTTGGTACAATGGTAAA 
9 TBX5ex9 GACGCTCCCTGGCATCCTA GCGACAGACAGCTGGAAAGAC 
Chromosome 10q24 (SHFM3) locus 
10 BTRCintr2 (Pr1) CTGCCAACCAGATTGGAATTC TCTTAATCCTGTTTGGAGCTGTCA 
11 FGF8ex6 (Pr2) GGTGTCTGGCTCCCCTACCT CTCCAGCACAATCTCCGTGAA 
Chromosome 15q13.3 (GREM1-FMN1) locus 
12 SNP_A-4240484 AAGAGCCAGCATGGCTGTAAG TCAGCAGCTTTTAATGCAAGTTTG 
13 SNP_A-4201883 GAAGGTGTTGCAGGACAAACC TGACCAGCTCTTCTCTGTTCATTG 
14 SNP_A-2241478 TGTGAGGCTCACAGCACTCTAAG CCCCTTTGGATGTGTTCCAA 
15 SNP_A-2176534 GGGTGGAAAGATCAAGGAAACAC AGACTGTTGCCCATCCATGAG 
16 SNP_A-2233558 AGAATCAGCTAGTCTTTCTCAGAACTCA ACAGGAGCCAGTTGCACACA 
17 SNP_A-1865339 TCAAACTCAGGTACTGCATGCTTT TTTTCCTTTGACACTTCAGCAACT 
18 SNP_A-1854043 GGCCTGTTCTAGGCTTTCCA AATGAACAGTAACTACAATATGTGGTATTCC 
19 SNP_A-1949971 ATCTTATCCCCTTCCCTTTCTATTG CAACAGAGCCCTTGGTATGGA 
20 SNP_A-2022976 GCTGTGAGAAGTGTCTTCGTGTTATT CTCGCCTCACTCACAGAAGCT 
21 SNP_A-2284222 TGCTCCAGGCAGGTCAGATC GGCTGATGGTCATTCACACAGT 
22 SNP_A-2248182 AATCTGTGAAAGCTCAAGGGAAA GTTGGAAGCTTTGAGAGCAGAAG 
23 SNP_A-2124352 GGTGATTTGCCCTCGTTTTC AACTTCCCATGCCACAGCTT 
Chromosome 17 (p53) locus 
 p53 CCCAAGCAATGGATGATTTGA GAGCTTCATCTGGACCTGGGT 
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RT Q-PCR analysis of RNA 
Quantitative transcript analyses of ORMDL1, GDF8, LRCH, SUCLA2, 
VDRIP, DIRC1, GULP, PMS1, ITM2B, LRRTM4, HsG10342, SALL3, 
Esterase D, WDR75, GREM1 and FMN1 were performed. The RNA 
real-time quantitative PCR was carried out using SYBR Green assays. 
Intraexonic or exon-exon-boundary-spanning primers were designed 
by PrimerExpress v2.0 (Applied Biosystems, Foster City, California, 
USA) software with default parameters (Table 2). Before the cDNA 
conversion, RNA aliquots were taken and used later on as a non-
amplification control to check the quality of the DNaseI treatment and 
DNA contamination. The amplification efficiency of each assay was 
checked by a cDNA dilution series (Livak and Schmittgen, 2001). For 
all reactions 50ng cDNA and qPCR mastermix (Eurogentec, Seraing, 
Belgium) in a 15µl volume in duplicates were used. Reactions were 
run in an ABI 7500 Sequence Detection System (Applied Biosystems, 
Foster City, California, USA) with standard conditions. To calculate 
relative expression levels Ct values (SDS2.0 Applied Biosystems, 
Foster City, California, USA) were normalized in a two step 
procedure according the ∆∆Ct method (Livak and Schmittgen, 2001). 
Combination of means of seven reference genes Cts, ACTB, UBC, 
GUSB, B2M, CLK2, GAPDH and YWHAZ, was used for the first 
normalization (Vandesompele et al., 2002). Subsequently, each 
individual patient’s value was normalized to the mean value of at least 
three control individuals. All assays of interest were repeated two 
times, thus providing in total four runs per sample. Means of these two 
independent experiments (four runs), with standard deviation (SD) 
less than 0.15, were used for final fold difference calculation. 
Calculations were carried out in Excel 2003 (Microsoft Corporation, 
Redmond, Washington, USA). 
 
Array CGH analysis 
Four different array CGH platforms were used for: (1) primary 
screening for CNVs; (2) fine mapping of breakpoints in genomic 
deletions/ duplications; and (3) genotyping. 
 
1Mb array CGH 
Primary genomic screening for CNVs was performed with a modified 
array CGH platform from the donated 1 Mb BAC/PAC clone set of 
Sanger Institute (Hinxton, UK). This homemade array CGH with an 
approximate 1Mb resolution was used for analysis of patients with 
complex phenotypes and an abnormal skeletal/limb development. The  
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Table 2. Primers for RT Q-PCR analysis of RNA 
No ID Forward primer 5’→3’ Reverse primer 5’→3’ 
Chromosome 2p12 
1 
2 
LRRTM4 
 
CGCAGCTGAAAGGCATGA 
GGGATCAGAATGGTGTGAATGA 
AGCACCCGTGAGCATAACAAG  
TGGTCTCTTGTGCGGAAACC 
Chromosome 2q32.2 
3 DIRC1 GCTTCTCATCACCAGAAGGAAAA 
ACATCACTGCCCACCACAGA 
TGGGCCTCAGGCATTTGT 
TTGCTGAGTGGTGGCAAGTAA 
4 GULP1 TGTGTGCGGGAGGGAACT 
CTAAGTCGCCCTCCACTGACA
CAAGTCCCATTCAACATCGTAAAC 
GGCATCGAAGACTGGTGTGA 
5 
6 
7 
WDR75 TTTCAGTGACAGGCACCAGTCT 
GGTGCTACTGAAAATGGCATTCT 
CATACCCGCAATTAGTGAGCTTCT 
TGCATCGCGCCACTCTAC 
TGCATTCCACTCCAATGCA 
GAGCACAGGAAAGCAGCAGAT 
8 
9 
ORMDL1 CCCACAGTGAAGTGAATCCAAA 
CAGGTCTGCAGTAAAAGATAACATTTTC 
CCAATGCATATGTCAGCCACAT 
ACCCACGTATTCAAAGGCAAA 
10 
11 
12 
PMS1 CTTGCGGCTAGTGGATGGTAA 
AACAAGGCAGTTATTTGGCAGAA 
AAATGTCACTAAAAGATGGCAGAAAA 
TTTCGCTTTTAACAGAGCAGCTT 
GCAGTCCCCAGAACTGACATG 
CTTGTGCTTCTGGGCCAAA 
13 
14 
GDF8 AGTATGATGTCCAGAGGGATGACA 
CCCAGGACCAGGAGAAGATG 
TTGTTTCCGTTGTAGCGTGATAA 
AAATCCCTTCTGGATCTTTTTGG 
Chromosome 13q14.2 
15 
16 
LRCH AACCTGAGCGCCAGGAAAT 
CGACGACTGCAAAGTGTATGC 
CCGTGTCCGAGAGGTCATG 
GGCACTGCTGCTGGCACTA 
17 
18 
Est D 
 
TCGGCCCGCTTCTTCTG 
AGCAATTGGACAGGAAAAGAATG 
TTTTTGCTTGCACCAAATGG 
TGCAATCCCCCAAAGCA 
19 SUCLA2 TGTGGAATCAGCAGCAGAAAA 
TGGACCCAGGAAGATGAAAGG 
TGCTGCTAAGGCAAATCTCAAC 
TCTATCATGGTTGCATCGTATTTCA 
TTTCCATCGAGGCCAATGTAG 
GCCAAACCAGCACCATTTACTAG 
20 
21 
22 
VDRIP (=MED4) GCTGCTGTCTGCGCTTGAG 
GGGTTACTGGGTCAGATGAACAA 
TCCACTGACCTGGGTTCCA 
TTCTTGAAATTGCCAGCATTTCT 
GCAAGTGCATCTCCTGGTAAATG 
CCAGTAACCCACTTCTCATCTCTAAA 
23 
24 
ITM2B CCGCGCCATGGTGAA 
CAGAAACGTGAAGCCAGCAA 
TCGTCCTTCTTGGCCTCCTT 
TTAAAGTTTCCACGGCAAATTTG 
Chromosome 18q23 
25 
26 
27 
28 
HsG10342 GGTGTGCGGGCTCATCTG 
TCGCTGCTGCCAATGACA 
TGGGCGCCAGGACATCT 
TGGGCGCCAGGACATC 
TCACGGGAAGCACGATCTACT 
CGATGGCCTCCATGATCCT 
AGATGTGGGTCCTTCACAGAGAA 
ACATCATGACCACGAGCAGAT 
29 
30 
SALL3 
 
CCAAAGCACTCCTAGCCTGATC 
GCAGCTCGGGCAATGAAC 
TGACCGTTCACTTCCATTTTGA 
TGGCGAGCCCGTTAGTGA 
Chromosome 15q13.3 (GREM1-FMN1) locus 
31 GREM1ex2 GCAAAACCCAGCCGCTTAA GGTTGATGATGGTGCGACTGT 
39 
 
Table 2 continued 
32 FMN1ex15 CAAAGTCTGGTGAGAAGGAGATCA TTGTCTTGAAGTCACTGCAGAACTC 
reference genes 
33 
34 
ACTB1 
ACTB2 
CTGGAACGGTGAAGGTGACA 
CACCCTGAAGTACCCCATCG 
AAGGGACTTCCTGTAACAATGCA 
TGCCAGATTTTCTCCATGTCG 
35 B2M TGCTGTCTCCATGTTTGATGTATCT TCTCTGCTCCCCACCTCTAAGT 
36 CLK2 TCGTTAGCACCTTAGGAGAGG TGATCTTCAGGGCAACTCGGG 
37 GAPDH TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG 
38 GUSB AGAGTGGTGCTGAGGATTGG CCCTCATGCTCTAGCGTGTC 
39 UBC ATTTGGGTCGCGGTTCTTG TGCCTTGACATTCTCGATGGT 
40 YWHAZ ACTTTTGGTACATTGTGGCTTCAA CCGCCAGGACAAACCAGTAT 
 
hybridizations and the calculations were done as previously described 
(Vermeesch et al., 2005; Menten et al., 2006). A loop-design was used 
for all experiments allowing dye-swap analysis replicates at 
substantially reduced costs per patient. Thus, three differentially 
labelled patient’s samples were two-times hybridized in a way that 
any one was combined against the two others (Allemeersch et al., 
2009).  
 
Full tiling-path array CGH 
Fine mapping of the breakpoints in patients with 2q31 deletions was 
done using chromosome 2 specific tiling path BAC array. The 32K 
BAC clone set was donation of BACPAC (BPRC) Resource Centre at 
Children’s Hospital Oakland Research Institute (BPRC-CHORI, 
Oakland California, USA) (Krzywinski et al. 2004). All 
hybridizations with dye-swap replicates and the analyses were done as 
described (Van Buggenhout et al., 2005). The size of the detected 
aberrations is the maximum one defined by the first flanking BAC 
clones on the tiling-path array CGH platform for which a normal log2 
ratio was found.  
 
Affymetrix 250NspI array CGH 
Fine mapping of the chromosome 15q13.3 CNV breakpoints was 
performed with the Affymetrix 250K NspI oligoarray platform 
(Affymetrix, Santa Clara, California, USA). Samples were processed 
in accordance to the manufacturer’s instructions. In brief, 250ng of 
genomic DNA was digested with Nsp1 and after ligation to adaptors, 
amplified using generic primers recognizing the adaptor sequences. 
Subsequently 90µg of PCR product was fragmented and labelled with 
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biotin. All hybridizations were performed in an Affymetrix GeneChip 
Hybridization Oven and the arrays were washed and stained in the 
Affymetrix GeneChip Fluidics Station 450. Array scanning and image 
analysis were performed with Affymetrix GeneChip Scanner and 
Affymetrix GeneChip Operating Software v1.4 (GCOS), respectively. 
Genotype calls were obtained with Affymetrix Genotyping Analysis 
Software v4.1 (GTYPE) using the BRLMM algorithm. CNV analysis 
was performed by Affymetrix Chromosome Copy Number Analysis 
Tool v.4.0.1 (CNAT) using as control 41 female HapMap CEU 
individuals. 
 
Agilent 244K array CGH 
For fine mapping of the 10q24 duplication/ triplication breakpoints, 
the 244K oligoarray (Agilent, Santa Clara, California, USA) was used. 
All hybridizations and the analysis were performed according to the 
manufacturer’s protocol with small modifications (Thienpont, 2009) 
using a circular binary segmentation (CBS) algorithm for aberration 
detection, and a smoothing window of 10 points (Venkatraman and 
Olshen, 2007). The arrays were scanned with Genepix Axon 4000B 
(Molecular Devices, Sunnyvale, California, USA). The feature 
extraction from the scanned slides was done with the Agilent Feature 
Extraction Software v.9.5.3.1. (Agilent, Santa Clara, California, 
USA). The extracted data were processed with CGH-v4_10_Apr08 or 
CGH-v4_95_Feb07 protocol using the provided slide and probe 
annotation files (Agilent, Santa Clara, California, USA). The CBS 
method was described by Venkatraman and Olshen (2007) and we 
used this hybrid method for p-value calculations of our data. It was 
implemented in R using the following settings: a=0.002, 5000 
permutations. Splits were undone if they differed less than the 0.1 
times the standard deviation (calculated after a 0.05 trim of the input 
data). Four abnormal consecutive clones were used to call a 
duplication, allowing 3.5% false negative results (Thienpont, 2009).  
 
PCR amplification and direct sequencing 
The coding part of the GDF6 and GREM1 exons, including the intron-
exon boundaries, was PCR amplified from genomic DNA. In addition, 
to look for mono-allelic expression on cDNA level, two genes 
Esterase D and WDR75 were sequenced for known coding SNPs 
(dbSNP). Gene specific primers were designed using RepeatMasker 
pre-analyzed sequences as an input for the Primer3 and/ or 
ExonPrimer software (Table 3). Subsequently, the amplicons and the 
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primer specificity were checked in-silico by BLAST, BLAT and 
UCSC in-silico PCR (Altschul et al., 1990; Kent, 2002; Karolchik et 
al., 2003; Johnson et al., 2008) against the NCBI Build 36.1 reference 
human genome sequence. For the amplification 100-150ng genomic 
DNA or cDNA were used with 0.2µl Taq polymerase (50U/µl, Roche 
Diagnostics GmbH, Penzberg, Germany), 5µl 10xPCR buffer (Roche 
Diagnostics GmbH, Penzberg, Germany), 5µl dNTPs (2µmol) and 
sterile water up to 50µl total reaction volume. The thermo-cycling 
conditions were adjusted according the primer specifications. After 
purification of the PCR product with ExoSAP IT (Roche), sequencing 
was performed with BigDye Terminator cycle sequencing kit on ABI 
3100 Avant system (Applied Biosystems, Foster City, California, 
USA). The output sequence reads were analyzed with Seqman 
software (DNA star, Konstanz, Germany). 
 
Table 3. Primers for PCR amplification and direct sequencing 
No ID Forward primer 5’→3’ Reverse primer 5’→3’ 
primers for direct sequencing of the coding part of GREM1 
1 GREM1ex2_1 TGCGTTTAAATGCTAGGTGC GAAGCGGTTGATGATGGTG 
2 GREM1ex2_2 CAAGAGGCCCTGCATGTG TCTGGTTGTTTTAGGTCTGGG 
 
 
Web-based electronic sources: 
BLAST: http://blast.ncbi.nlm.nih.gov/ 
BLAT: http://genome.ucsc.edu/cgi-bin/hgBlat?command=start 
BPRC-CHORI: http://bacpac.chori.org/home.htm 
Ensembl Genome 
Browser: http://www.ensembl.org/index.html 
ExonPrimer: http://ihg2.helmholtz-muenchen.de/ihg/ExonPrimer.html 
GeneCards: http://www.genecards.org  
GeneSeeker:  http://www.cmbi.kun.nl/GeneSeeker  
GEO: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=geo  
HomoloGene: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db= 
  homologene 
MGI: http://www.informatics.jax.org/  
NCBI:  http://www.ncbi.nlm.nih.gov 
OMIM: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM 
Primer3: http://frodo.wi.mit.edu/primer3/  
Materials and Methods 
42 
PubMed: http://www.ncbi.nlm.nih.gov/pubmed/  
RepeatMasker: http://www.repeatmasker.org/ 
UCSC Genome:  
Browser: http://genome.ucsc.edu/  
UniGene:   http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=unigene  
UCSC: http://genome.ucsc.edu/ 
VISTA:   http://genome.lbl.gov/vista/index.shtml 
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4. RESULTS 
Chapter I. Positional cloning of candidate genes in 
apparently balanced chromosomal aberrations 
Reciprocal translocations are rearrangements that result from a single 
break in each of the two participating chromosomes. All chromosomes 
have been reported to participate in reciprocal translocations. They 
occur in about 1 in 625 individuals in the population and most of them 
are considered “private” as they are only found in members of the 
same family (Gardner and Sutherland, 2004).  
Inversions are intrachromosomal structural rearrangements. The most 
common are the simple (or single) inversions. If the inversion coexists 
with another rearrangement in the same chromosome it is a complex 
inversion. The simple inversions comprise a two-breakpoint event 
involving just one chromosome. If the inverted segment includes the 
centromere, the inversion is pericentric, if not it is paracentric.  
Balanced chromosomal rearrangements may be either familial or de 
novo. Warburton (1991) estimated that 6.7% of the de novo reciprocal 
translocations and inversions are associated with phenotypic 
abnormalities. However, there could be an underestimation of the 
causal genotype/ phenotype relationship since there are no data about 
long term follow-up of “phenotypically normal” carriers for the 
presence of late onset diseases which remained undetected at the time 
of the cytogenetic finding (Bache et al., 2006). 
A number of hypotheses have been postulated to explain the observed 
phenotypic abnormalities: (1) a direct disruption of gene(s) at the 
aberration breakpoint(s), with loss of function of the affected 
transcript(s)/ protein(s); (2) a position effect of the cytogenetic 
rearrangement upon the function of neighbouring gene(s); (3) the 
presence of cryptic (cis- or trans-), undetected cytogenetically 
deletion(s)/ duplication(s) leading to an abrogated function of gene(s); 
(4) unmasking of a recessive allele; and (5) uniparental disomy if the 
locus is known to be imprinted. Finally, there may be no causal 
relationship between the patient’s phenotype and the balanced 
chromosome rearrangement (Astbury et al., 2004).  
Over the years, mapping of translocation breakpoints in patients 
proved to be a straightforward method for the identification of new 
disease genes (Bugge et al., 2000). The number of published de novo 
and familial chromosomal rearrangements associated with phenotypic 
abnormalities is gradually increasing, thus providing more candidate 
loci for the corresponding phenotypes. Nowadays, the combined use 
of classical high-resolution G-banded karyotyping and new molecular 
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cytogenetic techniques resulted in faster investigation of these 
chromosomal aberrations at a relatively low cost. This is possible 
thanks to the availability of the reference Human Genome Sequence 
and the utilization of human genomic libraries of bacterial artificial 
chromosomes (BACs), fosmids and other vectors derived from the 
Human Genome Project (Krzywinski et al., 2004). These sources in 
conjunction with classical FISH analysis and new techniques such as 
array CGH (Backx et al., 2007; Gribble et al., 2007), chromatin 
conformation capture on chip (4C) (Simonis et al., 2009) and new 
generation sequencing (Chen et al., 2008) enable more in-depth 
characterization of a series of patients, providing potentially 
interesting phenotype/genotype correlations (Vandeweyer and Kooy, 
2009). Unfortunately, time constraints, and more importantly the limit 
of available reliable methodologies for further evaluation of candidate 
genes, especially in cases where no directly affected transcript by the 
translocation(s) is present, still remain a restricting issue. 
In summary, chromosomal aberrations are a major cause of congenital 
malformations in man. The study of these cytogenetic abnormalities 
may lead to the discovery of new disease gene(s) or to the 
identification of novel pathogenic mutations in already described 
gene(s). 
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Part 1. Mesomelic form of chondrodysplasia and congenital 
glaucoma associated with de novo translocation (13; 18)(q14; q23) 
Adapted from Genetic Counseling 2004;15:191-197 
B. Dimitrov, K. Devriendt, N.M.C. Maas, J.R. Vermeesch, D. 
Zahariev, D. Avdjieva, A. Popova, J.P. Fryns and E. Simeonov 
 
Introduction 
The skeletal dysplasias are a large, heterogeneous group of genetic 
conditions characterized by abnormal development, growth and 
maintenance of the human skeleton. The overall incidence rate of 
congenital anomalies affecting the skeleton reaches almost 16 per 
10000 births and congenital skeletal dysplasias represent less than one 
third of this group (Stoll et al., 1989; Rasmussen et al., 1996; 
Dimitrov et al., 2000). 
There are at least 200 well-recognized forms of bone dysplasias and 
skeletal dysostoses, which can be differentiated by clinical, 
radiological and genetic features. Many result in a deformity of 
skeletal cartilage or bone, leading to common features such as short 
stature, limb malalignment, muscle hypotonia and joint contractures. 
Non-skeletal cartilage may also be involved, resulting in upper airway 
or respiratory disorders in infancy, hearing defects, dental and ocular 
pathology.  
In the past, several well distinct mesomelic forms of disproportionate 
short stature have been described, e.g. Dyschondrosteosis (Leri-
Weill), Langer type (homozygous dyschondrosteosis), Nievergelt 
type, Kozlowski-Reardon type, Reinhard-Pfeiffer type, Werner type, 
dominant and recessive Robinow type, Mesomelic dysplasia with 
synostoses, Mesomelic dysplasia Kantaputra type, Mesomelic 
dysplasia Verloes type, Mesomelic dysplasia Savarirayan type. In 
addition, a few less delineated sporadic patients and familial 
observations of mesomelic dysplasias were published (Ventruto et al., 
1983; Fryns et al., 1988; Brodie et al., 1998; Kerner et al., 1998; 
Nishimura et al., 1998; Kozlowski and Masel, 1999; Kitoh and 
Lachman, 2001; Camera and Camera, 2003).  
We report the clinical and cytogenetic data in a female patient 
presenting an unusual form of mesomelic skeletal dysplasia with other 
systemic anomalies and an associated de novo translocation 
(13;18)(q14;q23).
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Clinical report  
This Bulgarian girl, product of an uneventful second pregnancy to 
young unrelated and healthy parents, was referred to the Clinical 
Genetic Unit at the age of one month because of an atypical form of 
skeletal dysplasia. Birth weight, length and head circumference were 
3000g (SDS= -0.73), 46cm (SDS= -2.16) and 36cm (SDS= 1.22), 
respectively. The family history was unremarkable except that the 
mother had had one miscarriage. 
Clinical follow-up noted a disproportionate mesomelic short stature 
and developmental delay (Figure 1A-G). There was mild facial 
dysmorphism with a high forehead, fine and sparse hair, 
hypertelorism, greyish-blue sclerae, midface hypoplasia, with de- 
Figure 1. A, B, C, D, E, F & G: The phenotype at different ages: at 1 month of age 
(A & B); at 1 year of age (C, D & E); at 2,5 years of age (F & G). Note the midfacial 
hypoplasia, high promonent forehead, fine and sparse hair, downslanting palpebral 
fissures, small mouth, mesomelic shortening of the upper limbs and ulnar deviation 
of the hands. 
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pressed nasal bridge, down-slanting palpebral fissures (also seen in the 
mother), short up-turned nose, and long philtrum. Short forearms, 
ulnar deviation of the hands, fifth finger clinodactyly, varus position 
of the feet, bilateral sandal-gap, persistent mild muscular hypotonia 
with an open mouth and a low, hoarse voice were also present. 
Ultrasound screening revealed patent ductus arteriosus and an 
ophthalmologic examination revealed bilateral glaucoma with opaque 
corneal stroma, and a shallow anterior chamber. 
At the age of two years (Figure 1C-E) surgical correction of the heart 
defect was performed. A month later, two episodes of convulsions 
were observed. Brain CT scan did not detect any abnormalities but the 
seizures persist until the age of nine years.  
Serial skeletal radiographs showed progressive shortening of the 
forearms with distally hypoplastic ulnae and curved, proximally 
subluxated radii (Figure 2A,B). Dysplastic and irregular metaphyses 
were noted. The ulnae were more severely affected and a delayed  
Figure 2. Upper limb radiographs at 1 year of age (A- AP position): there was 
striking shortening of the forearm bones (radiograph of right upper limb- AP 
position). The ulna was shorter with distally hypoplastic cup-shaped metaphysis. 
There were also bowing of radius and ulnar deviation of the hand; B) At 2.6 years of 
age radiographs of the left upper limb (B- AP position) detected delayed bone age, 
clinodactyly, subluxated proximally radius and hypoplastic lateral part of the ulna as 
a result of metaphyseal dysplasia affecting preferably the distal part of the forearm 
bones. 
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bone age was present (Figure 2A). Vertebral abnormalities were not 
detected. No striking lower limb deformities were observed. However, 
mild shortening of the femurs, broad and short femoral necks and an 
irregular ossification of the distal tibia metaphyses were detected over 
the years of follow-up (Figure 3A,B). Serum alkaline phosphatase and 
electrolytes were repeatedly normal. 
 
Figure 3. X-ray examinations of the lower limbs at 1 year (A- AP position) and 2.5 
years of age (B- AP position) At 1 year of age (A) there was delayed ossification of 
the proximal femoral and tibial epiphyses. At 2.5 year of age (B) was detected 
irregular ossification of the distal metaphyses of the tibiae is noted (indicated with 
arrow).  
 
 
High resolution G-banded karyotyping revealed a de novo reciprocal 
translocation (13;18)(q14;q23) (Figure 4).  
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Figure 4. Partial karyotype and ideograms of chromosomes 13 and 18 showing a de 
novo translocation (13;18)(q14;q23). Arrows indicate the breakpoints. 
 
Chromosomes 13q14 and 18q23 as candidate loci for an apparent-
ly new form of mesomelic chondrodysplasia 
The present female patient has a mesomelic form of skeletal dysplasia, 
congenital glaucoma, cardiac defect and muscular hypotonia. In 
addition she carries a de novo reciprocal translocation 
(13;18)(q14;q23).  
Based on the clinical and radiological findings, we could not classify 
the skeletal phenotype of this patient into one of the well-delineated 
syndromic or non-syndromic forms of mesomelic dysplasias (see also 
Table I). 
There are a few other reports in the literature on not-well classifiable 
mesomelic shortening of the upper limbs. Fryns et al. (1989) 
published isolated mesomelic shortening of the forearms in father and 
daughter. More recently, Camera and Camera (2003) described 
another 5-year-old boy with mesomelic dysplasia affecting mainly the 
upper extremities. In both publications, the affected individuals had 
metaphyseal abnormalities similar to those observed in the present 
patient.  
However, the present girl has additional ocular defects. Bilateral 
congenital glaucoma with shallow anterior chamber and opaque 
corneal stroma are seen in the Axenfeld-Rieger Malformation (ARM). 
The ARM syndrome is an autosomal dominant disorder characterized 
by abnormal development of the anterior segment of the eye and 
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subsequent glaucoma. There is genetic heterogeneity and at least 5 
associated genomic loci exist. Most of the detected mutations affect 
PITX2 and FOXC1 genes (Lines et al., 2002). PAX6 mutations have 
been also reported (Rijse et al., 2001). Two additional loci are mapped 
at chromosome 13q14 (13) and 16q24 (Ferguson and Hicks, 1987; 
Werner et al., 1997). Interestingly, one of the two translocation 
breakpoints in our patient is 13q14. These data suggest that a gene(s) 
disrupted by the detected de novo translocation may explain her 
skeletal and/ or ocular abnormalities.  
 
Chapter I. Part 1 
51 
 
Pr
es
en
t c
as
e 
B
irt
h 
Sh
or
t s
ta
tu
re
 
Sh
or
t w
ith
 d
is
ta
l 
m
et
ap
hy
se
al
 
hy
po
pl
as
ia
 
Sh
or
t w
ith
 d
is
ta
l 
m
et
ap
hy
se
al
 
ch
an
ge
s a
nd
 
pr
ox
im
al
 
di
sl
oc
at
io
n 
D
is
ta
l i
rr
eg
ul
ar
 
m
et
ap
hy
se
al
 
os
si
fic
at
io
n - 
C
lin
od
ac
ty
ly
 
Pr
om
in
en
t 
fo
re
he
ad
, m
id
fa
ce
 
hy
po
pl
as
ia
, p
at
en
t 
du
ct
us
 a
rte
rio
su
s, 
gl
au
co
m
a 
t(1
3;
18
)(
q1
4;
q2
3)
 
C
am
er
a 
20
03
 
2 
ye
ar
s 
N
or
m
al
 st
at
ur
e 
Sh
or
t w
ith
 d
is
ta
l 
m
et
ap
hy
se
al
 
irr
eg
ul
ar
iti
es
 
Sh
or
t w
ith
 d
is
ta
l 
m
et
ap
hy
se
al
  
ch
an
ge
s a
nd
  
pr
ox
im
al
  
di
sl
oc
at
io
n 
D
is
ta
l  
m
et
ap
hy
se
al
 
os
si
fic
at
io
n 
irr
eg
ul
ar
iti
es
 
- - 
Pr
om
in
en
t  
fo
re
he
ad
, m
ax
ill
ar
y 
hy
po
pl
as
ia
, e
lb
ow
 
co
nt
ra
ct
ur
es
 
N
ot
 k
no
w
n 
Fr
yn
s 1
98
3 
B
irt
h 
N
or
m
al
 st
at
ur
e 
Sh
or
t a
nd
 th
ic
k 
Sh
or
t, 
dy
sp
la
st
ic
  
an
d 
cu
rv
ed
 - - - - - 
N
ot
 k
no
w
n 
R
ob
in
ow
 ty
pe
 
B
irt
h 
M
ild
 sh
or
te
ni
ng
 
D
is
ta
l h
yp
op
la
si
a 
Sh
or
t, 
pr
ox
im
al
 
di
sl
oc
at
io
n -
 - - 
C
lin
od
ac
ty
ly
 
C
ra
ni
of
ac
ia
l 
dy
sm
or
ph
is
m
, 
hy
po
pl
as
tic
 g
en
ita
lia
, 
ve
rte
br
al
 a
nd
 ri
b 
ab
no
rm
al
iti
es
 
RO
R2
 a
nd
 W
N
T5
a*
 
N
ie
ve
rg
el
t t
yp
e 
B
irt
h 
Sh
or
t s
ta
tu
re
 
R
ho
m
bo
id
 
R
ho
m
bo
id
, p
ro
xi
m
al
 
di
sl
oc
at
io
n 
R
ho
m
bo
id
 
R
ho
m
bo
id
 
Ta
rs
al
 sy
no
st
os
is
 
- 
R
ad
io
ul
na
r  
sy
no
st
os
is
, e
lb
ow
 
co
nt
ra
ct
ur
es
,  
cl
ub
fo
ot
 
N
ot
 k
no
w
n 
L
an
ge
r 
ty
pe
 
B
irt
h 
Sh
or
t s
ta
tu
re
 
D
is
ta
l h
yp
op
la
si
a 
Sh
or
t a
nd
 d
ef
or
m
ed
, 
pr
ox
im
al
 h
yp
op
la
si
a 
 Sh
or
t, 
 
pr
ox
im
al
 h
yp
op
la
si
a 
Pr
ox
im
al
 h
yp
op
la
si
a 
- - 
M
an
di
bu
la
r 
hy
po
pl
as
ia
, u
ln
ar
 
de
vi
at
io
n 
of
 h
an
ds
 
SH
O
X 
Le
ri
-W
ei
ll 
D
ys
ch
on
-
dr
os
te
os
is 
La
te
 c
hi
ld
 
M
ild
 
M
ad
el
un
g 
 
de
fo
rm
ity
 
Sh
or
t a
nd
  
cu
rv
ed
 
Sh
or
t 
Sh
or
t 
Sh
or
t 
Sh
or
t 
C
ub
itu
s v
al
gu
s, 
 
co
xa
 v
al
ga
, e
lb
ow
 
co
nt
ra
ct
ur
es
 
SH
O
X 
   
   
   
M
SD
  
 ph
en
ot
yp
e 
A
ge
 a
t o
ns
et
 
Sh
or
t s
ta
tu
re
 
U
ln
ae
 
R
ad
ii 
Ti
bi
ae
 
Fi
bu
la
s 
M
et
ac
ar
pa
ls
/ 
ta
rs
al
s 
Ph
al
an
ge
s 
O
th
er
  
ra
di
ol
og
ic
/ 
cl
in
ic
al
 
ch
an
ge
s 
G
en
e 
- n
or
m
al
 o
r n
o 
da
ta
; *
 R
O
R2
 a
nd
 W
N
T5
a 
m
ut
at
io
ns
 a
re
 fo
un
d 
in
 A
R
 a
nd
 A
D
 ty
pe
s o
f R
ob
in
ow
 sy
nd
ro
m
e,
 re
sp
ec
tiv
el
y 
T
ab
le
 I.
 D
iff
er
en
tia
l d
ia
gn
os
is
 o
f t
he
 re
po
rte
d 
pa
tie
nt
 a
nd
 so
m
e 
fo
rm
s o
f m
es
om
el
ic
 sk
el
et
al
 d
ys
pl
as
ia
s 
Results 
52 
  
Chapter I. Part 2 
53 
Part 2. Physical mapping of the breakpoints in two patients: (1) a 
girl with mesomelic chondrodysplasia associated with de novo 
translocation (13; 18)(q14; q23) (Dimitrov et al., 2004) and (2) a 
female patient with a syndromic form of Klippel-Feil anomaly 
associated with de novo inversion (2)(p12q34) (Papagrigirakis et al., 
2003) 
 
Introduction 
Over the last years several approaches have been applied to identify 
genes involved in skeletal development and causing different bone 
dysplasias/ dysostoses. As was discussed above, one possibility is the 
study of de novo or familial chromosomal translocations associated 
with a distinct phenotype.  
Two individuals with a specific phenotype associated with a de novo 
apparently balanced chromosomal aberration were identified. The first 
patient with mesomelic skeletal dysplasia (MSDP1), congenital 
glaucoma, congenital heart defect and a de novo translocation 
(13;18)(q14;q23) was described by Dimitrov et al. (2004). The second 
patient (KFP2) is carrier of a de novo inversion (2)(p12q34) associated 
with Klippel-Feil anomaly (fusion of 3-5th cervical vertebrae), 
developmental delay, short stature, facial asymmetry, hearing loss due 
to abnormal ossicles, hypodontia and hypothyroidism. She was the 
third child of healthy parents with a normal family history. At birth 
the mother and father were respectively 38 and 47 year old. Her 
clinical phenotype was published by Papagrigorakis et al. (2004) and 
provides a new candidate locus for the Klippel-Feil syndrome.  
There was no known molecular defect for these two conditions. We 
hypothesized that a disrupted gene could explain the abnormal 
phenotypes. Positional candidate gene approach was used to identify 
these putative genes.  
 
Results 
Fine breakpoint mapping 
Physical mapping of the four breakpoints to a resolution of 20-80Kb 
was carried out by “walking” FISH using commercially available 
BAC and fosmid clones as probes. In the first patient (MSDP1), two 
partially overlapping fosmids, WI2-2361G3 and WI2-1145P21, 
covered the breakpoint at chromosome 13q14.2 (Figure 1). For the 
second involved chromosome, there was a breakpoint spanning FISH 
probe WI2-414C22 at 18q23 (Figure 2). Similarly, in the second 
patient (KFP2) we were able to detect a split FISH signal with BAC 
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CTC-444N24 located at chromosome 2q32.2 (Figure 3) and the 
second inversion breakpoint at 2p12 locus was flanked by BAC RP11-
9O10 and fosmid WI2-3162E4. 
No genes were identified to be directly disrupted by the aberrations 
according the available data of the reference Human Genome 
Sequence (Ensembl, UCSC and NCBI) in these two patients. Several 
recent publications report on additional cis- and/ or trans-CNVs in 
carriers of apparently balanced chromosomal rearrangements. 
Therefore, a 1Mb array CGH analysis was performed but no 
additional loss or gain of genomic material was detected at this 
resolution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. A) Chromosome 13q (not drawn to scale) with genes located between 47-
49Mb. The red arrow demonstrates the position of the breakpoint. Red bars 
represent the two fosmid clones that flank the breakpoint. Vertical black lines 
represent the size of 13q deletions in patients published by Thienpont et al. (2005), 
Caseli et al. (2007), Brichard et al. (2008) and Roche et al. (2010). The transparent 
green bar highlights the locus and genes analyzed for a possible position effect. B-C) 
FISH analysis results with the breakpoint-flanking fosmids WI2-2361G3 and WI2-
1145P2 labelled in red are shown. The subtelomeric probe 13q (red signal) is used as 
control. D) Freeze of the UCSC genome browser (GRCh37/hg19) representing the 
highlighted area in part A. The transparent vertical red bar represents the position of 
the breakpoint. Horizontal red bars show the position of fosmids WI2-2361G3 and 
WI2-1145P2. There is no gene disrupted by the translocation. 
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Figure 2. Chromosome 18q (not drawn to scale) with some of the genes located 
between 74-78Mb. The red arrow marks the position of the breakpoint. The red bar 
represents the breakpoint-spanning fosmid WI2-414C22. Vertical black lines, named 
p1, p2 and p3, represent the size of the 18q deletions in patients from our Centre. 
None of these patients have skeletal anomalies similar to MSDP1. The transparent 
green bar highlights the 18q23 locus. B) Fosmid WI2-414C22 (red signal) spans the 
breakpoint. A centromeric probe 18 (red signal) is used as control. C) Freeze of the 
UCSC genome browser (GRCh37/hg19) showing band 18q23. The transparent 
vertical red bar represents the position of the breakpoint. The horizontal red bar 
shows the position of fosmid WI2-414C22. There is no gene disrupted by the 
translocation. 
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Figure 3. A) Chromosome 2q (not drawn to scale) with some of the genes located 
between 189-191Mb. The red arrow marks the position of the breakpoint. The green 
bar represents the breakpoint-spanning BAC CTC-444N24. The transparent green 
bar highlights the 2q32.1q32.2 locus. B-C) A split signal of BAC CTC-444N24 
(green signal) was detected. BAC RP11-440P5 (red signal) is used as control.C) 
Freeze of the UCSC genome browser (GRCh37/hg19) showing band 2q32.1q32.2. 
The transparent vertical red bar represents the position of the breakpoint. The 
horizontal green bar shows the position of BAC CTC-444N24. It lies almost 40Kbps 
downstream from COL5A2 and does not cover any currently known genes. 
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Selection of “candidate gene(s)” 
Computational analysis 
To exclude/ confirm the possibility of a position effect, all genes 
located in a region of 1.5Mb up- and down-stream of the breakpoints 
were considered as “putative” candidate genes. Based on an 
evaluation of their potential to represent a “reliable candidate gene”, 
fourteen transcripts in the vicinity of the translocation breakpoints 
were selected for further evaluation. Literature review (PubMed), 
expression profiles (GEO, UniGene), known or suspected biological 
functions (HomoloGene) and known associations with human or 
animal disorders (OMIM, OMIA, MGI) were the major criteria for 
selection. The restriction of our interest to transcripts with “proven” 
current status in the three major human genome browsers (Ensembl, 
UCSC and NCBI) was based on observations that the maximal 
distance of a position effect described thus far is approximately 1.3Mb 
(Velagaleti et al., 2005). In addition, terminal deletions of 
chromosome 18q are frequent and often include band 18q23. None of 
the currently known individuals with the 18q deletion syndrome 
feature skeletal abnormalities consistent with a diagnosis of 
mesomelic skeletal dysplasia. Thus, the involvement of a gene at 
chromosome 18q23 as a cause of the skeletal phenotype in the first 
patient (MSDP1) is unlikely. Therefore, the investigations at this locus 
were restricted to two transcripts, HsG10342 and SALL3. 
Finally, the following fourteen candidate genes were selected: (1) for 
chromosome 2p12 - LRRTM4; (2) for chromosome 2q34 – DIRC1, 
GULP1, WDR75, ORMDL1, PMS1, GDF8; (3) for chromosome 
13q14 – LRCH, Esterase D, SUCLA2, VDRIP (=MED4), ITM2B; and 
(4) for chromosome 18q23 – HsG10342 and SALL3.  
 
Expression analysis of the “candidate genes” 
The expression levels of the selected “candidate genes” were analyzed 
in EBV-cell-line derived cDNA (Table 1). Normal expression patterns 
were observed for ORMDL1, GDF8, LRCH, SUCLA2, VDRIP, 
DIRC1, GULP, PMS1 and ITM2B. No expression was detected for 
LRRTM4, HsG10342 and SALL3. For two genes, Esterase D and 
WDR75, there was a wide variability of the expression profile within 
the control samples. Therefore, it was impossible to conclude whether 
the expression was significantly disturbed in the patients. For these 
two genes, the mono-allelic expression of currently known coding 
SNPs was alternatively analyzed at cDNA level and no heterozygosity 
was detected (Table 1). 
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Table 1. Expression patterns of the selected for analysis genes. 
gene chromosome distance to the 
breakpoint* 
expression 
   RT-Q-PCR SNPs 
LRRTM4 2p12 350 kbps (5’) no expression in EBV cell line  
DIRC1 2q32.2 500kbps (5’) no significant abnormalities in 
EBV cell line 
 
GULP1 2q32.2 700kbps (3’) no significant abnormalities in 
EBV cell line 
 
WDR75 2q32.2 160kbps (5’) high variability among the 
controls in EBV cell line 
not detected 
ORMDL1 2q32.2 490kbps (3’) no significant abnormalities in 
EBV cell line 
 
PMS1 2q32.2 500kbps (5’) no significant abnormalities in 
EBV cell line 
 
GDF8 2q32.2 780kbps (3’) no significant abnormalities in 
EBV cell line 
 
LRCH 13q14.2 200kbps (3’) no significant abnormalities in 
EBV cell line 
 
Est D 13q14.2 160kbps (5’) high variability among the 
controls in EBV cell line 
not detected 
SUCLA 
 
13q14.2 1mbps (3’) no significant abnormalities in 
EBV cell line 
 
VDRIP 
(=MED4) 
13q14.2 1.1mbps (3’) no significant abnormalities in 
EBV cell line 
 
ITM2B 13q14.2 1.2mbps (5’) no significant abnormalities in 
EBV cell line 
 
HsG10342 18q23 directly  
disrupted 
no expression in EBV cell line  
SALL3 18q23 150kbps (5’) no expression in EBV cell line  
*- according the May 2004 Human reference sequence, NCBI build 35 
(NCBI35/hg17)  
 
Discussion 
In both patients, the chromosomal aberrations did not disrupt any 
known genes. Moreover, we did not find any gross alterations in the 
expression pattern of all selected “candidate genes” in EBV-
lymphoblastoid cell lines. The implementation of array CGH analysis 
in the clinical practice allowed the detection of an enormous number 
of genomic CNVs scattered throughout the entire human genome. 
Based on searches in databases with information reporting human 
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CNVs (Cartagenia, DECIPHER, ECARUCA) (Feenstra et al., 2006; 
Van Vooren et al., 2007; Firth et al., 2009) and review of the current 
literature we found a few individuals carrying deletions encompassing 
all four breakpoints that we mapped (Barber et al., 2005; Thienpont et 
al., 2005; Caselli et al., 2007; Brichard et al., 2008; Roche et al., 
2010). None of these published patients had any skeletal defects. This 
excludes the possibility that a position effect and subsequent simple 
haploinsufficiency of genes in close proximity to the delineated 
breakpoints could explain the skeletal phenotypes in Patient 
1(MSDP1) and Patient 2 (KFAP2). After these negative findings 
further analyses were not performed. However, we cannot firmly 
exclude or confirm the genotype/ phenotype relationship in the studied 
individuals. Of interest, RB1 gene is located on chromosome 13q14.2. 
Individuals with disturbed RB1 function as a result of gene mutations 
or genomic deletions have retinoblastoma (Thienpont et al., 2005; 
Caselli et al., 2007; Brichard et al., 2008). Recently it was 
demonstrated that Axenfeld-Rieger anomaly can also be observed in 
the 13q14.2 deletion/ retinoblastoma syndrome (Roche et al., 2010). 
The physical distance between the RB1 gene and the 13q14 breakpoint 
in our patient with MSD and Axenfeld-Rieger-like ocular defects is 
approximately 1.5Mb. Therefore a hypothetical position effect upon 
the RB1 function could explain at least partially the eye defect in this 
individual. No retinoblastoma has been detected in this Bulgarian girl. 
 
The lack of explanation for the phenotypes in patients with balanced 
chromosomal aberrations and no directly disrupted gene is a well-
known phenomenon (Kleinjan and Lettice, 2008; Spitz and Duboule, 
2008; Vandeweyer and Kooy, 2009). 
At present, only the abnormal patient’s phenotype still suggests a 
suspected position effect. However, the full normal and abnormal 
phenotypic effect of the majority of the human genes remains 
unknown. Several recent publications demonstrate that genomic 
rearrangements affecting the regulatory landscapes of developmental 
master genes (e.g. SOX9) cause a spectrum of different developmental 
anomalies (Benko et al., 2009; Gordon et al., 2009; Kurth et al., 
2009).  
In addition, restricting the research interest of a possible position 
effect to the limit of its currently known maximum distance (e.g. 
1.3Kb in SOX9 gene), is imprecise and biased.  
A general rule of thumb is that a position effect is due to a loss-of-
gene-function. However, recent studies demonstrate more complex 
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interactions affecting the function of several contiguous genes in 
vicinity in the genome. Thus, the ulnaless (ul) strain if mice carry an 
inversion which disrupts the GCR-Lnp-Evx2-Hoxd regulatory 
landscape. This leads to both loss-of-function and gain-of-function 
tissue specific effects of different Hoxd genes in the developing limbs 
(Spitz et al., 2003).  
Finally, currently there are technical limitations to the available 
approaches for prediction and analysis of regulatory sequences. This 
field is still under development (Poulin et al., 2005; Pennacchio et al., 
2006; Prabhakar et al., 2006; Kleinjan and Lettice, 2008; Loots, 
2008). Thus, it could be a daunting task to prove a position effect in 
early developmental genes due to: (1) limitation of patient samples, 
(2) dissimilarities with an inappropriately chosen animal model and 
(3) difficulties in  the precise gene expression quantification during 
the development (Kleinjan and Lettice, 2008; Spitz and Duboule, 
2008; Zeller et al., 2009). Hence, there is an urgent need for the 
development and application of new systems biology approaches to 
the study of developmental disorders.  
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Chapter II. CNVs as a cause of congenital skeletal defects 
Genomic Copy Number Variations (CNVs) were defined as DNA 
segments that are present at a variable copy number in comparison 
with a reference genome sequence, e.g. deletions (homozygous or 
heterozygous), duplications, triplications, amplifications (Feuk et al., 
2006; Zhang et al., 2009). The availability of new techniques for 
genome analysis resulted in the establishment of the concept of 
genomic disorders and led to explosion of new knowledge regarding 
the importance of structural genomic variations in human evolution, 
health and disease (Lupski, 1998, 2009). Even more, CNVs have been 
found to be implicated in the aetiology of complex traits such as 
autism, schizophrenia, epilepsy, Parkinson disease, Alzheimer disease, 
and emphysema. It was also demonstrated that they can behave as 
susceptibility factors for common disorders such as HIV infection, 
Crohn disease, glomerulonephritis, psoriasis, systemic lupus 
erythematosus. Finally, by changing our biased way of singe-locus 
thinking and thus the algorithm for genetic testing of patients with 
congenital anomalies of unknown aetiology, the analysis for CNVs 
helped to unravel the genetic cause of several anomalies affecting the 
skeleton and the limbs (Hurles et al., 2008; Conrad et al., 2010; 
Fanciulli et al., 2010; Stankiewicz and Lupski, 2010). In this project 
two different methods for CNV detection were used: quantitative PCR 
(RT Q-PCR) and array CGH analysis. 
Re
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(~12%) of intragenic deletions, confirming previous observations that 
strict clinical selection criteria improve the genetic testing yield 
(McDermott et al., 2005; Debeer et al., 2007). A substantial portion of 
patients with “classical” HOS or HOS-like phenotypes remain without 
known molecular defect, thus leaving room for new causal gene(s) to 
be discovered. 
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Part 2. Array CGH analysis of individuals with congenital skeletal 
anomalies 
The CGH array is a relatively new, high throughput method for total 
genome screening in a single experiment. Given its enormous 
potential in identifying submicroscopic duplications/ deletions, it has 
already been implemented in the diagnostics of patients with 
developmental/ congenital abnormalities of unknown aetiology. This 
method has helped in identifying new genes causing inherited 
disorders (Vissers et al., 2004).  
Forty-two patients with congenital skeletal anomalies as part of a 
syndrome, (e.g. Distal limb deficiency/micrognathia syndrome 
(OMIM 246560), syndromic forms of SHFM, polysyndactyly, 
multiple synostoses, Hajdu-Cheney syndrome, vertebral segmentation 
defects) have been selected for 1Mb array CGH analysis. Based on 
well-defined algorithm in this Centre for interpretation of CNVs (de 
Ravel, 2009; Thienpont, 2009), 10/42 (23%) causal deletions/ 
duplications were detected. The detected chromosomal aberrations 
and corresponding patients’ phenotypes are summarized in Table 1. 
These results demonstrate the importance of array CHG in 
identification of the genetic aetiology of congenital skeletal defects. 
We were able (1) to extend the clinical spectrum of SHFM3, (2) to 
delineate two new genetic syndromes, and (3) to characterize further 
the phenotype of patients with 2q31 microdeletions and to define the 
critical loci for the observed limb/ skeletal defects and characteristic 
Facial Gestalt in the 2q31.1 microdeletion syndrome. 
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Distal limb deficiencies, micrognathia syndrome (OMIM 246560) 
and syndromic forms of split hand foot malformation (SHFM) are 
caused by chromosome 10q genomic rearrangements  
Adapted from Journal of Medical Genetics 2010;47:103-111 
B.I. Dimitrov, T. de Ravel, J. Van Driessche, C. de Die-Smulders, A. 
Toutain, J.R. Vermeesch, J.P. Fryns, K. Devriendt, P. Debeer 
 
Introduction 
Split Hand Foot Malformation (SHFM) is a relatively rare anomaly 
characterized by central ray deficiencies and fusions of the remaining 
bones to variable degrees. Occasionally only remnants of the autopod 
are present (oligo/monodactylous ectrodactyly or peromelia). This 
condition represents 8-17% of all limb reduction defects and occurs in 
1 in 20000 newborns (de Mollerat et al., 2003; Elliott et al., 2006). 
Non-syndromic and syndromic forms have been described and both 
can be familial or sporadic representing all possible types of 
inheritance. Reduced penetrance is often observed in affected families. 
Until now, five SHFM loci have been mapped in humans: SHFM1 at 
7q21.2q22.1; SHFM2 at Xq26; SHFM3 at 10q24q25; SHFM4 at 
3q27; and SHFM5 at 2q31. Only for one of them (SHFM4) the causal 
gene, p63, has been identified (Basel et al., 2006). 
Using classical linkage analysis, the SHFM3 locus was originally 
mapped to 10q24, a region syntenic to mouse chromosome 19 (Ozen 
et al., 1999; Roscioli et al., 2004). The fact that the mouse 
Dactylaplasia phenotype, caused by insertional mutations of Fbxw4, 
resembles SHFM in man made the genes within the linkage region 
good candidates for the human phenotype (Sidow et al., 1999). No 
causal sequence alterations have been found, although two interesting 
genes (FGF8 and FBXW4) reside within the critical locus. 
Intriguingly, a tandem duplication of 325-570Kb was detected in 17 
familial and sporadic cases. All affected individuals had an isolated 
form of typical SHFM, except two. In one patient the phenotype was 
associated with medulloblastoma and another had a submucous cleft 
palate. Two genes, BTRC and POLL, were constantly included in the 
detected aberrations, whereas FBXW4 was partially involved (de 
Mollerat et al., 2003; Basel et al., 2006; Kano et al., 2005; Everman et 
al., 2006; Lyle et al., 2006). 
 
Selection criteria and patient’s phenotypes 
A group of individuals with a variety of syndromic forms of reduction 
limb defects were selected for genomic screening with a homemade 
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1Mb array CGH (Table 1). All patients were examined by experienced 
clinical geneticists and have normal high-resolution G-banded 
karyotypes. For two patients, C2755 and C224256, mutations in the 
coding part of OSR1 and OSR2 genes have been excluded by direct 
sequencing (Debeer et al., 2002a).  
 
Family 1 (F1) 
Case C2755, initially reported by Buttiens and Fryns (1987), is the 
second child of reportedly healthy unrelated parents. He has an 
affected younger sister (patient C224256). He presented with short 
stature, an asymmetric face, micrognathia, limited movements of the 
lower jaw, maxillary hypoplasia, high arched palate, severe myopia, 
high pitched voice, bilateral conductive hearing loss thought to be due 
to recurrent ear infections in childhood, oligomeganephronia leading 
to chronic renal insufficiency and severe, symmetric, terminal 
reduction limb defects affecting the hands and feet. He has mild to 
moderate mental retardation which is more pronounced than in his 
affected sister. X-ray examination revealed mid-facial hypoplasia and 
microretrognathia. There were severe truncation defects of the 
autopod, leading to a complete loss of both hands. Both radii were 
missing and the ulnae were hypoplastic and curved. The pre-axial part 
of the feet was more severely affected with many absent bones and 
synostoses of the remaining tarsal bones (Figure 1a-c) (Buttiens and 
Fryns, 1987). 
Case C224256 is the younger sister of C2755. She presented with a 
similar, but milder facial and skeletal phenotype, and borderline to 
mild mental retardation. She had short stature, mild micrognathia and 
maxillary hypoplasia, high arched palate, and symmetric pre-axial 
reduction defects of the hands, affecting all four limbs. Both radii 
were mildly dysplastic and curved. The remaining skeletal structures 
were normal. Vision, hearing and kidney function were normal 
(Buttiens and Fryns, 1987). 
 
Family 2 (F2) 
Case C211000 is the second child of healthy, unrelated parents 
(C364835 and C364837). Clinical examination revealed short stature, 
micrognathia, mild maxillary hypoplasia, cleft palate, nystagmus and 
severe myopia, low set ears, preaxial reduction defects of all limbs 
with one remaining ulnar/fibular digit on both hands and feet, 
respectively. He had bilateral renal hypoplasia and progressive 
decreasing renal function leading to chronic renal failure necessitating  
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Figure 1. Clinical phenotypes of case C2755, C369374 and C365650. a-c) C2755 
with LDMS originally published by Buttiens and Fryns (1987). All four limbs are 
symmetrically affected. There is marked facial asymmetry with pronounced 
micrognathia, maxillary hypoplasia and short stature; d-g) The facial gestalt of 
C369374 is similar to that of the affected siblings in Family 1- maxillary hypoplasia, 
micrognathia and low set ears. There are symmetrical terminal reduction defects of 
both hands with one ulnar finger remaining. An appendage like mass on the left 
hand is medially linked by a skin bridge to the palm. A large medial gap separates 
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the two digits of both feet; h-j) Hand and foot radiographs of C369374 demonstrate 
symmetrical terminal reductions of all four limbs. There are only four metacarpals 
and one ulnar (fifth) digit with three phalanges of both hands. In addition, an 
accessory short tubular bone pointing to the fifth metacarpo-phalangeal joint and one 
not very well defined ossification centre of bone remnant are present. Both feet have 
a classical SHFM phenotype with three metatarsal bones and two digits, each with 
phalanges. The last two metatarsals are fused at their distal ends and a big gap 
separates them from the first metatarsal. There is no ossification of carpal bones at 
that age and two tarsal bones are present; k and l) classic four limb SHFM 
phenotype of patient C365650. 
 
a kidney transplantation. In addition, a bilateral 40dB conductive 
hearing loss due to recurrent ear infections was revealed. His 
phenotype is similar to those of the siblings in F1 (Keymolen et al., 
2000). 
 
Family 3 (F3) 
C365650 is a patient with four limb ectrodactyly and renal hypoplasia 
(Figure 1k-l). His parents C381158 and C381159 are healthy and 
unrelated. He underwent a renal transplantation for chronic renal 
failure. 
 
Family 4 (F4) 
C369374 is the second child of healthy unrelated parents. Clinical 
examination revealed facial dysmorphism with remarkable 
micrognathia, limited movements of the lower jaw, midfacial 
hypoplasia and low set ears. He has severe preaxial reduction defects 
of both hands. On the right site there is one ulnar finger. On the left 
hand a medially placed rudimentary appendage that could be a 
remnant of a thumb, linked to the palm with a skin bridge and one 
wider ulnar finger with bifid nail are present. There is a classical split 
foot malformation bilaterally. X-ray examination of the right hand 
during his first year revealed four metacarpal bones, one ulnar digit 
with three phalanges, an additional phalanx, whose proximal end 
points toward the metacarpo-phalangeal joint of the single finger, and 
an ossification centre of a phalangeal remnant on the top of the second 
(from medial to lateral direction) metacarpal bone. There was no 
ossification of carpal bones. Both feet had two digits separated by a 
wide gap. The medial (first) ray had one metatarsal bone and two 
phalanges. The lateral ray had two metatarsal bones and one digit with 
three phalanges. Both talus and calcaneus and one additional tarsal 
ossification centre were also present. All long bones of the zeugopod 
were normal. Since the age of seven years on a progressive mixed 
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conductive-sensorineural hearing loss was detected (Figure 1d-j). 
There is history of recurrent ear infections. The skeletal defects, facial 
gestalt and detected hearing loss of this boy (C369374) resemble those 
of the patients with Distal limb deficiencies with micrognathia 
syndrome (DLDMS) (Buttiens and Fryns, 1987; Keymolen et al., 
2000). 
Patient C369373 is the younger sister of C369374. Classical SHFM of 
both hands and feet is present. She has no facial dysmorphism, 
particularly no micrognathia. Up to the age of six years no renal 
problems and no hearing loss were evident. 
C369371 is the mother of C369373 and C369374, and is unaffected. 
X-ray examination of hands and feet did not reveal any skeletal 
abnormalities.  
C369372 is the father of C369373 and C369374. He was born with 
oesophageal atresia. Clinical examination revealed micrognathia. No 
hand or foot malformations were noted clinically or radiographically. 
 
Results 
Detection of 10q24 CNVs 
1Mb array CGH screening in a group of patients with unexplained 
syndromic forms of congenital skeletal anomalies revealed in two of 
them (C2755 and C224256) a gain of signal of three consecutive 
clones- RP11-324L3, RP11-529I10, RP11-264H19 (Supplemental 
Figure 1a,b). All three BACs were located on chromosome 
10q24.31q24.32. The probands were originally published as having a 
new autosomal recessive syndrome (Buttiens and Fryns, 1987). Based 
on their phenotype- terminal limb reduction defects/SHFM in 
combination with facial dysmorphism and/or hearing problems, and/or 
renal insufficiency- three additional cases were selected for array 
CGH analysis. All patients carried an aberration of the same region. 
In 4/5 analyzed individuals the Log2 ratio of the abnormal clones 
corresponded to a duplication. However, one patient (C2755), in 
contrast to his less severely affected sister, had a Log2 ratio consistent 
with a triplication (Supplemental Figure 1a). 
Since apparently simple genomic rearrangements were often found to 
be more complex (Thienpont et al., 2008), the extent of the 
duplication and the presence of additional cis- and/or trans-copy 
number variations in this group of patients were further investigated. 
Therefore 10 individuals, including all affected members of the four 
families and the parents of one sporadic and one familial case, were 
analyzed with a 244K array CGH platform (Agilent). 
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Table 1. Patient’s phenotypes. 
MD- mental development; OA- other abnormalities; SHFM- Split Hand Foot 
Malformation; *- patients published by Buttiens and Fryns (1987); **- patient 
published by Kemolen et al. (2000). 
  
       Patients  
 
 
Phenotype 
 
C2755* 
 
 
C224256* 
 
Face 
 
 
maxillary hypoplasia, 
micrognathia, high arched palate 
maxillary hypoplasia, 
micrognathia, high arched palate 
Eyes 
 
Severe myopia normal 
Ears low set ears, recurrent otitis in 
childhood, bilateral conductive 
hearing loss 
low set ears 
Upper limbs Absent radii, hypoplastic curved 
ulnae, rudimentary carpal bones, 
absence of other bones of the 
hands 
deformation and bowing of distal 
radii, absent carpal bones, 
missing 1st right and 2nd right and 
1st left metacarpals, one 
rudimentary dysmorphic bone 
between 3rd and 4th metacarpals, 
only one 5th finger with three 
phalanges 
Lower limbs normal long bones, bilateral 
synostosis of rudimentary 
calcaneus and talus, absent tarsal 
bones, one short and dysplastic 
tubular bone of both feet 
normal long bones, talus, 
calcaneus, naviculare and 
cuboideum, rudimentary 1st 
metatarsal, missing 2-4 
metatarsals, 5th metatarsal with 
large base and one two-
phalangeal digit 
Internal organ 
abnormalities 
 
oligomega-nephronia none 
MD moderate Borderline 
 
OA 
 
undescended left testis none 
Chapter II. Part 2 
77 
 
 
  
 
C211000** 
 
 
C369373 
 
C369374 
 
 
C365650 
maxillary hypoplasia, 
micrognathia, cleft palate 
 
normal maxillary hypoplasia, 
micrognathia 
normal 
nystagmus, severe 
myopia 
normal normal normal 
low set ears, recurrent 
otitis, bilateral 
conductive hearing loss, 
normal low set ears, recurrent otitis, 
bilateral mixed conductive-
sensorineural hearing loss 
normal 
normal long bones, two 
metacarpals, one 
postaxial (5th ) finger with 
two phalanges 
classical SHFM normal long bones, four 
metacarpals, one postaxial (5th) 
finger with three phalanges, 
one phalanx crossing between 
4th and 5th metacarpals and one 
rudimentary bone between 3rd 
and 4th metacarpals 
 
classical 
SHFM 
normal long bones, one 
metatarsal, one postaxial 
digit with one phalanx 
 
 
 
 
classical SHFM classical SHFM classical 
SHFM 
renal hypoplasia none none renal 
hypoplasia 
 
Normal 
 
normal normal normal 
None 
 
none none none 
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No other common cis- or trans-copy number variations that can 
explain the more extended clinical features of our patients, have been 
detected. All affected individuals, except case C365650, carried a 
duplication of at least 500Kb, including five genes- LBX1, BTRC, 
POLL, RP11-529I10.4 (DPCD) and FBXW4. Only C365650 had a 
larger duplication of 630Kb encompassing all genes from TLX1 to 
FGF8 (Figures 2 and 3).  
 
 
Figure 2. Agilent 244K array result of all six patients carrying a 10q duplication, 
C369371(the suspected of somatic mosaicism mother of C369373 and C369374) 
and the phenotypicaly normal father C369372 of the same siblings. For the exact 
position of the breakpoints and the size of the aberration in all four families see the 
text and Table 2. The severity of the phenotype corresponds to the colour marking 
the aberration- from greyish-blue as the most severe to light-blue as the less severe 
observed phenotype. 
 
The proximal breakpoints were spread over an area of more than 
100Kb, at least from probe A_16_P39153053 (102876069-
102876128bp) to probe A_14_P139489 (102977418-102977470bp). 
In contrast, for five patients the telomeric ends of the duplication were 
clustered between probes A_16_P02330019 (103468797-
103468856bp) and A_16_P02330056 (103498069- 103498128bp),  
Chapter II. Part 2 
79 
Figure 3. Organization of 10q24 duplication locus (not to scale). a) The brown 
colour line represents the genomic organization of the 10q24 locus duplicated in 
nonsyndromic and syndromic SHFM patients. Filled brown bars correspond to the 
genes and arrows indicate the 5’ end of each of them. The black line above 
highlights some parts of the aberration- BTRC, FBXW4 and the last two exons of 
FGF8, as well as the area between the last two genes. Vertical lines demarcate the 
exons of each pointed gene. The mutations in Dactylaplasia mice Dac1J and Dac2J 
are indicated with red triangles above the line (Kano et al., 2007). Blue and purple 
squares highlight the positions of Pr1 and Pr2, also shown in (b). Red triangles 
above and green triangles below the line demonstrate the position of regulatory 
sequences in mice and zebrafish, proven to drive the expression of reporter genes 
within the AER and in developing limbs (for CR3 see Beermann et al. (2006); for 
#667 and #508 see Kikuta et al. (2007); and for e326 and e511 see VISTA Enhancer 
Browser - http://enhancer.lbl.gov/frnt_page.shtml and Visel et al. (2007)); b) Red, 
green, blue and purple bars and squares present the position of BACs and primer 
pairs Pr1, and Pr2 used for FISH, and Q-PCR. They are aligned to the map shown in 
(a) but for their exact position see the text and Ensembl 52, Human Reference 
Sequence 2005, NCBI Build 36 - http://dec2008.archive.ensembl.org/ 
Homo_sapiens/Info/Index; c) Black lines F1, F2, F3 and F4 show the family specific 
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size of the 10q24 duplication with respect to the gene positions represented with 
brown bars in (a). For exact breakpoint positions see the text and Table 2. The last 
line named SHFM3 summarizes the duplication sizes of previously published cases. 
The dotted part of the line represents the different breakpoint positions as described 
(de Mollerat et al., 2003; Kano et al., 2005; Lyle et al., 2006); d) Q-PCR with 
primer pair Pr1 confirmed the presence of one additional copy in all affected 
individuals, except one. Only C2755 had fold difference of 2 using the same 
primers. This corresponds to the presence of a triplication in this individual. In 
addition, the healthy mother C369371 of C369373 and C369374 had fold difference 
of 1.25, which in addition to the FISH and array CGH data confirms that she is a 
carrier of somatic mosaicism. Q-PCR using Pr2 primer pair demonstrated a presence 
of one additional copy only in patient C365650. 
 
except for C365650. In this case the distal breakpoint was flanked by 
A_14_P123126 (103524624-103524683bp) and A_16_P02330105 
(103528589-103528648bp), thus suggesting that at least the last three 
exons of FGF8 were also included in the duplication. All affected 
individuals from a same family shared the same breakpoints (Table 2). 
These data demonstrate that the observed rearrangement was similar 
in size to those previously detected in non-syndromic SHFM3 patients 
but extended more distally in the FGF8 direction. 
To confirm the array CGH results, FISH analysis with probes within 
and flanking the detected aberration was performed. Bacterial artificial 
chromosomes (BACs) were labelled with red and green dyes, 
respectively.  
Three different combinations of labelled probes were hybridized on 
slides with spreads from cultured peripheral blood lymphocytes of 
C2755 and C224256 (Figure 4a-e). In concordance with previous data 
(de Mollerat et al., 2003), hybridization with combination of probes 
within the duplication (BACs RP11-744C22 in red and RP11-619N16 
in green) on interphase nuclei from patient C224256 revealed 
presence of three red and three green signals. Four of the signals, two 
red and two green respectively, were grouped together. Their linear 
order red-green-red-green suggested a tandem duplication (Figure 4b). 
However, in the more severely affected brother C2755, FISH with the 
same probes detected four signals for each BAC, as was expected 
from the array CGH and Q-PCR results. Six signals, three red and 
three green, were always clustered but it was not possible to evaluate 
their relative position (in tandem or inverted orientation) (Figure 4c). 
One explanation of the different phenotype in the syndromic SHFM 
patients could be the more complex character of the observed 
aberration, representing an insertion instead of simple tandem 
duplication. Thus the inserted fragment could disrupt a gene(s) in 
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Table 2. Results of genetic studies 
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Legend to Table 2. SHFM- Split Hand Foot Malformation; sSHFM- syndromic 
SHFM; DLDMS- Distal limb deficiencies with micrtognathia syndrome; na- not 
analyzed; *- max size of the aberration according UCSC genome browser, Human 
Reference Sequence March 2006, NCBI Build 36.1.; **- present genomic copy 
numbers (gCNs) after RT Q-PCR analysis with Pr1; ***- carrier of somatic 
mosaicism; ****- surgically corrected congenital oesophageal atresia, micrognathia 
 
 
vicinity thus contributing to the additional phenotypic features.  
To further shed light on the genomic architecture, FISH experiments 
combining two additional BACs (RP11-108L07 labelled in red and 
RP11-489E24 in green) flanking the aberration were performed 
(Figure 4a). Depending on the combination, a string of two/three red 
or green signals followed by one red or green signal from the probe 
outside the rearrangement were always present (Figure 4d,e). Thus, 
the presence of an insertion was excluded. 
 
Detection of somatic mosaicism for the 10q24 duplication in a 
healthy mother 
Two of the cases were familial, each with two affected sibs and 
healthy parents, the other two were sporadic. Only in one familial case 
the parents were available for analysis. To further investigate the 
suspected somatic mosaicism of the phenotypicaly normal mother 
(C369371) of C369373 and C369374, a direct FISH analysis with two 
additional probe combinations was done. Each BAC combination, (1) 
RP11-774C22 labelled in red and PR11-489E24 labelled in green; and 
(2) RP11-108L07 labelled in red and RP11-529I10 labelled in green, 
detected a presence of 30% mosaicism in non-cultured peripheral 
white blood cells (Figure 4f,g).  
Q-PCR assays were additionally carried out to confirm the array CGH 
result. Two primer pairs, one within BAC RP11-529I10 (Pr1) and 
another spanning the exon-intron boundary of exon 6 of FGF8 gene 
(Pr2) were used (see Material and Methods Table 1). Twelve 
individuals were included in the analysis. Unfortunately the parents of 
the original probands (C2755 and C224256) were not available for 
further study. 
In all affected individuals, except one, the Pr1 amplicon showed a 1.5 
fold difference, corresponding to the presence of three copies in the 
analyzed genome. Only for C2755 a fold difference of 2 was detected 
suggesting the presence of a triplication, which is in correlation with 
the array CGH and FISH result. The unaffected mother (C369371) 
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Figure 4. a) Five 
BACs, three within 
and two flanking the 
duplication, were 
labelled in red and 
green as shown. The 
dashed bar represents 
the aberration and the 
coloured circles the 
corresponding FISH 
probes. Below each 
individual experiment 
in (b), (c), (d), (e), (f) 
and (g) a similar 
schematic graph 
shows the position 
and colour of the used 
FISH probes; b) 
Interphase FISH 
analysis with probes 
RP11-774C22 (red) 
and RP11-619N16 
(green), both within 
the 10q24 duplication, 
revealed the presence 
of a tandem 
duplication in 
C224256; c) The same 
combination of BACs 
demonstrated the 
presence of four 
hybridization signals 
for both probes in 
lymphocyte nuclei of 
C2755, her more 
severely affected brother. Three red and three green signals were always brought 
together, suggesting that they share one allele; d) Interphase FISH with combination 
of BAC RP11-489E24 (lying distally to the aberration) and BAC RP11-774C22 
(within the rearrangement) showed the presence of four red signals and two green 
signal in C2755. A string of three red and one green and separately paired red and 
green signals were present in each screened nucleus; e) In the same patient (C2755), 
a similar result was obtained using a combination of BAC RP11-108L07 (proximal 
to the duplication/triplication) and BAC RP11-619N16 lying within the aberration; 
f-g) Direct FISH with two different probe combinations, (1) RP11-774C22 labelled 
in red and PR11-489E24 labelled in green, and (2) RP11-108L07 labelled in red and 
RP11-529I10 labelled in green, demonstrates the presence of a cell line with 
10q24q25 duplication in individual C369371 (the normal cell population is not 
shown). 
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of C369373 and C369374 consistently showed a 1.24 fold difference. 
This could be explained if she is a somatic mosaicism carrier, this 
again in agreement with the 244K Agilent array CGH and FISH 
results (Figure 3). 
All tested individuals except one, had one copy of the FGF8 gene 
(Pr2). Only C365650 was a carrier of a duplication of at least the last 
sixth exon of the gene (Figure 3). 
 
Discussion 
Syndromic forms of SHFM are caused by a 10q24 duplication 
In this study 10q24 duplications were detected in six patients with 
Distal limb deficiencies, micrognathia syndrome (DLDMS) or 
syndromic forms of SHFM. All cases had duplications between 
500Kb and 650Kb, including the LBX1, BTRC, POLL, RP11-529I10.4 
(DPCD) and FBXW4 genes. In one of them (C365650) TLX1 and at 
least the last three exons of FGF8 were also engaged. Thus the size of 
the aberrations overlapped those of previously published non-
syndromic SHFM3 cases with 10q24 rearrangements. However, the 
affected individuals in this study had a more severe and complex 
clinical phenotype including specific facial gestalt (4/6 patients), 
hearing problems (3/6 patients) and kidney dysfunction (3/6 patients). 
One patient had mental retardation. The limb defects ranged from 
classical SHFM of hands and feet (2/6 patients) to severe symmetric 
terminal reduction defects of all extremities (3/6 patients). One patient 
(C369374) had severe reduction defects of the hands (atypical SHFM) 
and typical SHFM of feet. Compared to a previous survey (Elliott et 
al., 2005) the upper limbs of our patients were also more severely 
affected than the lower, with mainly preaxial involvement and one 
remaining lateral (fifth) digit ray (4/6 patients). 
 
How does the 10q24 duplication cause syndromic and non-
syndromic phenotypes 
Until now, there is no explanation how the observed 10q24 genomic 
aberration causes the phenotype of SHFM. Expression profiling of 
several candidate genes did not resolve the question (Basel et al., 
2003; Lyle et al., 2006). Since these experiments were done using 
immortalized EBV cell lines, this may not represent the expression of 
developmental genes during embryogenesis. In addition, 
Dactylaplasia mice were thought to be the corresponding model of 
SHFM3. It was shown that the semidominant phenotypes were caused 
by two (Dac1J and Dac2J) highly identical LTR retrotransposon 
insertions of a type D mouse endogenous provirus element (MusD). 
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The presence of the Dac phenotype was under the control of a 
homozygous Mdac trans-allele, which can completely block the 
development of skeletal abnormalities. However, even the observed 
normal skeletal phenotype in homozygous Dac2J-animals, which are 
heterozygous for Mdac, the reduced dactylyn expression was not 
restored, thus raising questions about the causal effect of Fbxw4. 
Moreover, if the phenotype in SHFM3 patients was the result of 
increased copies or expression levels of gene(s) lying within the 
duplication, the corresponding ortholog(s) in Dac mice should also 
have a disturbed expression. None of Lbx1, Btrc, Poll and Dpcd 
showed any changes (Sidow et al., 1999; Kano et al., 2005, 2007). In 
addition, several other genes in the vicinity (FGF8, IKKa, WNT8b, 
SUFU, and NFJB2) also have a role in normal limb development. 
Therefore, Friedli et al. (2008) recently suggested that the genomic 
aberration could alter the proper balance and interactions between 
more than one cis-acting regulatory elements and their target genes. 
Thus, the abnormal phenotype could be the result of disturbed 
function of several genes and a different extent of the duplication 
could contribute to the observed phenotypic differences, respectively. 
To answer this question, a fine mapping of the duplication size was 
done using a high-resolution oligo-array platform. All syndromic 
SHFM patients in this study, compared with non-syndromic cases, had 
a rearrangement encompassing the whole FBXW4 gene at the 
telomeric end. This extension of the aberration cannot explain the 
phenotypic differences since the individual (C365650) with the largest 
rearrangement in this group, including at least the last three exons of 
FGF8 gene, was not more severely affected. Furthermore, published 
cases with larger abnormalities of chromosome 10q (deletions and/or 
duplications), including the SHFM3 locus, do not have any SHFM 
like defects (Schinzel, 2001). All these data indicate that there is no 
obvious correlation between the size of the 10q24 duplication and the 
phenotype. 
In one patient (C2755) a triplication of 10q24 was detected. He had 
almost complete reduction of all elements of both forearms and hands, 
and a more pronounced mental deficit, while his less severely affected 
sister (C224256) was a carrier of duplication (Table 1, Table 2 and 
Figures 1-4). Thus the presence of a cryptic triplication instead of a 
duplication of causative sequences within the SHFM3 locus could be 
another possible explanation for the observed syndromic phenotype. 
However, with this resolution of array-CGH platform (Agilent 244K) 
no similar observations for the other cases in this study were detected. 
Therefore the triplication itself could contribute to the phenotypic 
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severity in this particular patient but cannot explain the extra-skeletal 
abnormalities. 
We can also not explain how this triplication occurred. There are no 
flanking low copy repeats, which could promote a recurrent non-
allelic homologous recombination. Probably other DNA instability 
mechanisms like Break-Induced Replication Repair and Fork Stalling 
and Template Switching are involved (Lee et al., 2007; Bauters et al., 
2008). Further research and breakpoint sequencing of more patients 
are necessary to unravel the genomic mechanisms causing these 
10q24 rearrangements. 
In 2/4 of our families, there were two affected siblings with healthy 
parents. Parental samples were available only from one couple 
(C369373 and C369374) and presence of somatic mosaicism was 
confirmed in the mother. Her clinical and X-ray examination did not 
reveal any visible abnormalities. However 3 of 21 currently known 
SHFM3 cases are the result of parental somatic and/or germline 
mosaicism for the 10q24 microduplication. Thus, at least for some 
patients, this also could be an explanation for the different extent of 
observed abnormalities. Genetic counselling of affected families 
should consider this. 
A final possible explanation for the observed phenotypic differences 
could be the presence of polymorphism(s) (mutations) in causal 
gene(s) or regulatory motif(s) on the second allele. The skeletal 
abnormalities observed in our patients are similar to those observed in 
homozygous conditional Fgf8 knock-out mice. The heterozygous Fgf8 
knock-outs are normal but there are other examples where a dominant 
phenotype in humans is only observed in homozygous mice and could 
be associated with long range regulator effects, e.g. Shh and 
holoprosencephaly (Chiang et al., 1996; Kleinjan and van Heyningen, 
2005). 
Additional support for a possible role of FGF8 in the observed 
skeletal and extra-skeletal defects is given by transgenic studies 
looking for regulatory sequences downstream of Fgf8 (Fig. 3) 
(Beermann et al., 2006; Kikuta et al., 2007; Visel et al., 2007). 
Intriguingly, in these transgenic animals the studied highly conserved 
elements can specifically drive the expression of the reporter gene 
within the AER, otic placode, nephrogenic cord, maxillary and 
mandibular arches. Some of these regulatory sequences can also 
partially rescue the mouse phenotype of Fgf8 double null allele. The 
mutant mice survive until birth and die shortly thereafter 
demonstrating an abnormal facial development with maxillary and 
mandibular hypoplasia, an abnormal “open eye” phenotype, and an 
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inappropriate limb development (Beermann et al., 2006). This 
expression profile, cranio-facial and limb dysmorphism cover all the 
observed anomalies in our patients– maxillary hypoplasia, 
micrognathia, hearing problems, renal hypoplasia/dysfunction and 
truncation limb defects. Therefore looking for polymorphisms/ 
mutations in FGF8 and its regulatory sequences in the future could 
extend our knowledge as to how this 10q duplication causes abnormal 
phenotypes. 
 
In summary, this study demonstrates that 10q24.31q24.32 
microduplications also cause syndromic forms of SHFM. There is 
high variability in the observed skeletal anomalies and Distal limb 
deficiencies with micrognathia syndrome (MIM 246560) represents 
the most severe end of SHFM3 spectrum. These findings strongly 
support the importance of array CGH analysis in entities where the 
underlined aetiology and/or the real extent of the clinical phenotype 
are not well defined. For example, Patterson-Stevenson-Fontaine 
syndrome (PSFS) is a condition combining partially the facial gestalt 
and the skeletal anomalies of DLDMS, syndromic/nonsyndromic 
SHFM3 patients and SHFM1 cases. The observed intra-familial 
variability of the PSFS is similar to the one detected in DLDMS and 
familial SHFM3 (Wilkie et al., 1997). Recently, Bigo et al. (2009) 
detected a 7q21.3 microdeletion, containing 3 genes- DLX5, DLX6 
and DSS1, in the originally described by Fontaine et al. (1974) family. 
However, no similar chromosomal aberration was found in the second 
PSFS family published by Patterson and Stevenson (1964). Further 
research needs to unravel to what extent these conditions, as well as 
other rare forms of acrofacial dysostoses share common aetiology 
and/or pathways. Until now there is no reliable explanation how the 
10q24 genomic aberration causes an abnormal limb development or 
why some patients have extra-skeletal anomalies. It is also difficult to 
apply one common mechanism to explain the phenotype both in 
humans and Dactylaplasia mice. In conclusion, the real contribution 
of FBXW4, FGF8 and other genes within or in the vicinity of the 
duplication associated with the observed phenotypic spectrum still 
remains to be discovered. 
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Supplemental Figure 1. 1Mb array results of chromosome 10 of patient C2755 
(a) and his sister C224256 (b). Three clones, RP11-324L3, RP11-529I10 and 
RP11-264H19 have Log2 ratios suggestive of the presence of a triplication (a) and a 
duplication (b) in C2755 and C224256, respectively. X and Y axes of the graphs 
represent the position of the clones (in M-basepairs), and the corresponding Log2 
ratios, respectively. 
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Genomic rearrangements of the GREM1-FMN1 locus cause 
Oligosyndactyly, Radio-Ulnar synostosis, Hearing loss, Renal 
defects syndrome and Cenani-Lenz-like non-syndromic 
oligosyndactyly 
Adapted from Journal of Medical Genetics 2010;47:569-574 
B.I. Dimitrov, T. Voet, L. De Smet, J.R. Vermeesch, K. Devriendt, 
J.P. Fryns and P. Debeer 
 
Introduction 
Vertebrate limb development serves as an important model to show 
how different processes and pathways are synchronized and involved 
in morpho- and organogenesis. As limb formation is not necessary for 
embryonic survival, the study of several spontaneous and molecularly 
manipulated (transgenic) animal models contributed to the discovery 
of the many genes involved in limb and skeleton patterning and 
development. Since several of these key genes play a role in other 
developmental cascades, it was also believed that this knowledge 
could be applied to understand the pattern formation of other tissues 
and organs (Niswander, 2003; Tickle, 2006). 
 
The crosstalk between two important signalling centres was found to 
be crucial in the complex process of limb formation - the Zone of 
Polarizing Activity (ZPA) and the Apical Ectodermal Ridge (AER). 
Key components of this mesenchymal-ectodermal (m-e) interaction 
are Sonic hedgehog (Shh), limb specific Fibroblast Growth Factors 
(FGFs), Bone Morphogenic Proteins (BMPs) and BMP antagonists 
like Gremlin 1 (Grem1). The study of targeted mutations of limb 
specific FGF and BMP/ BMP antagonist genes revealed the existence 
of self-regulatory loops controlling the appropriate initiation and 
termination of m-e signalling in the coordination of limb development 
(Zuniga et al., 1999; Khokha et al., 2003; Scherz et al., 2004; Mariani 
et al., 2008; Verheyden and Sun, 2008; Benazet et al., 2009). In 
addition, the correct spatio-temporal expression of these limb 
morphogens depends on regulatory sequences surrounding the gene 
landscape in the vicinity (Zuniga et al., 2004; Zeller and Zuniga, 
2007). A good example is the limb deformity (ld) mouse. The ld 
phenotype is autosomal recessively inherited and characterized by 
distinct reduction defects of the digit rays, complete radioulnar 
synostosis, missing fibulae and variable renal defects (Kleinebrecht et 
al., 1982). These abnormalities are most likely a result of disturbed 
function of Grem1 protein in the developing limbs due to homozygous 
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Grem1 mutations or loss/rearrangements of a limb bud specific Grem1 
transcriptional global controlling region (GCR) within Fmn1 gene 
(Zuniga et al., 2004; Michos et al., 2004; Pavel et al., 2007). The 
importance of Grem1 in limb development is further supported by the 
fact that its over-expression in chick limb primordia results in 
truncations of distal autopod elements and syndactyly (Capdevila et 
al., 1999; Merino et al., 1999). Recent studies reinforce the hypothesis 
that a disturbed Fmn1 protein function in limb buds may also 
contribute to the abnormal mouse ld phenotype (Zhou et al., 2009).  
 
Given the recent observation that causal submicroscopic copy number 
variations (CNV’s) can be detected in a significant proportion of 
patients with unexplained congenital malformations, we analyzed 
seventeen individuals with either non-classified syndromic congenital 
skeletal anomalies or severe classified limb malformations of 
unknown molecular aetiology.  
Since the association between skeletal and renal defects is well 
known, the patients for array CGH analysis were selected based on the 
presence of combination of relatively homogenous limb and/or kidney 
anomalies. Two of them (Patient 1 and Patient 2) were previously 
published as SHFM1 (Debeer et al., 2004) and Cenani-Lenz syndrome 
(de Smet et al., 1992), respectively. The remaining fifteen individuals 
have not been assigned to a specific syndrome. All patients were 
examined by experienced dysmorphologists. 
 
Clinical reports 
Patient 1 
The first patient (C255625) is the fourth child of healthy second 
cousin parents. He was born after a normal pregnancy at 41 weeks of 
gestation. Birth weight was 3.62kg, length 53cm and head 
circumference 36cm. He presented with reduction defects of the four 
limbs, initially classified as an atypical SHFM, bilateral subluxation of 
the elbows with limited pronation and supination and bilateral 
sensorineural hearing loss of 60 dB. Skin dimples were present on the 
posterior part of both elbows. His right hand had four fingers: a 
hypoplastic first finger with one phalanx resembling a thumb and 
three additional rays which could tentatively be assigned as fingers 
two, four and five. On the left hand there were three fingers appearing 
as digits two, four and five (Figure 1A,B). X-ray examination at the 
age of five months revealed the presence of four rays on the right 
hand. There was a hypoplastic first metacarpal and a thumb with only 
one phalanx, a delta-shaped second metacarpal, and two 
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Figure 1. Clinical phenotype of patients C255625 and C80286. Patient C255625 
was published as an atypical case of SHFM1 (Debeer et al., 2004). There is bilateral 
oligosyndactyly with four fingers on the right hand (1A) and three on the left (1B). 
The nails of the present digits are normal. Absent second ray on both feet with 
remaining four toes (1C). Excretory contrast X-ray examination demonstrating 
agenesis of the left kidney (1D). The phenotype of patient C80286 was previously 
classified as an isolated Cenani-Lenz-like oligosyndactyly of all fingers of both 
hands. Radiographs of the hands at 6 months of age (1E) and at 27 years of age (1F) 
show progressive multiple fusions of metacarpal bones and phalanges with several 
missing skeletal elements. Consolidation of carpal bones is also present. Both feet 
have no skeletal anomalies (1G). 
 
metacarpal bones with normal structure. All three fingers had three 
phalanges. On the left hand there were three rays, each with one 
metacarpal and three phalanges. The first present metacarpal was 
delta-shaped. The other two fingers had a normal structure. Both feet 
had four toes (Figure 1C). On radiographs, a missing second ray and 
absence of the distal two phalanges on the fifth digit were noted 
(Debeer et al., 2004). No other remarkable skeletal abnormalities were 
present. Abdominal ultrasound screening revealed absence of the left 
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kidney, which was confirmed by contrast excretory urography (Figure 
1D). At the age of seven the boy had normal physical development, 
despite the observed skeletal anomalies. Mental development was at 
the lower end of the normal range. Family history was negative with 
regard to congenital malformations, and clinical examination of both 
parents revealed no limb anomalies. FISH screening for genomic 
deletions encompassing the SHFM1 locus on 7q21-22 as well as 
mutation screening of the candidate SHFM1 genes DSS1, DLX5, 
DLX6 and some regulatory sequences (hI56i and hI56ii) were normal 
(Debeer et al., 2004). 
 
Patient 2 
The second patient (C80286), a boy, had a birth weight of 1500g at 
thirty-one weeks of gestation. Both hands were spoon-like and 
hypoplastic due to a complete fusion of all fingers, which was 
classified as a Cenani-Lenz type syndactyly (de Smet et al., 1992). 
Multiple synostoses of morphologically abnormal carpal bones were 
detected radiographically and several skeletal elements of the hands 
were absent (Figure 1E-G). Apart from two hemangiomas on the 
shoulders, no other abnormalities were present. His mental 
development was normal. 
The phenotypes of the other fifteen patients are summarized in 
Supplemental Table 1.  
 
Results 
With a homemade 1Mb array Comparative Genomic Hybridization 
(CGH), two patients with a chromosomal rearrangement of the 
GREM1-FMN1 locus on chromosome 15q13.3 were identified. In the 
first patient (Patient 1- C255625) with oligosyndactyly of the four 
limbs, radioulnar synostosis, hearing loss and unilateral renal aplasia 
(Figure 1a-d), a homozygous deletion of one BAC clone (RP11-
250G15) was detected (not shown). He was previously reported as a 
case of Split-Hand-Foot-Malformation 1 (SHFM1) (Debeer et al., 
2004). In the second patient (Patient 2- C80286), a two clone 
duplication (RP11-3D4 and RP11-250G15) encompassing the 
GREM1-FMN1 locus was detected (not shown). This individual had 
non-syndromic Cenani-Lenz type oligosyndactyly (Figure 1E-G) (de 
Smet et al., 1992). No aberrations were detected in the remaining 
fifteen patients.  
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Figure 2. Pedigrees of Family 1 (case C255625) and Family 2 (case C80286). 
Below each individual partial metaphase spreads or interphase nuclei are shown 
summarizing the results of the performed FISH analysis. Filed red and green colored 
squares represent the patients. Striped red circles and squares show heterozygous 
carriers in Family 1. A) BAC RP11-250G15 (red color), with genomic position as 
shown on Figure 3C, was used as a FISH probe to confirm the abnormalities 
detected by the array CGH screening in Family 1. A chromosome 15q subtelomeric 
probe (green signal) served as a control. Arrows point to the aberrant alleles (with 
deletion) in the analyzed individuals. There was no hybridization of BAC RP11-
250G15 (red signal) on both chromosomes 15 in patient C255625. This is in 
correlation with the array CGH results and demonstrates that the patient has a 
homozygous deletion of the genomic locus covered by this probe. FISH analysis 
showed a hybridization of BAC RP11-250G15 (red signal) on only one metaphase 
chromosome fifteen in heterozygous carriers of the aberration in Family 1, the 
parents (C359656 and C359651) and two additional siblings (C367866 and 
C367867) respectively. In addition, a cross-hybridization of BAC RP11-250G15 
(red signal) on chromosome 3q was also observed in all analyzed metaphases. B) To 
confirm the presence of the microduplication in patient C80286, FISH analysis was 
done on interphase nuclei using two FISH probes residing within the aberration, 
BAC RP11-250G15 (red signal) and BAC RP11-3D4 (green signal). All patient’s 
nuclei had one pair of a red and a green signal representing the normal allele, and a 
string of two red and two green signals corresponding to the allele carrying the 
duplication. Arrow points the aberrant allele (with duplication). The linear order of 
these four signals was always red-green-red-green suggesting a tandem orientation 
of the duplicated fragments. Both parents (C80284 and C80285) were not carriers of 
the aberration. In addition, all analyzed patient’s and parental nuclei presented two 
more red signals. These two additional signals were every time separated from the 
others and were not paired with green one, demonstrating a cross-hybridization of 
BAC RP11-250G15 on chromosome 3q. Subsequently, this cross-hybridization was 
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also confirmed on parental and patient’s chromosomal metaphase spreads (not 
shown). 
 
Subsequent FISH analysis using probe RP11-250G15 (red signal) 
confirmed the presence of a homozygous deletion in patient C255625 
(Figure 2A). Several unaffected individuals from the same family 
were carriers of a heterozygous deletion (Figure 2A). FISH screening 
with probes RP11-250G15 (red signal) and RP11-3D4 (green signal) 
showed the de novo 15q13.3 tandem duplication in patient C80286 
(Figure 2B). 
 
The micro-deletion/duplication were further delineated by high-
resolution SNP array (Affymetrix 250K NspI) in patient C255625, his 
parents (C359651 and C359656) and case C80286. The homozygous 
deletion size was maximally 263kb (between SNPs SNP_A-4201883 
and SNP_A-2233558) and minimally 246kb (between SNPs SNP_A-
4240484 and SNP_A-2176534), encompassing the first twelve FMN1 
exons and non-coding upstream sequences (Figure 3A-C). The healthy 
parents (C359651 and C359656) were heterozygous carriers of the 
same aberration (not shown). The duplication in patient C80286 had a 
maximum size of 2.3Mb (between SNP_A-2022976 and SNP_A-
4217332) and a minimum size of 1.7Mb (between SNP_A-2284222 
and SNP_A-2248182), including both GREM1 and FMN1 (Figure 3A-
C). Other previously undetected CNVs, that could possibly explain the 
phenotype of these two affected individuals, were also excluded with 
the SNP array. 
The quality of the SNP array CGH results was validated by RT Q-
PCR. Twelve primer pairs, overlapping or in the vicinity of the 
detected deletion/duplication breakpoints, were designed (see 
Materials and Methods Table 1). All results were in concordance with 
the SNP array CGH data (not shown). One assay was used to 
demonstrate the de novo character of the microduplication in patient 
C80286, (Figure 3D). 
To investigate the effect of these rearrangements on GREM1 and 
FMN1 expression, we studied the gene expression in the fibroblasts of 
both patients (see Materials and Methods Table 1). As a highly 
variable expression pattern was observed in normal controls, a 
significant quantitative analysis was not possible (not shown). Of 
interest, in the patient C255625 with a homozygous deletion of the 
promoter and the first twelve FMN1 exons, a low expression of the 
FMN1 gene was detected (not shown).  
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Figure 3. GREM1-FMN1 locus on chromosome 15q13.3 and genomic positions of 
the detected homozygous deletion (C255625) and the de novo duplication (C80286) 
according the Human Reference Sequence March 2006, NCBI Build 36.1. A) Fine 
mapping of the breakpoints by 250 NspI SNP array of Affymetrix in patient 
C255625 and C80286. B) Genomic architecture of the aberrant locus. Transparent 
vertical green and pink lines demarcate the positions of the breakpoints. Low copy 
repeats (BP5 and BP6) flank the detected de novo 1.7Mb (minimal size) tandem 
duplication (dark green bar) of patient C80286. C) Coloured bars and triangles show 
the positions of the used BACs as FISH probes and some of the RT Q-PCR primers. 
Dark red and green bars represent the homozygous deletion (minimal size) of 
C255625 and the tandem de novo duplication (minimal size) of C80286, 
respectively. D) Results of the RT Q-PCR with five of the primers used to confirm 
the SNP array CGH results and their corresponding genomic locations according the 
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detected chromosomal aberrations in Family 1 and Family 2 (see Materials and 
methods Table 1). The bars visualize the present relative allele copy number (fold 
differences). Value of 1 stands for the normal diploid status, 0.5 is for 
hemizigousity, 0 for homozygous deletion and 1.5 for a duplication, respectively. 
The closest outside primers flanking the breakpoints of the detected homozygous 
deletion in case C255625 (Family 1) are shown in blue and yellow colours. The red 
and pink bars represent the closest inside primers to the breakpoints of the same 
patient. The green bar demonstrates the primer used for detection of the parental 
origin of the duplication in case C80286 (Family 2). Both parents (C80284 and 
C80285) have a normal diploid allele copy number. 
 
Discussion 
Identification of two new syndromes- Oligosyndactyly, Radio-Ulnar 
synostosis, Hearing loss, Renal defects syndrome and Cenani-Lenz-
like isolated oligosyndactyly 
The importance of the GREM1-FMN1 locus in limb development has 
been extensively studied in animal models. We present for the first 
time evidence that this locus is implicated in human limb 
development. In one patient (Debeer et al., 2004) a homozygous 
deletion of the first twelve 5’ exons of the FMN1 gene was detected. 
His phenotype is highly reminiscent of the ld mice with 
oligosyndactyly, radio-ulnar synostosis and renal aplasia (Figure 1A-
D). The phenotypic abnormalities in this individual are similar to 
those of animal models in which the function of Grem1 was 
abrogated, thus resulting in an abnormal m-e interaction during limb 
and metanephric kidney organogenesis (Kleinbrecht et al., 1982; 
Khokha et al., 2003; Michos et al., 2004; Scherz et al., 2004; Zuniga 
et al., 2004; Pavel et al., 2007; Verheyden and Sun, 2008; Benazet et 
al., 2009). In addition he has hearing loss, which has not yet been 
observed in the animal models. The second patient carried a de novo 
1.7 Mb duplication encompassing the GREM1- FMN1 locus. His 
isolated Cenani-Lenz-like oligosyndactyly phenotype (Figure 1E-G) 
(de Smet et al., 1992) is similar to that of the transgenic chick in 
which Grem1 over-expression causes primordial cartilage truncations 
and digit syndactyly due to a repression of the BMP dependant 
programmed cell death in the anterior necrotic zone and in the inter-
digital mesenchyme. The result is a completely disorganized bone 
pattern of the distal autopod (Capdevila et al., 1999; Merino et al., 
1999). 
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How the detected GREM1-FMN1 genomic rearrangements cause an 
abnormal phenotype 
The phenotype in ld mice is due to a disturbed function of the BMP 
antagonist Grem1 either by homozygous Grem1 mutations or a loss of 
Grem1 transcriptional GCR located within the neighbouring Fmn1 
gene (Figure 4) (Khokha et al., 2003; Zuniga et al., 2004; Michos et 
al., 2004; Pavel et al., 2007). Therefore, the coding part of GREM1  
Figure 4. Alignment of the human and mouse GREM1-FMN1 locus. a) The 
human GREM1-FMN1 locus (Human Reference Sequence March 2006, NCBI 
Build 36.1) and the detected in Family 1 deletion (transparent pink bar). b) The 
mouse Grem1 and Fmn1 genomic structure (Zuniga et al., 2004) and position (Build 
37 assembly by NCBI and the Mouse Genome Sequencing Consortium, July 2007). 
All known mouse mutations mapped to this landscape are indicated above or below 
the Grem1-Fmn1 genomic structure. ∆4, ∆5, ∆6, ∆9, ∆10-24, ldOR and Grem1∆ are 
targeted deletions. Point mutations (ldJ), inversions (ldIn2) and transgenic insertions 
(ldTgBri, ldTgHd) are also shown. Mutations marked in red cause the ld phenotype 
in mice (modified from Zeller and Zuniga, 2007). Transparent pink bars highlight 
the detected 246Kb (minimal size) deletion of patient C255625. 
 
was directly sequenced in the fifteen patients in whom no causal 
CNVs were detected by the array CGH screening (Supplemental 
Table 1). No mutations were found. In mice, the genomic region 
between the nineteenth and twenty-third Fmn1 exons contains 
regulatory sequences controlling the Grem1 expression in developing 
limbs and kidneys (Figure 4B) (Zuniga et al., 2004). We determined 
the human homologue of this region using BLAST (blastn and bl2seq) 
and VISTA (genomeVISTA) alignments (Frazer et al., 2004; 
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McGinnis and Madden, 2004). The familial deletion of the first twelve 
FMN1 exons observed in patient C255652 does not remove these 
regulatory sequences (Figure 4A,B). Therefore they were not included 
in the mutational analysis. Point mutations or undetected 
submicroscopic chromosomal aberrations of these or other limb 
specific GREM1 regulatory sequences cannot be excluded in the 
fifteen individuals with negative mutation and CNV screening. There 
could also be a patient selection bias, since ld mice carrying Grem1 
mutations have a more severe and sub-lethal phenotype (Michos et al., 
2004). Hence, the corresponding human phenotype could be different 
to those of our selected group (Kleinjan and Lettice, 2008).  
In addition, the phenotype of the recently published ld strain is a result 
of a targeted deletion of Fmn1 exon nine. This leads to a complete loss 
of any Fmn1 transcript, an unexpectedly extended zone of Grem1 
expression and an increased Bmp activity in ld limb buds, indicating a 
direct Fmn1 repression of the Bmp signalling. However the authors do 
not exclude the possibility that a loss of regulatory sequences could 
also explain the phenotype of their animal model (Zhou et al., 2009). 
Using computer analysis we searched for the presence of 
evolutionarily conserved sequences in the deleted genomic fragment 
in our patient. We found a few non-coding elements that could have a 
regulatory function and which were highly homologous through all 
tetrapods and chick but not present in xenopus, zebrafish and fugu 
(Figure 5) (Loots, 2008). Unfortunately, a direct proof of causal 
relationship between tissue specific regulatory sequences and their 
corresponding genes in humans is limited due to restrictions in 
obtaining appropriate patient samples for analysis (i.e. tissues in 
which the gene of interest is expressed at specific time points). All 
these findings make it difficult to judge to what extent either GREM1  
or FMN1 contribute to the phenotype of the carrier of the homozygous 
15q13.3 deletion in Family 1. 
 
High-resolution SNP array analysis of the breakpoints of the second 
patient (C80286) showed that low copy repeats (LCR) BP5 and BP6 
on chromosome 15q13.3q14.1 flank the detected duplication. Thus the 
aberration is proximal to the newly recognized microdeletion 15q13.3 
syndrome defined between LCR blocks BP3-BP4 and BP5 (Sharp et 
al., 2008). Previous studies focused on the analysis of the 15q13.3 
region did not identify a similar BP5-BP6 duplication in 3699 North 
American controls of predominantly European ancestry (Helbig et al., 
2009). Analysis of 2590 individuals in our Centre by 1Mb array CGH 
revealed a maternally inherited benign hemizygous deletion reciprocal 
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Figure 5. VISTA alignments of the deleted sequence in Patient 1 with syntenic 
sequences of nine other species visualized on the UCSC genome browser. HG 
(homo sapience), Ch (chimp), Or (orang-utan), Rh (rhesus), Hr (horse), M (mouse), 
Chi (chicken), Fr (frog), Zef (zebrafish) and Fu (fugu). The analysis is based on the 
Human Reference Sequence March 2006, NCBI Build 36.1 (HG18) and the Mouse 
Genome Reference Sequence 2007 (M2007). Red arrows point deeply conserved 
DNA stretches in tetrapods with high regulatory potential. Blue vertical lines 
highlight the conservation within exons and in red are labelled conserved non-
coding sequences. 
 
to the duplication in patient C80286. Hence, there is an equal 
proportion of detected benign hemizygous deletions and disease 
causing duplications for the locus between LCR BP5-BP6. None of 
the few published patients with larger proximal 15q13q14 deletions 
encompassing the BP5-BP6 locus had distal limb anomalies 
(Matsumura et al., 2003; Windpassinger et al., 2003; Erdogan et al., 
2007). 
The duplication of patient C80286 includes at least fourteen other 
genes besides GREM1 and FMN1 (Figure 3B). Currently there is no 
evidence in the literature that overexpression of these other genes 
would contribute to an abnormal limb development in humans or 
animal models. However, we do believe that the de novo character of 
the observed duplication in patient C80286, the absence of similar 
chromosomal rearrangements in a large cohort of controls screened in 
previous surveys (Sharp et al., 2008; Helbig et al., 2009) and the 
strong support of an existing corresponding animal model with similar 
skeletal defects (Capdevila et al., 1999; Merino et al., 1999) confirm 
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the causal relationship between the patient’s phenotype and the 
increased copy number at the GREM1-FMN1 locus. Since LCRs flank 
the detected aberration (Figure 3b), the most probable causative 
mechanism is non-allelic homologous recombination (NAHR) (Gu et 
al., 2008). 
 
In summary, the present study delineates for the first time the human 
phenotype associated with a homozygous microdeletion of the FMN1 
gene. The patient’s skeletal and renal defects are identical to those of 
ld mice. We also detected the human phenotype associated with a 
microduplication of the GREM1-FMN1 locus in an individual with 
bilateral hand oligosyndactyly. No mutations of the GREM1 gene 
were found among individuals with similar limb defects and/or renal 
anomalies. The low yield of our screening to detect genomic 
aberrations/point mutations in additional cases may be explained by a 
patient selection bias or due to restriction of the mutation analysis to 
the coding sequence of GREM1. Cenani-Lenz syndrome (CLS) was 
defined as a form of hand and foot syndactyly due to complete 
cutaneous and bony fusions. This results in disorganisation and 
sometimes loss of individual digit rays, and spoon-like hands. The feet 
are similarly affected but to a less degree. Radioulnar synostosis, 
mesomelic shortness, renal hypoplasia and other miscellaneous 
anomalies have been also observed (Harpf et al., 2005). No linkage to 
the GREM1-FMN1 locus was found in a consanguineous family with 
offspring with classical spoon-like hands/ renal hypoplasia CLS 
(Bacchelli et al., 2001). Hence, even though our patients share some 
common clinical features (oligosyndactyly, radioulnar synostosis and 
renal abnormalities) with published CLS cases, they represent unique 
phenotypes caused by GREM1/FMN1 alterations. Of course, genetic 
heterogeneity could be expected since abnormalities of genes 
participating or interacting with the SHH-GREM1-FMN1-FGF8/4 
pathway in developing limbs, might cause identical/similar 
developmental defects. Therefore, our patients represent new clinical 
entities within the Cenani-Lenz phenotypic spectrum- (1) an 
autosomal recessive Oligosyndactyly, Radio-Ulnar Synostosis, 
Hearing loss and Renal defect syndrome due to a homozygous 
genomic deletion of FMN1 gene, and (2) a dominant Cenani-Lenz-
like non-syndromic oligosyndactyly caused by a duplication of the 
GREM1-FMN1 locus. The detected tandem 15q13.3q14 duplication 
delineates a new candidate for recurrent genomic disorder. Analyzing 
more patients and further research will be necessary to unravel the 
clinical extent of these two new phenotypes/syndromes. 
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2q31 microdeletion syndrome- redefining the associated clinical 
phenotype 
Adapted from 2010 (manuscript submitted) 
B.I. Dimitrov, I. Balikova, T. de Ravel, H. Van Esch, M. De Smedt, 
J.R. Vermeesch, I. Bradinova, E. Simeonov, K. Devriendt, J.P. Fryns 
and P. Debeer  
 
Introduction 
Several patients with chromosome 2q31 interstitial deletions have 
been described. The clinical phenotype was first delineated by Boles 
et al. (1995) and consists of developmental delay, facial dysmorphism, 
a variety of limb defects and other internal organ anomalies affecting 
the brain, eyes, heart, and the uro-genital system (Boles et al., 1995; 
Maas et al., 2000). Remarkably, the spectrum of upper/ lower limb 
abnormalities can range from (1) ectrodactyly/ monodactyly, through 
(2) syndactyly and (3) brachydactyly to (4) isolated camptodactyly or 
(5) clinodactyly. The HOXD cluster was initially accepted as a major 
candidate responsible for the observed abnormal limb morphogenesis 
(Moller et al., 1984; Boles et al., 1995). Genes important for the 
mental, cranio-facial and heart development were thought to be 
located more proximally on chromosome 2q24 (Maas et al., 2000).  
Recently, based on the phenotype of patients with overlapping 
interstitial deletions of the 2q31 region, a new locus responsible for 
split foot-hand malformation (SHFM) was proposed- SHFM5. It was 
positioned proximally to the HOXD cluster between EVX2 and marker 
D2S294 thus including DLX1 and DLX2. The last two genes have 
been suggested as the most probable candidates causing the phenotype 
(Goodman et al., 2002). 
In an attempt to investigate further the phenotype/ genotype 
correlations at the 2q31 region and to refine the hypothetical SHFM5 
locus, five patients with different size chromosome deletions 
encompassing this band were collected for fine breakpoint mapping 
with array CGH. By alignment of the detected aberrations and 
reviewing previously published 2q31 deletion cases (Nixon et al., 
1997; Del Campo et al., 1999; Slavotinek et al., 1999; Goodman et 
al., 2002; Pereira et al., 2004; Bijlsma et al., 2005; Langer et al., 
2006; Mencarelli et al., 2007; Svensson et al., 2007; Pescucci et al., 
2007; Monfort et al., 2008; Prontera et al., 2009; Tsai et al., 2009) we 
were able to show that hemizygosity of only the HOXD genes and 
HOXD regulatory sequences in vicinity (Spitz et al., 2003; Gonzalez 
et al., 2007) is responsible for the observed limb defects in these 
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individuals. Even more, for the first time we demonstrate that the 
2q31.1 microdeletion is a clinically recognizable contiguous gene 
syndrome, consisting of two partially overlapping but distinct loci 
responsible for the specific facial gestalt and skeletal abnormalities. 
 
Clinical reports 
All five patients have been examined by at least one of the authors and 
long term follow-up was available for all individuals. 
 
Patient 1 
This boy is the first child of healthy and young Caucasian parents. 
Birth weight was 3.500kg (P25-P50) and the length 49cm (P3-P10). 
At the age of 4 and 1/2 years he had short stature (<P3) and moderate 
to severe mental retardation, no speech, generalised muscular 
hypotonia, relative microcephaly (P3-P10), thin, sparse hair, a 
prominent forehead, ptosis, down-slanting palpebral fissures, a 
bulbous nasal tip, cleft soft palate, open mouth with downturned 
corners, everted and thick lower lip, low-set ears with large lobes, 
short neck with low-set hair line, camptodactyly, bilateral fifth finger 
clinodactyly, and bilateral syndactyly of toes II-V. In addition, a 
ventricular septal defect closed spontaneously (Figure 1A-D). 
MRI imaging revealed a complex brain anomaly with hydrocephaly, 
hypoplastic corpus callosum, small sella tursica with hypoplastic 
pituitary gland and an ectopic neurohypophysis (Figure 1E). 
Radiographs of hands and feet showed delayed bone age, relatively 
elongated proximal and hypoplastic middle phalanges particularly of 
the second and fifth fingers, irregular ossification of tarsal bones, wide 
metatarsals with irregular metaphyses and epiphyses, widening of the 
first toe rays with very short first proximal phalanges, and absent 
middle phalanges of toes II-V (Figure 1F,G). 
High resolution karyotyping revealed a de novo interstitial deletion 
2q24.3q31.  
 
Patient 2 
The proposita is the second child of healthy parents. After a difficult 
pregnancy complicated with bleeding in the 12th week, she was born 
by Caesarean section at the 36th week of gestation because of 
transverse position of the foetus. There were signs of prematurity. Her 
birth weight was 1.900kg (P3-P10), length 41cm (<P3) and head 
circumference 29cm (<P3). Due to adaptation problems she was 
admitted to the neonatal intensive care unit for a short period. The 
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Figure 1. Patients phenotypes. A-G) Facial gestalt, complex CNS anomaly and 
limb defects of Patient 1. There is hypoplasia of the second and fifth phalanges (F), 
broad first toe ray, wide and short, bullet-like first proximal phalanges of both feet 
and absent middle toe phalanges II-V (G). H-K) Patient 2 at three months (H) and 
two years of age (I). She presents bilateral toe syndactyly II-IV (J,K), broad first 
metatarsals and first toe phalanges, wide and short (bullet-like) first proximal 
phalanges (L), absent ossification centres of middle phalanges II-V (L). Brain 
imaging shows cortical CNS abnormalities and bilateral periventricular cysts (M). 
N-P) Patient 3 has elongated and asymmetric face with long nose, and high nasal 
bridge (N). Mild syndactyly III-IV of hands (O) and bilateral hallux valgus, sandal 
gap, and short 5th metatarsal are present (P). Q-R) Patient 4 at one year and four 
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years, respectively (see the clinical report). S-T) Facies of patient 5 (see the text for 
more details).  
 
mother had one previous miscarriage and a normal older daughter 
from another relation. Patient 2 was referred to the Genetic Clinic 
because of developmental delay, microcephaly (<P3) and facial 
dysmorphism characterised by a narrow forehead with a prominent 
metopic suture resulting in a trigonocephalic shape of the head, 
downslanting palpebral fissures, hypotelorism, shallow orbits with 
protruding eyes, ptosis, asymmetric pupils (R>L), bulbous nasal tip 
with a small pit, protruding ears with simple pinnae, a thin upper lip, 
downturned corners of the mouth and mild micrognathia (Figure 
1H,I). The left foot had complete cutaneous syndactyly II-V. On the 
right foot there was only soft tissue syndactyly of the second and third 
toes. Both halluces looked larger and were separated by a wide gap 
from the second digit (“sandal gap” sign) (Figure 1J,K). In addition, 
there were also two flat pre-sacral haemangiomata, dimples on both 
elbows, and a ventriculo-septal heart defect that closed spontaneously. 
At two years of age her height was below the third percentile (<P3) 
and she had thin hair. There was marked microcephaly (<P3) and 
developmental delay with a developmental age of seven months. A 
conventional G-banded karyotype was normal. 
Babygram and Radiographs of lower limbs showed short second and 
fifth middle phalanges of the hands, wide first toe rays, short and 
broad first metatarsals, short, bullet-like middle phalanx of the first 
toes and absent ossification centres of II-V digits of the feet (Figure 
1L). Brain imaging revealed abnormal cortical gyration and 
periventricular cyst lesions affecting the thalami (Figure 1M).  
 
Patient 3 
The third patient is the second child of healthy and young Caucasian 
parents. She was born at 37 gestation weeks with a birth weight of 
3.000kg (P50), length of 49cm (P25-P50) and head circumference of 
34cm (P25-P50). Due to severe neonatal hypotonia, feeding problems 
and an increased risk for Sudden Infant Death Syndrome she was on 
monitoring until the age of four months. Over the years she developed 
a progressive thoraco-lumbar scoliosis with short stature, persistent 
hypotonia, hyperlaxity and tapering fingers. At 13½ years clinical re-
evaluation revealed a standing height at the 3rd centile, truncal 
hypotonia, a prominent thoracic kyphoscoliosis, and elongated 
asymmetric face with long nose, high nasal bridge, full lower lip and 
retrognathia (Figure 1N). There was developmental delay and marked 
Results 
108 
microcephaly (<P3). The hands had tapering fingers, mild syndactyly 
of digits III-IV and smooth palmar creases (Figure 1O). Short fifth 
metatarsals, increased distance between the first and second toes with 
hallux valgus and flat foot arches were present bilaterally (Figure 1P). 
In addition she suffered from urinary infections and a urinary reflux 
was detected. A G-banded karyotype was normal and FMR-1 gene 
mutations were excluded. 
 
Patient 4 
Patient 4 is the eldest daughter of two children of non-consanguineous 
parents. Her brother is healthy. She has moderate intellectual 
disability with slow developmental milestones and is always good-
humoured and continually active. She is unable to concentrate and 
therefore attends special education. 
At 6 years of age her height was 106.5cm (P3), weight 17kg and head 
circumference 48cm (<P3). She is thus microcephalic and displays 
downslanting palpebral fissures, epicanthus inversus, a fine nose 
bridge and a pointed chin (Figure 1Q,R). Her teeth are tightly packed. 
She has clinodactyly of the fifth fingers and foetal finger pads.  
No chromosomal abnormalities were detected by conventional 
karyotyping.  
 
Patient 5 
This girl is the second child of healthy, non-related parents. She was 
born at term with normal physical parameters after an uncomplicated 
pregnancy. At the age of 6 months, she was admitted to the hospital 
because of febrile seizures and anti-epileptic therapy was initiated. 
Clinical examination at the age of 9 months revealed developmental 
delay with pronounced hypotonia. She had a narrow thorax, a narrow 
forehead with a prominent metopic suture, a short nose with thin 
nares, depressed and wide nasal bridge, a long and smooth philtrum, 
blepharophimosis, epicanthic folds, nystagmus, strabismus, Duane 
anomaly, simple ears with uplifted ear lobules, a high arched palate, a 
small tent-shaped mouth, micrognathia, and relatively small hands and 
feet (Figure 1S,T). Both the head circumference and length were at the 
25th centile (P25). High resolution karyotyping did not reveal any 
abnormalities. 
 
Results 
Identification of a 2q13 deletion in the five patients 
High resolution standard karyotyping revealed a 2q31 chromosomal 
aberration in Patient 1. Subsequently, a 1Mb array CGH analysis 
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confirmed this and excluded the presence of other submicroscopic 
copy number variations that would contribute in addition to the 
phenotype of this individual. The 2q31 microdeletions of Patients 2-5 
were detected by routine 1Mb array CGH screening. In all five 
individuals, the detected chromosomal abnormalities were de novo.  
 
Fine mapping of the size of the detected 2q31 deletions 
To confirm the 1Mb array CGH data and to define the correct size of 
the deleted segment, a chromosome 2 tiling path array CGH analysis 
was carried out. All results were consistent with those of the 1Mb 
array CGH screening. 
An 11.36Mb interstitial deletion flanked by BACs RP11-656M07 and 
RP11-600I19 was detected in Patient 1. This aberration removes 134 
genes including DLX1, DLX2 and the entire HOXD cluster on 
chromosome 2q31.1 and extends from band 2q31.1 to band 2q31.3 
(Figure 2A). 
Patient 2 carried the largest deletion, which removes 16.9Mb on 
chromosome 2q31.1-q32.1 from BACRP11-703L16 to BAC 
RP1189E07, thus encompassing 140 genes. The HOXD and DLX were 
present in a hemizygous state (Figure 2A).  
Patient 3 had a complex karyotype. A 2.74Mb deletion on 
chromosome 2q31.1-q31.2 (between BACs RP11-118L08 and RP11-
592D06) was found. The detected aberration starts 59Kb proximal to 
the EVX2 gene and extends to the TNN gene (Figure 2A). There was 
an additional deletion of chromosome 16p13.11 with a minimum size 
of 1.9Mb (between BACs RP11-489O1 and RP11-288I13) and 
maximum size of 7Mb (between BACs RP11-174B4 and RP11-
489A11). This aberration is identical to the recently described 
microdeletions in this locus, which are a predisposition factor for 
developmental disabilities (Hannes et al., 2009). The reciprocal 
duplications are likely benign polymorphisms. No consistent limb 
abnormalities were found in individuals carrying either 16p13.11 
deletions or duplications (Hannes et al., 2009). FISH analysis with 
BAC RP11-49401 (chromosome 16p13.11) and BAC RP11-157E8 
(chromosome 2q31.1) labelled with Spectrum Orange™-dUTP was 
used to confirm the 1Mb array CGH results (data not shown). 
In Patients 4 and 5, a 6.32Mb deletion on chromosome 2q24.3-q31.1 
(between BACs RP11-760C21 and RP11-1E20) and a 4.12Mb 
deletion on chromosome 2q31.1 (between BACs RP11-121K19 and 
RP11-388J7) were found, respectively. In both patients the detected 
aberration removed DLX1 and DLX2 genes but the HOXD cluster 
remained intact (Figure 2A).  
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Figure 2. Chromosome 2q24.2-q32.3. A) Alignment of the 2q deletions of patients 
1-5 and literature cases (Nixon et al., 1997; Del Campo et al., 1999; Slavotinek et 
al., 1999; Goodman et al., 2002; Pereira et al., 2004; Bijlsma et al., 2005; Langer et 
al., 2006; Mencarelli et al., 2007; Svensson et al., 2007; Pescucci et al., 2007; 
Monfort et al., 2008; Prontera et al., 2009; Tsai et al., 2009). Yellow lines mark 
patients without skeletal defects. Blue and green lines show patients with “typical”, 
and severe limb defects (SHFM/ monodactylous ectrodactyly), respectively. The red 
line represents a patient with synpolydactyly (SPD) (Goodman et al., 2002). Red, 
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green and orange ovals point to the 2q31 breakpoints of patients carrying apparently 
balanced chromosomal translocations and an associated abnormal phenotype: 
mesomelic skeletal dysplasia (orange) (Spitz et al., 2002), SPD (red) (Dlugaszewska 
et al., 2006), and SHFM/ monodactylous ectrodactyly (green) (Dlugaszewska et al., 
2006), respectively. Transparent pink (facies) and yellow (limbs) vertical bars 
demarcate the FG and LA specific loci. Both regions with the candidate genes for 
cranio-facial and limb development are highlighted in sections (B) and (C). Genes 
associated with OMIM diseases are highlighted in red. In section (C) blue bars and 
red stars show the positions of HOXD regulatory sequences in mice as follow: GCR 
is for global control region, Pr for Prox, ELCR for early limb control region, and 
CsA, CsB and CsB for control sequence A, B, and C, respectively (Spitz et al., 
2003; Zakany et al., 2004; Gonzalez et al., 2007). 
 
Delineation of a common locus for Limb Anomalies 
In two out of five patients in this study (Patients 1 and 2) there were 
mild limb defects associated with a deletion encompassing the HOXD, 
DLX1 and DLX2 genes. Thus the detected aberrations remove the 
entire SHFM5 locus proposed by Goodman et al. (2002). In one 
additional case with mild abnormalities of hands and feet (Patient 3) 
there was a 2q31.1 deletion affecting only the HOXD cluster, but not 
DLX1 and DLX2. No limb defects were present in the remaining two 
individuals (Patients 4 and 5). However they were carriers of a more 
proximal 2q31.1 deletion including DLX1 and DLX2 genes, but not 
the HOXD locus. In addition, we reviewed other published cases in 
the literature for which any molecular data for the size of the detected 
2q31.1 aberration were available (Nixon et al., 1997; Del Campo et 
al., 1999; Slavotinek et al., 1999; Goodman et al., 2002; Pereira et al., 
2004; Bijlsma et al., 2005; Langer et al., 2006; Mencarelli et al., 
2007; Svensson et al., 2007; Pescucci et al., 2007; Monfort et al., 
2008; Prontera et al., 2009; Tsai et al., 2009). 
Alignment of the detected 2q31 aberrations in our patients with those 
from the literature clearly demonstrates that only the HOXD cluster 
and surrounding up-/ down-stream sequences are responsible for the 
observed Limb Anomalies (LA) in individuals with 2q31 
microdeletion syndrome (Figure 2A). This critical LA region extends 
1.5Mb centromeric and 1Mb telomeric from the HOXD genes. It 
covers approximately 2.5Mb including all well defined HOXD 
regulatory elements such as the Global Control Region (GCR) and 
Proxy (Pr) with the Control sequences A (CsA), B (CsB), and C 
(CsC), as well as the hypothetical Earlier Limb Control Region 
(ELCR) (Figure 2C) (Spitz et al., 2003; Zakany et al., 2004; Gonzalez 
et al., 2007; Yamagishi et al., 2007). Of interest, in four published 
patients with 2q31.1 microdeletions and limb defects (Svensson et al., 
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2007; Pescucci et al., 2007; Monfort et al., 2008; Prontera et al., 
2009), the detected chromosomal aberration did not remove any of 
these currently known limb specific HOXD enhancers/ suppressors. 
Therefore, based on these findings and some preliminary data from 
animal models (Spitz et al., 2003; Zakany et al., 2004; Gonzalez et al., 
2007; Spitz- personal communications), the presence of more 
regulatory elements involved in the limb development between the 
GCR and ATP5G3 gene, and downstream to the HOXD cluster is 
hypothesized (Figure 2C). Indeed, there are several highly conserved 
sequences in tetrapods within this region and further research should 
unravel their importance for autopod development (not shown). In 
addition to the HOXD group, this specific LA locus harbours ten other 
genes. Two of them are associated with OMIM diseases (CHRNA1 
and CHN1). However, patients with 2q31 microdeletions do not share 
common features with any of these OMIM phenotypes.  
 
Delineation of a common locus for the Facial Gestalt 
Three patients in this study had similar facial features (Figure 
1A,B,H,I,Q,R- Patients 1, 2 and 4). A genotype/phenotype correlation, 
based on their phenotypes and cases in the literature, reveals a 
common 2.4Mb locus (maximum size) on chromosome 2q31.1 that 
could harbour a causal gene(s) for the observed Facial Gestalt (FG) 
(Figure 2A,B). This critical FG region covers at least 15 known genes. 
Mutations in three of them are implicated in known OMIM disorders. 
Some of these “candidates” are transcription factors or are involved in 
the cell division cycle. Hence, they might be functionally important 
for the cranio-facial development. Of course, a positional effect of the 
detected 2q31 aberrations upon the function of genes in vicinity like 
DLX1 and DLX2 cannot be excluded since a partial facial phenotype 
could be observed in patients with 2q31 deletions ending in a close 
proximity to the defined critical FG locus in our study. 
 
Discussion 
Five individuals were analyzed by array CGH in this study (Table 1). 
They were carriers of partially overlapping 2q31 deletions extending 
either centromerically or telomerically. Subsequently, their data from 
the molecular karyotyping were aligned with those of published 
patients (Nixon et al., 1997; Del Campo et al., 1999; Slavotinek et al., 
1999; Goodman et al., 2002; Pereira et al., 2004; Bijlsma et al., 2005; 
Langer et al., 2006; Mencarelli et al., 2007; Svensson et al., 2007; 
Pescucci et al., 2007; Monfort et al., 2008; Prontera et al., 2009; Tsai 
et al., 2009). All analyzed individuals had different sized 2q31 
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aberrations. No common breakpoints were observed. Therefore, a 
mutual genomic mechanism cannot be suggested with certainty for the 
occurrence of these deletions (Figure 2A) (Gu et al., 2008). Specific 
loci for the limb defects (LA) and for the facial gestalt (FG), both 
located on chromosome 2q31.1, were found. Based on these results, 
we suggest that the detected common 2q31.1 microdeletion is a 
recognizable contiguous gene syndrome. (Figure 2A-C). The 
phenotype is characterized by moderate to severe mental retardation, 
microcephaly, short stature, hypotonia, specific facial dysmorphism 
and variable limb defects with distinct pattern. The common facial 
gestalt includes a narrow forehead sometimes with prominent metopic 
suture, craniosynostosis (very rare), a small nose with bulbous tip, 
long and smooth philtrum, downslanting palpebral fissures, thin upper 
lip, thick and everted lower lip, low set and dysplastic ears, and 
micrognathia. The observed upper limb defects are clenched hands, 
shortening of middle phalanges leading often to clinodactyly of the 
fifth finger, brachy-metacarpy and partial cutaneous syndactyly. 
Absent middle and terminal phalanges, sometimes associated with nail 
hypoplasia, partial to complete cutaneous syndactyly II-IV, short 
metatarsals and wide first ray tubular bones are typical for the feet. 
Due to a digit hypoplasia and syndactyly, there could be a wide 
distance between the hallux and the remaining toes. This has been 
occasionally described as an ectrodactyly (Boles et al., 1995; Maas et 
al., 2000). Some affected individuals have fusions of phalanges, 
metatarsals and metacarpals. There is tendency for the lower limbs to 
be more often and more severely affected than the upper limbs (Table 
1). Congenital defects of the heart, brain and eyes, as well as clefts, 
scoliosis, an abnormal vertebral segmentation and seizures are 
common but not specific. The presence and extent of these additional 
anomalies clearly depends on the size and the direction of the detected 
2q31 deletion (Table 1 and Figure 2A).  
 
Limb development and limb defects 
A 2.5Mb critical locus (LA) for the observed limb anomalies in 
patients with 2q31.1 deletion syndrome was delineated including the 
HOXD genes and its regulatory sequences (Figure 2C). A HOXD 
haploinsufficiency is the only plausible explanation for the disturbed 
limb development in these individuals since their hand and foot 
defects are comparable with those of HOXD mutant mouse models 
(Zakany and Duboule, 1996; Kmita et al., 2002; Zakany et al., 2004). 
There were also a few published “atypical” cases that had more severe  
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Table 1. Clinical features of the selected patients with molecularly 
confirmed deletions encompassing chromosome 2q31 
Patients Sex General findings Cranio-facial 
Patient 1 
(this study) 
M growth retardation, short 
stature, developmental delay, 
hypotonia 
microcephaly, bitemporal 
narrowing, bulbous nasal tip, 
flat long philtrum, thin upper 
lip, thick/ everted lower lip, 
cleft palate, micrognathia, 
low-set dysplastic ears 
 
Patient 2 
(this study) 
F low birth weight, growth 
retardation, short stature, 
developmental delay, 
hypotonia, pre-sacral 
haemangioma, dimples on both 
elbows 
trigono-microcephaly, 
bulbous nasal tip, flat long 
philtrum, thin upper lip, 
everted lower lip, cleft palate, 
micrognathia, protruding 
dysplastic ears 
Patient 3 
(this study) 
F growth retardation, short 
stature, developmental delay, 
hypotonia, kyphoscoliosis 
microcephaly, long face, 
facial asymmetry, high nasal 
bridge, thick lower lip, 
retrognathia  
Patient 4 
(this study) 
F developmental delay, short 
stature 
microcephaly, thin nose with 
bulbous tip, smooth philtrum, 
thin upper lip, small pointed 
chin 
Patient 5 
(this study) 
F developmental delay, 
hypotonia, seizures 
trigonocephaly, short nose, 
smooth philtrum, small 
mouth, low-set dys-plastic 
ears micrognathia,  
 
Nixon et al., 1997 M low birth weight , growth 
retardation, short stature, 
developmental delay 
microcephaly, cranio-
synostosis, bitemporal 
narrowing, bulbous nasal tip, 
flat long philtrum, thin upper 
lip, high palate, 
micrognathia, low-set ears 
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Eyes Upper limbs Lower limbs Others 
ptosis, downslanting 
palpebral fissures 
camptodactyly, 
clinodactyly V, 
delayed bone age, 
brachidactyly, 
hypoplastic middle 
phalanges II and V 
syndactyly II-V, sandal 
gap, irregular ossification, 
wide metatarsals, short and 
wide (bullet-like) proximal 
phalanx I, absent middle 
phalanges II-V 
spontaneously closed 
VSD, hydrocephaly, 
hypoplastic corpus 
callosum, small sella 
turcica, hypoplastic 
pituitary gland, ectopic 
neurohypophysis 
ptosis, downslanting 
palpebral fissures, 
hypotelorism, 
shallow orbits, 
protruding eye bulbs, 
asymmetric pupils 
camptodactyly, 
clinodactyly V 
left syndactyly II-V, right 
syndactyly II-III, sandal 
gap, broad first rays, 
bullet-like proximal 
phalanx I, absent middle 
phalanges II-V 
spontaneously closed 
VSD, cortical brain 
abnormalities, bilateral 
periventricular cysts 
no abnormalities tapering fingers, 
syndactyly III-IV, 
smooth palmar 
creases 
sandal gap, medial 
deviation of the halluces, 
short metatarsal V 
urinary reflux 
epicanthus inversus, 
downslanting 
palpebral fissures 
 
clinodactyly V, foetal 
finger pads 
no abnormalities no abnormalities 
blepharophimosis, 
epicanthic folds, 
strabismus, 
nystagmus, Duane 
anomaly 
no abnormalities no abnormalities no abnormalities 
proptosis, 
hypertelorism, small 
and downslanting 
palpebral fissures, 
coloboma of iris, 
retina and optic 
nerve 
camptodactyly, 
clinodactyly V, single 
palmar creases 
left syndactyly II-V, right 
syndactyly III-V, sandal 
gap, joint contractures 
ASD, VSD, PDA, 
bicuspid pulmonary 
valve, bilateral 
cryptorchidism and 
inguinal hernia 
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Table 1 continued 
Patients Sex General findings Cranio-facial 
Slavotinek et al., 
1999, p1 
F low birth weight, growth 
retardation, short stature, 
developmental delay, scoliosis, 
seizures 
microcephaly, facial 
asymmetry, bitemporal 
narrowing, short nose with 
bulbous tip, long philtrum, 
cleft uvula, micrognathia, 
simple ears 
Slavotinek et al., 
1999, p2 
M low birth weight, growth 
retardation, short stature, 
developmental delay, 
hypotonia, seizures,  
trigono-microcephaly, 
bulbous nose tip, flat long 
philtrum, thin upper lip, 
micrognathia, low-set ears 
 
Del Campo et al., 
1999, p1 
M growth retardation, 
developmental delay 
Microcephaly 
 
 
 
 
Del Campo et al., 
1999, p2 
M growth retardation, neonatal 
death 
cleft palate, low-set ears 
 
 
 
 
 
 
Goodman et al., 
2002, p1 
F normal no abnormalities 
 
 
 
 
Goodman et al., 
2002, p2 
F growth retardation, 
developmental delay, seizures 
preauricular tag 
Pereira et al., 
2004 
F low birth weight , growth 
retardation, seizures, 
developmental delay 
  
microcephaly, dysplastic ears 
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Eyes Upper limbs Lower limbs Others 
ptosis, small and 
downslanting 
palpebral fissures 
camptodactyly, 
tapering 
fingers,proximaly 
placed thumbs, 
clinodactyly V, single 
palmar creases 
syndactyly II-III, sandal 
gap, short metatarsal V 
dilatation of brain 
ventricles, hypoplastic 
external genitalia, 
anteriorly placed anus, 
hiatus hernia 
ptosis, downslanting 
palpebral fissures 
camptodactyly, 
tapering fingers, 
clinodactyly V, single 
palmar creases 
left syndactyly II-III and 
IV-V, right syndactyly II-
V, short metatarsal V 
bilateral 
cryptorchidism, 
cerebral atrophy, 
dilatation of brain 
ventricles 
NA thin humerus, single 
radius-like forearm 
bone, single 
metacarpal, one 
biphalangeal digit 
bowed femur, absent tibia 
and fibula, two tarsal 
bones, one metatarsal, one 
biphalangeal digit 
cryptorchidism, small 
phallus, hypospadia 
hypertelorism, left 
microphthalmia, left 
optic nerve 
hypoplasia 
left single radius-like 
forearm bone, right 
short radius and 
ulna, monodactyly 
several not well defined 
tarsal bones, two digits 
ASD, arrhinencephaly, 
ectopic brain gray 
matter, multicystic 
hypoplastic kidney, 
penoscrotal 
transposition, 
micropenis 
downslanting and 
small palpebral 
fissures 
SPD, clinodactyly V broad halluces, syndactyly 
II-V, absent middle 
phalanges II-V, short 
metatarsals II-V, partial 
metatarsal II duplication 
no other abnormalities 
blepharophimosis, 
retinal coloboma 
camptodactyly, 
clinodactyly V 
classical SHFM with 
present two digits 
NA 
downslanting and 
small palpebral 
fissures, dysplastic 
ears 
single palmar crease syndactyly II-III VSD 
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Table 1 continued 
Patients Sex General findings Cranio-facial 
Bijlsma et al., 
2005 
F 17g.w. foetus, pregnancy 
termination 
high nasal bridge, long 
philtrum, low-set ears, 
micrognathia 
 
 Langer et al., 
2006 
F low birth weight , growth 
retardation, developmental 
delay, hypotonia, seizures 
micrpcephaly, prominent 
metopic suture, dysplastic 
ears, micrognathia 
 
 
 
 
 Mencarelli et al., 
2007 
M low birth weight, 
developmental delay, 
kyphoscoliosis 
coarce face, high forehead, 
synophrys, bifid nasal tip, 
micrognathia, dysplastic ears 
 
Pescucci et al., 
2007 
F low birth weight, growth 
retardation, short stature, 
developmental delay, seizures 
microcephaly, cleft palate, 
high nasal bridge, bulbous 
nasal tip, dysplastic ears, 
micrognathia 
Svensson et al., 
2007 
F developmental delay microcephaly, bitemporal 
narrowing, high arched 
palate 
 
 
 
 Monfort et al., 
2008, p2 
M developmental delay, scoliosis high arched palate, dys-
plastic ears, micrognathia 
 Prontera et al., 
2009 
M developmental delay, short 
stature, scoliosis, pectus 
excavatum 
scaphocephaly, coarce face, 
facial asymmetry, long nose, 
synophris, cleft uvula, 
micrognathia, dysplastic ears 
Tsai et al., 2009, 
the index patient 
F low birth weight, short stature, 
developmental delay, hypotonia 
 
 
 
microcephaly, low-set ears 
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Eyes Upper limbs Lower limbs Others 
NA contractures, absent 
radii, right hand 
monodactyly, left 
hand with two digits  
contractures, SHFM  ASDII, VSD 
downslanting 
palpebral fissures, 
hypertelorism, 
microphthalmia, 
coloboma, 
blepharophimosis, 
myopia 
no abnormalities no abnormalities brain abnormality, 
apnoea episodes 
astigmatism, 
hypermetropia, 
exotropia 
tapering fingers genu valgum, sandal gap dilatation of brain 
ventricles, 
cryptorchidism, 
inguinal hernia 
hypotelorism, ptosis, 
downslanting 
palpebral fissures 
 
tapering fingers, 
clinodactyly V 
broad halluces, sandal gap, 
short toes, hypoplastic 
phalages 
no other abnormalities 
strabismus mild syndactyly II-III 
and IV-V, 
clinodactyly V, short 
middle phalanx V, 
proximal 
symphalangism 
hallux valgus, proximal 
and distal symphalangism 
no other abnormalities 
strabismus clinodactyly V syndactyly II-IV cortico-subcortical 
atrophy 
proptosis camtodactyly, 
tapering fingers, 
clinodactyly V 
short metatarsals III-V, 
sandal gap  
dilatation of brain 
ventricles, inguinal 
hernia, 
macroorchidism 
no abnormalities tapering fingers, 
short middle 
phalanges II and V, 
clinodactyly V 
duplication of the 1st distal 
phalanx, broad proximal 1st 
phalanx, broad 1st 
metatarsal, hypoplastic/ 
absent middle phalanges 
hearing loss 
 
  
Results 
120 
limb reduction anomalies described as a form of SHFM- 
monodactylous ectrodactyly (Del Campo et al., 1999; Goodman et al., 
2002; Bijlsma et al., 2005). They all carried larger 2q31deletions 
encompassing the HOXD cluster and extending in both centromeric 
and telomeric directions (Figure 2A). It was proposed that their limb 
defects were caused by a gene(s) at the new SHFM5 locus, of which 
DLX1 and DLX2 were the best candidates (Goodman et al., 2002). 
However, our data exclude this option, since hemizygosity of the 
transcripts surrounding the HOXD genes at chromosome 2q31.1, but 
not including the HOXD cluster and its regulatory sequences, is not 
sufficient to produce any abnormal limb development (Patients 4 and 
5). In addition, individuals with homozygous HOXD13 polyalanine 
tract expansions or compound heterozygotes for HOXD13 and 
HOXA13 alterations present with hand and foot anomalies which 
partially overlap the severe limb defects in some patients with 2q31.1 
deletions (Muragaki et al., 1996; Debeer et al., 2002; Kuru et al., 
2004; Horsnell et al., 2006). Hence, mainly the HOXD 
haploinsufficiency should explain the more severe skeletal phenotype 
of these unusual cases. 
Interestingly, there are four published patients where different, 
apparently balanced de novo chromosomal rearrangements affecting 
the 2q31.1 locus were associated with skeletal defects (Spitz et al., 
2002; Sugawara et al., 2002; Dlugaszewska et al., 2006). Each of 
these individuals had a unique phenotype. This ranged from (1) 
mesomelic dysplasia (Spitz et al., 2002; Sugawara et al., 2002); 
through (2) hand brachy-/synpoly-dactyly (patient 1 of Dlugaszewska 
et al. (2006); to (3) severe terminal limb truncations similar to those 
described as SHFM- monodactylous ectrodactyly (Patient 2 and 
Patient 3 of Dlugaszewska et al. (2006). In all these patients, the 
chromosome 2q31.1 breakpoints were in close proximity to the HOXD 
cluster and none of the aberrations directly disrupted a known gene 
(Figure 2A). Therefore, the authors proposed that an abrogated 
function of centromeric or telomeric HOXD regulatory sequences 
would explain the corresponding preferential anomalies of hands/ feet 
or forearms/ lower legs (Spitz et al., 2002; Sugawara et al., 2002; 
Dlugaszewska et al., 2006). However, our survey did not confirm this 
hypothesis since no segregation of the observed limb defects was 
detected in patients with different chromosome 2q31.1 deletions 
(Figure 2A and references (Svensson et al., 2007; Pescucci et al., 
2007; Monfort et al., 2008; Prontera et al., 2009)). Hence, we suppose 
that not just simply removing the HOXD cluster and/ or its known 
regulatory sequences (Spitz et al., 2003; Zakany et al., 2004; 
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Gonzalez et al., 2007; Yamagishi et al., 2007), but a more complex, 
and probably more than one, mechanisms are responsible for this 
phenotypic variability in these affected individuals (Spitz et al., 2002; 
Sugawara et al., 2002; Dlugaszewska et al., 2006). The different 
genetic background is one possibility, such as e.g. (1) the presence of 
cis- or trans-acting HOXD modifiers as mutations/ polymorphisms/ 
CNVs of other genes involved in the skeletal/ limb development 
(Debeer et al., 2002; Kmita et al., 2005; Kmita and Duboule, 2007). 
Another option is that the acquired new chromosomal landscape or 
nuclear environment might cause an aberrant/ neomorphic effect upon 
the HOXD function due to (2) a loss of limb specific and adopting of 
new enhancers/ suppressors (Kleinjan and van Heyningen, 2005; 
Kleinjan and Lettice, 2008; Spitz and Duboule, 2008). Last but not 
least, there could be (3) a creation of chimera transcripts 
(Dlugaszewska et al., 2006; Kleinjan and Lettice, 2008; Spitz and 
Duboule, 2008) or other (4) epigenetic modifications of the chromatin 
structure which seem to be important for the appropriate spatio-
temporal and/ or collinear HOXD expression (Tarchini and Duboule, 
2006; Morey et al., 2007; Montavon et al., 2008; Soshnikova and 
Duboule, 2009). Thus, the effect of one of these factors or the 
stochastic combination of more than a single event can trigger the 
observed discrepancy in the abnormal limb morphogenesis. 
Finally, patients with hemizygosity of the complete HOXD cluster or 
its regulatory sequences present with a pure HOXD genes’ 
haploinsuficiency. This explains their different and less severe limb 
defects in comparison with those in individuals with HOXD13 
mutations (polyalanine tract extension and point mutations) or small 
HOXD9-13 deletions (Goodman et al., 1998, 2002; Caronia et al., 
2003; Johnson et al., 2003; Kan et al., 2003; Zhao et al., 2007; Fantini 
et al., 2009). These clinical observations correlate well with available 
animal models, functional studies and the principle for HOXD 
functional collinearity (Bruneau et al., 2001; Caronia et al., 2003; 
Johnson et al., 2003; Zhao et al., 2007; Fantini et al., 2009; Kuss et 
al., 2009). 
 
Facial dysmorphism 
The facial gestalt in the 2q31 microdeletion syndrome is well-defined 
and clinically identifiable. Individuals that are hemizygous for the 
2q31.1 locus involved in the cranio-facial development (FG) share 
common features as described above (Table 1, Figure2B). Despite this 
distinctive clinical pattern, it is difficult to assign a single gene within 
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the defined critical FG region to the observed mental handicap and 
facial dysmorphism.  
 
Other abnormalities 
The observed internal organ and axial skeleton abnormalities, oral 
clefts, and craniosynostosis cannot be certainly linked to chromosome 
2q31.1 region. Some of them, like seizures (Pereira et al., 2004; 
Langer et al., 2006) and heart defects (Maas et al., 2000), are often 
referred to up- and down-stream sequences outside the 2q31.1 
microdeletion syndrome critical locus. Preliminary data suggest the 
presence of gene(s) involved in the brain and eye development located 
at 2q31.1 (Delle Chiaie and Mortier- unpublished data). 
 
In summary, the results of this study provide clear evidence that the 
limb defects in patients with 2q31 deletions are due only to the HOXD 
cluster hemizygosity. Reinforcing the previous hypothesis for HOXD 
causality, our data unambiguously exclude the possibility for the 
presence of a separate, HOXD-independent SHFM5 locus (Goodman 
et al., 2002). Mechanisms that can explain the observed severe 
skeletal anomalies in some “atypical” cases are suggested. In addition, 
a critical region for the common facial phenotype of individuals 
carrying 2q31 deletions is proposed. Thus, we demonstrate that the 
2q31.1 microdeletion is a well-defined and clinically recognizable 
contiguous gene syndrome mapped to a specific genomic locus. The 
distinctive combination of limb defects, developmental delay and 
characteristic facial gestalt is strongly suggestive for the correct 
diagnosis and appropriate genetic testing.  
 
 123 
5. CONCLUSIONS AND FUTURE PERSPECTIVES  
The available data from the Human Genome Project about the 
reference Human Genome Sequence and the advent of new, more 
powerful techniques for genome analysis led to an explosion of often 
unpredictable findings. In the present project, we exploited all these 
recent advances in human genetics and related technologies, and we 
introduced and applied a combination of classical and novel 
techniques for the genetic analysis of a selected group of patients with 
variable developmental skeletal and limb defects of unknown 
aetiology. All individuals were clinically characterized and sub-
grouped for subsequent genetic analysis in a stepwise way. Starting 
from the clinic, going through gene and/ or genomic screening, and 
returning to the patients’ phenotype results in re-grouping for future 
investigations and the development of a systematic approach for 
genetic testing in the Clinic. In addition to this “systematic approach” 
combining classical “forward genetic” and “reverse genetic” 
methodologies, we exploited data from different electronic sources to 
explain our findings. Finally, the findings from our studies were used 
subsequently to complement previous observations. Based on this 
systematic approach for clinical classification and genetic analysis we 
were able to detect causal genetic abnormalities in 18.5% of the 
studied individuals. 
In the first part of this thesis classical and new techniques have been 
applied for molecular characterization of balanced chromosomal 
rearrangement (de novo translocation and inversion) associated with 
specific skeletal phenotypes (MSD and KFA). The precise breakpoint 
mapping revealed neither directly disrupted known genes by the 
chromosomal aberrations nor abnormal expression in EBV-cell lines 
of selected candidate genes in the vicinity. In addition, recent 
publications reported on chromosomal deletions encompassing all 
four breakpoint described in this thesis (Barber et al., 2005; Thienpont 
et al., 2005; Caselli et al., 2007; Brichard et al., 2008). However, no 
skeletal defects were detected in these patients. Therefore, 
haploinsufficiency of gene expression up- and down-stream from the 
breakpoints due to position effect could be ruled out.  
In more than 40% of individuals, who are carriers of balanced 
chromosomal aberrations, there is no gene disrupted by the 
chromosomal rearrangement (Vandeweyer and Kooy, 2009). This  is 
probably an underestimation since many similar cases probably 
remain unpublished. The absence of plausible candidate gene(s) in the 
vicinity represents currently a real challenge. There is no doubt that at 
least in certain of these cases the observed chromosomal aberrations 
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probably contribute to the phenotypic abnormalities and only 
technology limitations restrict our ability to prove this. 
The second part of the thesis illustrates the relevance of the array 
CGH analysis in patients with congenital skeletal defects, particularly 
LRDs. Based on this approach we were able to define 10q24q25 
microduplication/ triplication as a molecular cause of Distal Limb 
Deficiency Micrognathia Syndrome. We showed that the same 
chromosomal aberration is associated with syndromic forms of SHFM 
thus demonstrating the broad clinical spectrum of SHFM3. Our 
findings confirm the existence of DLDMS and make a molecular 
verification of the clinical diagnosis with all its important 
consequences for genetic counselling available. In addition, they 
provide an important contribution to understanding the underling 
molecular mechanism of disturbed limb development. The currently 
accepted cause of disturbed Dactylyn (FBXW4) function in the 
pathogenesis of SHFM3 seems to be insufficient to explain the 
observed limb and non-skeletal defects. Several recent publications 
suggest that FBXW4 is probably a “bystander” rather than a real cause 
of the phenotype (Kano et al., 2005, 2007; Kikuta et al., 2007; Friedli 
et al., 2008). For the first time we report that the severity of the 
phenotype is not linked to the extent of the detected duplications but is 
influenced by the increased genomic copy numbers at the SHFM3 
locus. This finding, together with the other molecular studies, supports 
the hypothesis that an altered balance and interactions between 
regulatory elements and their target genes could more satisfactorily 
explain the complex SHFM3 phenotype. Logically, the phenotypic 
variability could be a result of the affected function of more than one 
gene. Thus, FGF8 could be the cause of the observed limb and facial 
abnormalities, whereas PITX3 and PAX2 could be responsible for the 
ocular and kidney defects. PITX3, together with PITX1and PITX2, 
belongs to a novel family of a paired-like class of homeodomain PTX 
transcription factors. PITX3 mutations are associated with congenital 
glaucoma, anterior eye segment mesenchymal dysgenesis and myopia 
(Sakazume et al., 2007). Similarly, PAX2 is currently the only known 
gene causing oligomeganephronia/ renal hypoplasia in man (Salomon 
et al., 2001). Both PAX2 and PITX3 are in close proximity to the 
detected 10q24 duplication/ triplication in syndromic forms of 
SHFM3. Interestingly FGF8 is also involved in the eye and kidney 
development. Therefore the combined effect of several genes under 
the control of stochastic events could determine the highly variable 
final phenotype, but this hypothesis needs further research. Good 
options for analysis provide the availability of different strains of FGF 
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knock-out mice. Future collaboration with a research group (Spitz- 
Heidelberg, Germany) who was able to generate a mutant mouse 
corresponding to the detected 10q24 duplication in patients with 
SHFM3 will allow more precise investigation of the intimate 
molecular mechanisms underlying the abnormal mouse and human 
development. A presumptive outcome is the selection of candidate 
gene(s). Therefore, the collection of samples from SHFM3 families 
with positive linkage but no associated 10q24 duplication/ triplication 
is an important issue for further candidate gene validation.  
Another original finding was the detection of CNVs within the 
GREMLIN1-FORMIN1 region in individuals with two new 
syndromes. Since a long time, this locus has been known to be 
implicated in mouse limb development. Now, for the first time we 
were able to demonstrate its importance in human limb development 
and pathology. We were able to identify a homozygous FMN1 
deletion in a patient with Oligosyndactyly, Radio-Ulnar synostosis, 
Hearing loss and Renal defects, and a duplication of GREM1 and 
FMN1 in an individual with isolated Cenani-Lenz-like 
oligosyndactyly. Both phenotypes delineate new syndromes within the 
Cenani-Lenz oligosyndactyly spectrum. In addition, the isolated 
Cenani-Lenz-like oligosyndactyly is a good candidate for a new 
genomic disorder. Unfortunately no additional GREM1 and FMN1 
abnormalities were detected within a group of patients with 
phenotypes similar to those of the index individuals. Therefore 
extending the clinical criteria for genetic analysis should unravel the 
real clinical spectrum of these new syndromes.Although there are 
corresponding animal models with a reminiscent phenotype to those 
of the patients with GREM1 and FMN1 rearrangements, it is not clear 
to what extent each of these two genes contributes to the observed 
phenotypic characteristics. An option for future research would be to 
investigate the effects of the detected FMN1 homozygous deletion and 
FMN1 over-expression in transgenic mouse and chick.  
Interestingly, during the primary clinical selection all individuals with 
detected chromosome 10q24q25 (SHFM3 locus) and 15q13.3 
(GREM1-FMN1 locus) rearrangements were sub-grouped together for 
further genetic analysis. Based on our current knowledge, the 
phenotype of the patients with 15q13.3 deletions/ duplications 
affecting the GREM1-FMN1 locus is the result of abrogated m-e 
crosstalk between the ZPA and the AER. The final effect will be a 
disturbed FGF function (mainly FGF8/ FGF4) within the AER. This 
will subsequently lead to an abnormal limb development. As 
discussed above, FGF8 is one of the major candidates to cause the 
Conclusions and future perspectives 
126 
phenotype in syndromic and non-syndromic SHFM3 patients. In 
dactylaplasia mice there is an abnormal AER expression profile of the 
FGF8 gene. This could be used as indirect evidence for FGF8 
involvement in the SHFM3 clinical features. Vice versa it 
demonstrates the correct systematic approach for clinical 
management, evaluation and genetic analysis used in this study. In this 
way, the appropriate and systematic clinical selection and molecular 
testing will allow identification of genes involved in developmental 
pathways, causing gene family disorders. The gathered information 
will further improve our understanding for the genotype/ phenotype 
relationships in the group of developmental skeletal disorders. This 
process will certainly be enhanced with future implementation of 
database mining tools for gene prioritisation (e.g. ENDEAVOUR) in 
positional candidate gene approaches for gene identification (e.g. 
breakpoint mapping and array CGH) (Aerts et al., 2006).  
In this project, we also re-evaluated the clinical phenotype in patients 
with the 2q31 deletion syndrome and precisely redefined the 
genotype/phenotype correlations in an attempt to characterize more 
accurately the SHFM5 locus. We were able to demonstrate that only 
the HOXD genes are involved in the pathogenesis of limb defects in 
individuals with 2q31 deletions. Furthermore, we delineated the 
critical loci responsible for the facial gestalt and skeletal abnormalities 
suggesting a clinically recognizable 2q31.1 microdeletion syndrome. 
Affected individuals have variable hand and foot anomalies caused by 
“pure” HOXD haplo-insufficiency or hemizygosity of HOXD 
regulatory sequences. Therefore it is interesting to further investigate 
whether mutations (point mutations or genomic rearrangements) in 
these HOXD regulatory elements are responsible for the similar 
skeletal defects in patients with different forms of brachydactyly (e.g. 
brachydactyly type A2 and A3) or symphalangism. Characterization 
of the deletion size in more individuals with 2q31.1 deletions will 
differentiate whether a single gene can be assigned to specific facial 
characteristics or whether the delineated typical facial gestalt is a 
result of a continuous gene syndrome.  
Finally, a substantial part of the studied individuals with 
developmental skeletal and limb defects in this project (patients with 
Holt-Oram-like phenotype and no TBX5 mutations/ deletions and 
patients with normal 1MB array CGH analysis) are still waiting for a 
molecular explanation for their phenotype. This group represents a 
suitable population for future CNV screening at higher resolution. A 
more daunting task will be to explain some more complex phenotypes. 
For example, why do some 2q31 deletion patients have severe limb 
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defects like SHFM/ monodactylous ectrodactyly with absent long 
bones of the forearm? 
Therefore, the development and implementation of new techniques 
and systems biology approaches to study complex developmental 
disorders is a hallmark strategy to improve our knowledge about 
unresolved questions. The new generation sequencing and cell 
reprogramming (induced pluripotent stem cells) combined with the 
data of projects investigating the functional integrity of the Human 
Genome is envisaged. Their implication in genetic studies of 
congenital anomalies due to multifaceted errors in the development 
will certainly challenge our current single-gene way of thinking and 
will shift many basic paradigms in genetics and medicine.  
The next generation sequencing represents a variety of new strategies 
that allow the production of large-scale qualitative and quantitative 
information about any type of nucleic acid in a given genome at an 
unprecedented high throughput level. As its laboratory price 
dramatically diminished the last one-two years, it has become possible 
for more research projects to exploit this new technology. With the 
promised cost of 1000$ per genome, the next generation sequencing 
will certainly become routinely available in clinical diagnosis (Tucker 
et al., 2009; Metzker, 2010). An important application is whole 
genome screening for discovery of novel mutations in rare genetic 
disorders.  For several decades, the discovery of new genes underlying 
Mendelian disorders was based on positional cloning, physical 
mapping or candidate-gene sequencing. However, for rare phenotypes 
or for disorders with a high level of genetic heterogeneity these 
approaches failed to be efficient. Now, whole genome sequencing of 
the genomes of a few unrelated patients or even small nuclear families 
combined with filtering methods for selection of the most likely causal 
genome variants will be a straightforward and powerful method for 
gene “hunting”. As the majority of the currently detected mutations 
implicated in genetic disorders affect protein coding sequences, an 
alternative is the targeted sequencing of the exome (the protein coding 
part of the genome) which constitutes as much as 5% of the whole 
genome. Interestingly, a model for the recently published proof-of-
concept study was Miller syndrome, a form of acrofacial dysostosis 
characterized with postaxial RLDs (Ng et al., 2010). Transcriptome 
sequencing, proteomic or even epigenetic data could additionally 
enhance the efficacy of this strategy. Another opportunity is the 
combined exploitation of linkage analysis (including homozygosity 
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mapping) with next generation sequencing of the obtained loci under 
linkage (Nikopoulos et al., 2010).  This will substantially reduce the 
project costs and will allow the inclusion in the sequencing assay not 
only coding exons but also non-coding/ micro-RNAs, highly 
conserved non-coding elements or even the entire linkage interval. In 
addition, data from whole genome screening can be used to search 
modifiers of the phenotype or for parallel sequencing of entire 
pathways implicated in specific developmental processes and 
heterogeneous genetic syndromes/ syndrome families. 
 
The possibility for cell reprogramming to an embryonic stage and the 
creation of pluripotent cell lineages is another technique providing 
new perspectives to study normal and abnormal early human 
development. These induced pluripotent stem cells (e.g. fibroblast and 
keratinocyte derived) share a highly similar expression and epigenetic 
status with embryonic stem cells. In theory, this state should provide 
them a full developmental potential. Thus, they will have the 
characteristics to self-renew indefinitely and can give rise to all cell 
types in the human body, but are generated via reprogramming of 
somatic cells through the forced expression of a few key transcription 
factors as OCT4, SOX2, KLF4 and c-MYC. This technique has been 
used with success to generate an entire mouse by induced pluripotent 
stem cells (Boland et al., 2009; Zhao et al., 2009). Similarly, the 
abnormal genetic background in patient’s cells was genetically 
corrected and subsequently these genetically modified cells were 
reprogrammed (Raya et al., 2010). These experiments illustrate the 
promising use of this new technology in regenerative medicine, gene 
therapy and disease modelling. In this way, limitations in the study of 
the early limb and skeletal development discussed above can be 
circumvented. For example the limit of obtaining appropriate patients’ 
samples will not restrict the investigation of tissue specific spatio-
temporal expression of developmental genes, position effect, point 
mutations affecting regulatory sequences or teratogen mechanisms 
(Nishikawa et al., 2008; Kiskinis and Eggan, 2010).  In addition, 
patient derived induced pluripotent stem cells can be used in primary 
screenings for selection of new disease gene candidates (e.g. patients 
with Holt-Oram syndrome like phenotype and no TBX5 
mutations/intragenic deletions). 
In conclusion, exploitation of the capabilities of the new generation 
sequencing and induced pluripotent stem cells represents our vision 
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for future research in the field of limb formation and skeletogenesis.  
This new approach, recently referred as systems biomedicine, allows 
studying the limb development as integrated and complex 
developmental machinery, (Liu, 2009). 
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APPENDICES 
Appendix A. International Nosology and Classification of Genetic 
Skeletal Disorders—2006 revision (Adapted from Rimoin et al. 
2007) 
 
1. FGFR3 group 
2. Type II collagen group 
3. Type XI collagen group 
4. Sulfation disorders group 
5. Perlecan group 
6. Filamin group 
7. Short-rib dysplasia (SRP) (with or without polydactyly) group 
8. Multiple epiphyseal dysplasias and pseudoachondroplasia 
group 
9. Metaphyseal dysplasias 
10. Spondylometaphyseal dysplasias (SMD) 
11. Spondylo-epi(-meta)physeal dysplasias (SE(M)D) 
12. Severe spondylodysplastic dysplasias 
13. Moderate spondylodysplastic dysplasias (brachyolmias) 
14. Acromelic dysplasias 
15. Acromesomelic dysplasias 
16. Mesomelic and rhizomesomelic dysplasias 
17. Bent bones dysplasias 
18. Slender bone dysplasias 
19. Dysplasias with multiple joint dislocations 
20. Chondrodysplasia punctata (CDP) group 
21. Neonatal osteosclerotic dysplasias 
22. Increased bone density group (without modification of bone 
shape) 
23. Increased bone density group with metaphyseal and/or 
diaphyseal involvement 
24. Decreased bone density group 
25. Defective mineralization group 
26. Lysosomal storage diseases with skeletal involvement 
(dysostosis multiplex group) 
27. Osteolysis group 
28. Disorganized development of skeletal components group 
29. Cleidocranial dysplasia group 
30. Craniosynostosis syndromes and other cranial ossification 
disorders 
31. Dysostoses with predominant craniofacial involvement 
32. Dysostoses with predominant vertebral and costal involvement 
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33. Patellar dysostoses 
34. Brachydactylies (with or without extraskeletal manifestations) 
35. Limb hypoplasia–reduction defects group 
36. Polydactyly-syndactyly-triphalangism group 
37. Defects in joint formation and synostoses 
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Appendix B. Molecular – Pathogenesis Classification of Skeletal 
Dysplasias (Adapted from Rimoin et al. 2007) 
 
Defects in extracellular structural proteins 
COL1A1, COL1A2: Osteogenesis imperfecta 
COL2A1: achondrogenesis type 2, hypochondrogenesis, SEDC, 
SEMD, Kniest, Stickler, Familial osteoarthritis 
COL9A1, COL9A2, COL9A3: Multiple epiphyseal dysplasia 
(MED) 
COL10A1: Metaphyseal dysplasia Schmid 
COL11A1, COL11A2: Oto-spondylo-megaepiphyseal dysplasia 
(OSMED); Stickler (variant), Marshall syndrome 
COMP: Pseudoachondroplasia, MED 
MATN3: Multiple epiphyseal dysplasia (MED) 
Perlecan: Schwartz-Jampel type 1; dyssegmental dysplasia 
Defects in metabolic pathways 
TNSALP (tissue non-specific alkaline phosphatase): 
Hypophosphatasia (several) 
ANKH (pyrophosphate transporter): Craniometaphyseal dysplasia 
DTDST (diastrophic dysplasia sulfate transporter): 
achondrogenesis 1B, atelosteogenesis 2, diastrophic dysplasia, 
autosomal recessive MED (rMED) 
PAPSS2 (phosphoadenosine-phosphosulfate-synthase 2): 
Spondylo-epi-metaphyseal dysplasia Pakistani type 
CHST3 (chondroitin 6-O-sulfotransferase-1): SEMD Omani type 
Defects in folding, processing, transport, and degradation of 
macromolecules 
Sedlin (unknown function): X-linked Spondyloepiphyseal 
dysplasia (SED-XL) 
Cathepsin K (lysosomal proteinase): Pycnodysostosis 
Lysosomal acid hydrolases and transporters: 
Mucopolysaccharidoses, oligosaccharidoses, glycoproteinoses 
Targeting system for lysosomal enzymes (GlcNAc-1-
phosphotransferase): Mucolipidosis II & III 
MMP2 (matrix metalloproteinase 2): Torg type osteolysis 
Tubulin chaperonin E: Kenney-Caffey and Sanjod-Sakati 
syndromes (TBCE) 
EXT1, EXT2: Multiple exostoses syndrome types 1&2 
SH3BP2 (c-Abl-binding protein): Cherubism 
Defects in hormones, growth factors, receptors, and signal 
transduction 
FGFR1: Craniosynostosis syndromes (Pfeiffer) 
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FGFR2: Craniosynostosis syndromes (Apert, Crouzon, Pfeiffer) 
FGFR3: Thanatophoric dysplasia, achondroplasia, 
hypochondroplasia, SADDAN; craniosynostosis syndromes 
ROR-2 (“orphan receptor tyrosine kinase”): AR-Robinow 
syndrome, AD-Brachydactyly type B 
PTH/PTHrP receptor: (activating mutations) Metaphyseal 
dysplasia Jansen, (inactivating mutation) Blomstrand lethal 
dysplasia 
GNAS1 (stimulatory Gs _ protein of adenylate cyclase): 
Pseudohypoparathyroidism (Albright Hereditary Osteodystrophy) 
with constitutional haploinsufficiency mutations, McCune–
Albright syndrome with somatic mosaicism for activating 
mutations 
Defects in nuclear proteins and transcription factors 
SOX9: Campomelic dysplasia 
TRPS1 (zinc-finger gene): Tricho-Rhino-Phalangeal syndromes 
CBFA-1 (runt-type transcription factor): Cleidocranial dysplasia 
LXM1B (LIM homeodomain protein): Nail-patella syndrome 
SHOX (short stature—homeobox gene): Leri–Weill 
dyschondrosteosis, Turner syndrome 
EVC (Leucine-zipper gene): AR-Chondroectodermal dysplasia 
(Ellis-van Creveld), AD-Weyers acrodental dysostosis 
Defects in RNA processing and metabolism 
RMRP: Cartilage-hair-hypoplasia 
SDDS–Schwachman–Diamond syndrome 
Defects in cytoskeletal proteins 
Filamin (actin binding proteins): 
Filamin A: Otopaltodigfital syndromes I & II; frontometaphyseal 
dysplasia; Melnick-Needles 
Filamin B: Spondylocarpotarsal syndrome; Larsen syndrome; 
Atelosteogenesis I/III; Boomerang dysplasia 
Responsible gene identified, but function unknown 
Dymeclin: Dyggve–Melchior–Clausen syndrome; Smith–McCort 
syndrome 
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